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This	  thesis	  describes	  synthetic	  efforts	  towards	  the	  synthesis	  of	  enantiomerically	  pure,	  2-­‐substituted	  
4-­‐hydroxypiperidines	   using	   Negishi	   cross	   coupling	   reactions.	   A	   selection	   of	   α-­‐amino	   acids	   were	  
converted	  into	  protected	  β-­‐amino	  organozinc	  reagents	  I,	  which	  were	  reacted	  with	  α,β-­‐unsaturated	  
acid	  chlorides	  II	  under	  palladium	  catalysis	  to	  give	  a	  range	  of	  amino	  enones	  III,	  in	  moderate	  to	  good	  
yields	  (Scheme	  A).	  
	  




Attempts	   to	   apply	   a	   literature	   cyclisation	  method	   using	   hydrogen	   chloride	   in	   diethyl	   ether	   to	   Boc	  
protected	  amino	  enones	  III	  led	  to	  the	  discovery	  that	  the	  products	  of	  these	  reactions	  are	  actually	  β-­‐
chloroketones	  IV,	  rather	  than	  the	  previously	  reported	  4-­‐oxopiperidinium	  salts	  V	  (Scheme	  B).	  
	  
Scheme	   B.	   Treatment	   of	   amino	   enones	   III	  with	   hydrogen	   chloride	   in	   diethyl	   ether,	   leading	   to	   β-­‐
chloroketones	  IV	  rather	  than	  the	  previously	  reported	  4-­‐oxopiperidinium	  salts	  V.	  
	  
	  
After	   extensive	   experimentation,	   the	   cyclisation	   of	   amino	   enone	   IIIa	   was	   achieved	   through	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  iii	  
protection	  of	  the	  amine	  allowed	  the	  product	  VIa	  to	  be	  isolated,	  albeit	   in	  a	   low	  yield.	  Although	  the	  
desired	   reduction	  of	   4-­‐oxopiperidines	  VI	   could	   not	   be	   investigated	  due	   to	  difficulties	   in	   repeating	  
the	   cyclisation	   reaction,	   the	   deprotection	   of	   compound	  VIa	  was	   achieved,	   producing	   a	   sample	   of	  
methyl	   4-­‐oxo-­‐L-­‐pipecolate	  Va.	   This	   compound	  was	   compared	   to	   the	   product	   of	   the	   treatment	   of	  
compound	  IIIa	  with	  hydrogen	  chloride,	  corroborating	  the	  earlier	  claim	  that	  the	  product	  of	  this	  latter	  
reaction	   was	   in	   fact	   β-­‐chloroketone	   IVa,	   rather	   than	   the	   cyclic	   structure	   Va	   that	   was	   initially	  
expected	  based	  on	  the	  claims	  in	  the	  literature.	  
	  
Scheme	   C.	   Successful	   cyclisation	   of	   amino	   enone	   IIIa	   and	   subsequent	   deprotection	   leading	   to	  
methyl	  4-­‐oxo-­‐L-­‐pipecolate	  Va,	  allowing	  its	  comparison	  with	  compound	  IVa.	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(aq)	   	   aqueous	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Fmoc	   	   9-­‐fluorenylmethyloxycarbonyl	  
HIV	   	   human	  immunodeficiency	  virus	  
HMPA	   	   hexamethylphosphoramide	  
HPLC	   	   high	  performance	  liquid	  chromatography	  
i.e.	   	   that	  is	  
iBu	   	   iso-­‐butyl	  
iPr	   	   iso-­‐propyl	  
IR	   	   infrared	  
L	   	   ligand	  
LA	   	   Lewis	  acid	  
lit.	   	   literature	  
LUMO	   	   lowest	  unoccupied	  molecular	  orbital	  
m	   	   multiplet	  
m.p.	   	   melting	  point	  
M.S.	   	   molecular	  sieves	  
m/z	   	   mass	  to	  charge	  ratio	  
Me	   	   methyl	  
Mr	   	   molecular	  weight	  
MS	   	   mass	  spectrometry	  
nBu	   	   n-­‐butyl	  
NMR	   	   nuclear	  magnetic	  resonance	  
nPr	   	   n-­‐propyl	  
Nu	   	   nucleophile	  
o-­‐tol	   	   ortho-­‐tolyl	  
o/n	   	   overnight	  
P	   	   product	  
	  	  
	  x	  
p-­‐tol	   	   para-­‐tolyl	  
PG	   	   protecting	  group	  
Ph	   	   phenyl	  
phen	   	   phenanthroline	  
Phth	   	   phthaloyl	  
ppm	   	   parts	  per	  million	  
q	   	   quartet	  
R	   	   generic	  group	  
r.t.	   	   room	  temperature	  
Rf	   	   retention	  factor	  
s	   	   singlet	  
sat.	   	   saturated	  
sBu	   	   sec-­‐butyl	  
SM	   	   starting	  material	  
SN2	   	   bimolecular	  nucleophilic	  substitution	  
SPhos	   	   2-­‐dicyclohexylphosphino-­‐2’,6’-­‐dimethoxybiphenyl	  
t	   	   triplet	  
tBu	   	   tert-­‐butyl	  
Tf	   	   trifyl	  (trifluoromethanesulfonyl)	  	  
TFA	   	   trifluoroacetyl	  
TFAA	   	   trifluoroacetic	  anhydride	  
THF	   	   tetrahydrofuran	  
TLC	   	   thin	  layer	  chromatography	  
Tr	   	   trityl	  (triphenylmethyl)	  
Ts	   	   tosyl	  (para-­‐toluenesulfonyl)	  
UV	   	   ultraviolet	  
X	   	   halogen	  (unless	  otherwise	  stated)	  








1.1.1	  Natural	  Occurrence	  of	  4-­‐Hydroxypiperidines	  
	  
The	  piperidine	   ring	   system	   is	   a	   very	   common	   structure	   in	  Nature.1	  Much	  effort	  has	  been	   spent	   in	  
synthesising	   substituted	   piperidines,	   especially	   in	   a	   stereoselective	   manner.2	   One	   group	   of	  
compounds	   within	   the	   piperidine	   family	   are	   the	   4-­‐hydroxypiperidines.	   Although	   less	   commonly	  
encountered	  in	  Nature,	  there	  are	  a	  number	  of	  natural	  products	  that	  contain	  this	  structure	  (Figure	  1).	  
The	  synthesis	  of	  naturally	  occurring	  cis-­‐4-­‐hydroxy-­‐L-­‐pipecolic	  acid	  L-­‐1	  has	  been	  an	  area	  of	  particular	  
interest,3	  one	  of	  the	  reasons	  being	  that	  it	  forms	  part	  of	  the	  HIV-­‐protease	  inhibitor	  Palinavir	  (Figure	  
2).4	  
	  
Figure	  1.	  Examples	  of	  substituted	  4-­‐hydroxypiperidine	  natural	  products.	  
	  
	  




































1.1.2	  Pharmaceutical	  Relevance	  of	  4-­‐Hydroxypiperidines	  
	  
4-­‐Hydroxypiperidines	   are	   small,	   polar,	   chiral	   molecules	   containing	   two	   heteroatoms,	   which	  make	  
them	  attractive	  as	  pharmaceutical	  building	  blocks.	  Their	  small	  size	  means	  that	  they	  can	  be	  attached	  
to	   a	   lead	   compound	   in	   order	   to	   try	   and	   optimise	   its	   properties	   without	   increasing	   the	   overall	  
molecular	  weight	  too	  dramatically.	  This	  is	  an	  important	  consideration	  that	  is	  highlighted	  in	  Lipinski’s	  
Rule	  of	  Five,	  which	  states	  that	  ideal	  oral	  drug	  candidates	  should	  have	  a	  molecular	  weight	  of	  less	  than	  
500	  Daltons.5	  The	  two	  heteroatoms	  allow	  two	  different	  sites	  of	  attachment,	  and	  their	  polarity	  could	  
be	   used	   to	   increase	   the	   water	   solubility	   of	   a	   potential	   drug,	   which	   is	   often	   a	   challenge	   for	   the	  
medicinal	  chemist.	  
	  
When	  4-­‐hydroxypiperidines	   are	   substituted,	   they	  often	  become	   chiral.	   As	   a	   result,	   there	   can	  be	   a	  
large	  number	  of	  different	  stereoisomers	  for	  any	  given	  substituted	  4-­‐hydroxypiperidine.	  For	  example,	  
for	   a	   2-­‐substituted	  4-­‐hydroxypiperidine	   there	   are	   four	  possible	   isomers:	   two	  diastereoisomers	   (cis	  
and	  trans),	  both	  of	  which	  have	  two	  enantiomers	  (Figure	  3).	  	  
	  
Figure	  3.	  The	  four	  possible	  stereoisomers	  for	  every	  2-­‐substituted	  4-­‐hydroxypiperidine.	  
	  
	  
This	  stereochemical	  diversity	  allows	  for	  different	  areas	  of	  chemical	  space	  around	  the	  piperidine	  ring	  
to	  be	  occupied	  by	  the	  substituents.	  This	  is	  important	  when	  optimising	  a	  lead	  compound,	  as	  certain	  
spatial	   configurations	  may	   fit	   better	  with	   the	   desired	   biological	   target.	   This	   point	   is	   supported	   by	  
findings	  from	  Lovering	  and	  co-­‐workers,	  who	  stated	  that	  lead	  compounds	  are	  more	  likely	  to	  progress	  
through	  clinical	   trials	   to	  become	  drugs	   if	   they	  are	  more	   saturated,	  due	   to	   their	   ability	   to	  be	  more	  
three-­‐dimensional	   in	   shape,	   and	   so	   explore	   more	   chemical	   space	   than	   their	   flatter,	   unsaturated	  
analogues.6	  Lovering	  and	  co-­‐workers	  also	  reported	  that	  increased	  saturation	  correlates	  with	  a	  lower	  
melting	   point	   and	   a	   greater	   aqueous	   solubility,	   both	   important	   factors	   for	   the	   success	   of	   a	   drug	  
candidate.	  These	  additional	  benefits	  of	  increased	  saturation	  in	  drug	  molecules	  enhance	  the	  potential	  
usefulness	  of	  substituted	  4-­‐hydroxypiperidines	  as	  pharmaceutical	  building	  blocks.	  
















1.2	  Previous	  Syntheses	  of	  4-­‐Hydroxypiperidines	  
	  
There	  are	  a	  number	  of	  syntheses	  of	  4-­‐hydroxypiperidines	   in	  the	   literature,	  some	  of	  which	  give	  the	  
products	  as	  a	  racemate,	  and	  others	  that	  give	  the	  products	  in	  an	  enantiomerically	  enriched	  form.	  This	  
review	   will	   only	   discuss	   the	   latter,	   as	   these	   are	   of	   much	   greater	   use	   in	   the	   synthesis	   of	   natural	  
products	  or	  molecules	  of	  pharmaceutical	   interest.	   The	   syntheses	   reviewed	  have	  been	  divided	   into	  
different	   categories,	   based	   on	   the	   key	   disconnections	   used	   by	   the	   authors	   (Figure	   4).	   The	  
disconnections	  shown	  are	  numbered	  according	  to	  which	  atoms	  of	  the	  piperidine	  ring	  are	   joined	   in	  
the	  ring-­‐forming	  step.	  In	  some	  cases	  the	  6-­‐membered	  ring	  is	  present	  in	  the	  starting	  material,	  and	  a	  
substituent	  has	  been	  added	  to	  this	  ring;	  these	  have	  been	  designated	  an	  external	  disconnection.	  
	  





1.2.1	  Previous	  Syntheses	  using	  a	  4,5	  Disconnection	  
	  
Of	  the	  many	  syntheses	  of	  substituted	  4-­‐hydroxypiperidines	  found	  in	  the	  literature,	  there	  are	  a	  few	  
which	   involve	  a	  cyclisation	  step	  that	  connects	  together	  carbon	  atoms	  4	  and	  5	  (Figure	  5).	  One	  such	  
example	   has	   been	   reported	   by	   Snaith	   and	   co-­‐workers,	   who	   have	   synthesised	   a	   number	   of	   2,5-­‐
disubstituted	  4-­‐hydroxypiperidines	  using	  carbonyl	  ene	  and	  Prins	  cyclisation	  reactions.7-­‐9	  
	  



























1.2.1.1	  Snaith	  and	  co-­‐workers	  
	  
The	   cyclisation	   precursors	   2	   were	   synthesised	   in	   good	   yields	   over	   4	   steps	   from	   a	   range	   of	  
enantiomerically	   pure	   β-­‐amino	   alcohols.	   Compounds	   2	   were	   then	   subjected	   to	   carbonyl	   ene	  
cyclisation	  conditions	  with	  one	  equivalent	  of	  MeAlCl2	  acting	  as	  a	  Lewis	  acid	  (Scheme	  1).7-­‐8	   In	  every	  
case	  the	  trans	  diastereoisomer	  3	  was	  produced	  as	  the	  major	  product,	  along	  with	  a	  small	  amount	  of	  
the	  cis	  diastereoisomer	  4.	  
	  
Scheme	  1.	  Lewis	  acid	  mediated	  carbonyl	  ene	  cyclisation	  of	  compounds	  2.	  
	  
	  
The	   diastereoselectivity	   of	   these	   reactions	   arises	   from	   a	   combination	   of	   factors.	   Under	   the	  
equilibrating	   reaction	  conditions,	   the	   thermodynamic	  product	  3	   is	   favoured.	  This	  product	  contains	  
both	  the	  alkene	  and	  alcohol	  groups	  in	  the	  more	  stable	  equatorial	  orientation	  (Figure	  6).	  At	  the	  same	  
time	  the	  R	  group	  prefers	  to	  adopt	  an	  axial	  orientation	  so	  as	  to	  avoid	  the	  pseudo	  1,3-­‐allylic	  strain	  with	  
the	  tosyl	  group.8,10	  Equilibration	  to	  the	  thermodynamic	  product	  3	  occurs	  even	  at	  room	  temperature,	  
as	   the	   conversion	   of	   conformer	   5-­‐ax	   to	   conformer	   5-­‐eq	   also	   lessens	   the	   strain	   present	   in	   the	  
transition	  state,	  which	  results	  from	  the	  1,3-­‐diaxial	  interaction	  between	  the	  aldehyde	  coordinated	  to	  
the	   Lewis	   acid	   and	   the	   R	   group	   in	   conformer	   5-­‐ax.	   This	   factor	   also	   favours	   the	   production	   of	  












1 M MeAlCl2 in hexane
CH2Cl2 or CHCl3, reflux
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Figure	  6.	  Rationale	  for	  the	  diastereoselectivity	  of	  the	  Lewis	  acid	  mediated	  cyclisation	  of	  compounds	  
2.	  
	   	  
	  
When	  the	  same	  precursor	  molecules	  were	  cyclised	   in	  the	  presence	  of	  a	  Brønsted	  acid,	   in	  this	  case	  
hydrochloric	  acid,	  the	  opposite	  diastereoselectivity	  was	  generally	  observed,	  with	  the	  major	  product	  
containing	  the	  isopropenyl	  group	  and	  the	  alcohol	  cis	  to	  each	  other	  (Scheme	  2).7-­‐8	  
	  
Scheme	  2.	  Brønsted	  acid	  mediated	  Prins	  cyclisation	  of	  compounds	  2.	  
	  
	  
The	  observed	  diastereoselectivity	   in	  favour	  of	  the	  cis	  product	   is	  explained	  by	  invoking	  a	  concerted,	  
asynchronous	  Prins	   cyclisation	  mechanism.9	   If	   the	  mechanism	  were	   fully	   stepwise,	   addition	  of	   the	  
alkene	  onto	  the	  aldehyde	  would	  give	  cationic	  intermediate	  6	  (Figure	  7).	  The	  positive	  charge	  could	  be	  
stabilised	   by	   one	   of	   the	   lone	   pairs	   on	   the	   oxygen	   atom,	   which	   can	   either	   by	   cis	   or	   trans	   to	   the	  






















major product 3 - trans




















22:78 ≤ 3:4 ≤ 6:94
.
41–42% of 4
53:47 ≤ 3:4 ≤ 46:54
R = Me, iPr, Bn
R = tBu, Ph
	  	  
	  6	  
appear	  similar,	  Snaith	  and	  co-­‐workers	  have	  shown	  through	  calculations	  at	  the	  B3LYP/6-­‐31G(d)	  level	  
of	  theory	  that	  when	  R	  =	  H	  the	  6-­‐cis	  carbocation	  is	  more	  stable	  than	  the	  6-­‐trans	  carbocation	  by	  0.82	  
kcal.	   Although	   they	   readily	   admit	   that	   this	   difference	   is	   too	   small	   to	   completely	   account	   for	   the	  
diastereoselectivity	   of	   this	   cyclisation,	   they	   do	   suggest	   that	   these	   calculations	   go	   some	   way	   to	  
explaining	  the	  observed	  cis	  selectivity.	  
	  
Figure	   7.	   Rationale	   for	   the	   diastereoselectivity	   of	   the	   Brønsted	   acid	   mediated	   cyclisation	   of	  
compounds	  2,	  based	  on	  carbocation	  stabilities.	  
	  
	  
This	  explanation	  is	  also	  consistent	  with	  the	  observed	  reduction	  in	  diastereoselectivity	  as	  the	  R	  group	  
increases	   in	   size.7-­‐8	  More	  bulky	  R	  groups	  experience	  a	  greater	  degree	  of	  1,3-­‐diaxial	   strain	  with	   the	  
alcohol	  group	  in	  carbocation	  6-­‐cis.	  Significant	  amounts	  of	  the	  trans	  product	  3	  were	  formed	  for	  both	  
the	   tert-­‐leucinol	   and	   phenylglycinol	   derived	   products,	   which	   contain	   the	   bulky	   tert-­‐butyl	   and	   the	  
relatively	   bulky	   phenyl	   groups	   respectively.	   In	   all	   of	   these	   cases	   the	   R	   group	   is	   placed	   in	   an	   axial	  
orientation	  so	  as	  to	  avoid	  pseudo	  1,3-­‐allylic	  strain	  with	  the	  tosyl	  group,	  as	  previously	  explained.	  
	  
	  
1.2.2	  Previous	  Syntheses	  using	  a	  1,6	  Disconnection	  
	  
A	   much	   more	   common	   disconnection	   that	   has	   been	   made	   in	   order	   to	   construct	   substituted	   4-­‐
hydroxypiperidines	   is	  between	  the	  nitrogen	  atom	  and	  carbon	  number	  6	  (Figure	  8).	  The	  majority	  of	  
the	  methods	  reviewed	  here	  chose	  to	  first	  form	  a	  4-­‐oxopiperidine	  before	  subsequently	  reducing	  the	  






















minor product 3 - trans











Figure	  8.	  A	  1,6	  disconnection	  used	  to	  construct	  substituted	  4-­‐hydroxypiperidines.	  
	  
	  
1.2.2.1	  Sutherland	  and	  co-­‐workers	  
	  
Sutherland	  and	  co-­‐workers	  have	  reported	  the	  synthesis	  of	  a	  range	  of	  substituted	  enones	  7	   from	  L-­‐
aspartic	   acid	   using	   a	  Horner-­‐Wadsworth-­‐Emmons	   reaction.11-­‐12	   Treatment	   of	   these	   enones	  7	  with	  
trifluoroacetic	   acid	   removed	   the	   trityl	   protecting	   group	   to	   give	   the	   free	   amines	   as	   their	  
trifluoroacetate	  salts	  (Scheme	  3),	  which	  were	  then	  reacted	  with	  benzaldehyde	  to	  yield	  benzyl	  imines	  
8.11	   Reaction	   with	   sodium	   cyanoborohydride	   allowed	   both	   reduction	   of	   the	   imine	   group	   and	  
conjugate	  addition	  of	  the	  resulting	  amine	  to	  yield	  the	  trans	  6-­‐substituted	  4-­‐oxopipecolic	  acids	  9	  as	  
single	  diastereoisomers.	  
	  






















29–53% over 3 steps
single diastereoisomer
CF3CO2H











Similarly,	   treatment	   of	   enones	   7	   with	   hydrochloric	   acid	   yielded	   the	   free	   amines	   as	   their	  
hydrochloride	  salts,	  which	  were	  then	  cyclised	  using	  Hünig’s	  base	  to	  give	  the	  cis	  diastereoisomers	  10	  
as	  the	  major	  products	  (Scheme	  4).12	  
	  
Scheme	  4.	  Synthesis	  of	  cis	  6-­‐substituted	  pipecolic	  acid	  derivatives	  10.	  
	  
	  
The	   authors	   justified	   the	   selectivity	   of	   these	   cyclisations	   based	   on	   the	   chair-­‐like	   conformations	  
adopted	   by	   the	   molecules.	   During	   the	   cyclisation	   of	   compounds	   8,	   both	   the	   benzyl	   imine	   and	   R	  
group	  are	  placed	  in	  pseudo-­‐equatorial	  positions,	  whilst	  the	  ester	  group	  is	  positioned	  pseudo-­‐axial	  to	  
avoid	   1,3-­‐allylic	   strain	   with	   the	   imine	   (Figure	   9).	   This	   leads,	   after	   reduction	   of	   the	   imine	   and	  
subsequent	  cyclisation,	  to	  the	  trans	  diastereoisomer	  9	  preferentially.	  
	  
Figure	  9.	  Rationale	  for	  the	  diastereoselectivity	  of	  the	  reduction/cyclisation	  of	  compounds	  8.	  	  
	  
	  
A	  chair-­‐like	  conformation	  is	  also	  proposed	  for	  the	  base	  mediated	  cyclisation	  of	  free	  amines	  11.	  Both	  
the	  ester	  and	  R	  group	  are	  placed	  in	  pseudo-­‐equatorial	  positions	  (Figure	  10),	  which	  leads	  primarily	  to	  
the	  cis	  diastereoisomer	  10.	  
	  









































Both	  the	  cis	  and	  trans	  6-­‐substituted	  4-­‐oxopipecolic	  acids	  were	  reduced	  diastereoselectively	  to	  give	  
the	   equatorial	   alcohols,	   using	   sodium	   borohydride	   or	   sodium	   triacetoxyborohydride	   respectively	  
(Scheme	  5).11-­‐12	  
	  
Scheme	  5.	  Diastereoselective	  reduction	  of	  cis	  and	  trans	  6-­‐substituted	  4-­‐oxopipecolic	  acids	  9	  and	  10.	  
	  
	  
1.2.2.2	  Georg	  and	  co-­‐workers	  
	  
Another	   research	   group	   to	   use	   the	   1,6	   disconnection	   is	   that	   of	   Georg	   and	   co-­‐workers,	   who	   have	  
developed	  a	  synthesis	  of	  substituted	  2,3-­‐dihydro-­‐4-­‐pyridones	  12	  from	  amino	  ynones	  13.13	  Although	  
the	  authors	  did	  not	  convert	  these	  products	  into	  4-­‐hydroxpiperidines,	  this	  could	  easily	  be	  envisioned	  
by	  reduction	  of	  both	  the	  alkene	  and	  ketone	  functional	  groups	  in	  compounds	  12.	  	  
	  
The	  required	  ynones	  13	  were	  synthesised	  by	  the	  addition	  of	  an	  alkynyl	  Grignard	  reagent	  to	  Weinreb	  
amides	   14	   (Scheme	   6),	   which	   themselves	   were	   derived	   from	   α-­‐	   or	   β-­‐amino	   acids.	   The	   general	  
strategy	   involves	   an	   acidic	   deprotection	   of	   the	   tert-­‐butoxycarbonyl	   group	   followed	   by	   a	   base	  

































Scheme	   6.	   General	   synthesis	   of	   substituted	   2,3-­‐dihydro-­‐4-­‐pyridones	  12	   from	   amino	   acid	   derived	  
Weinreb	  amides	  14.	  
	  
	  
Two	  complementary	  nitrogen	  deprotection	  methods	  were	  disclosed,	  either	  using	  hydrogen	  chloride	  
in	  dioxane	  or	  formic	  acid	  combined	  with	  sodium	  iodide.	  The	  presence	  of	  a	  halide	  ion	  was	  required	  as	  
these	   were	   found	   to	   add	   to	   the	   ynone	   to	   form	   various	   β-­‐haloketones	   (Scheme	   7).	   When	   the	  
deprotection	  was	  carried	  out	  without	   the	  halide	  anion,	   the	  desired	  cyclisation	  proved	  either	   to	  be	  
low	  yielding	  or	  unsuccessful.	  
	  
Scheme	  7.	  Acidic	  deprotection	  of	  amino	  ynones	  13	  to	  yield	  various	  β-­‐haloketones.	  
	  
	  
Once	  formed,	  the	  β-­‐haloketones	  were	  cyclised	  using	  potassium	  carbonate	  in	  methanol	  (Scheme	  8).	  If	  
hydrogen	   chloride	   had	   been	   used	   previously	   and	   the	   β-­‐dichloroketone	  was	   present,	   this	  was	   first	  
converted	  to	  the	  β-­‐chloroenone.	  Regardless	  of	  which	  β-­‐haloenone	  was	  present,	  these	  underwent	  a	  










































































Scheme	  8.	  Base-­‐promoted	  cyclisation	  of	  β-­‐haloenones	  to	  give	  2,3-­‐dihydro-­‐4-­‐pyridones	  12.	  
	  
	  
One	  problem	  encountered	   in	   this	   synthesis	  was	  epimerization	  of	  both	   the	  α-­‐	  and	  β-­‐stereocentres,	  
which	   occurred	   in	   a	   number	   of	   cases.	   Some	   of	   the	   issues	   resulting	   from	   acid	   mediated	   α-­‐
epimerisation	   could	   be	   overcome	   by	   changing	   the	   deprotection	  method	   from	   the	   strongly	   acidic	  
hydrogen	   chloride	   to	   the	   weaker	   formic	   acid.	   However,	   for	   the	   slower	   cyclisation	   reactions	   of	  
internal	  ynones,	  base	  induced	  β-­‐amino	  elimination	  proved	  a	  significant	  problem	  (Scheme	  9).	  When	  
R1	   was	   not	   tethered	   to	   some	   other	   part	   of	   the	   molecule,	   β-­‐amino	   elimination	   resulted	   in	   the	  
irreversible	  loss	  of	  R1NH2	  from	  the	  starting	  material,	  giving	  a	  lower	  yield	  of	  2,3-­‐dihydro-­‐4-­‐pyridone.	  
	  
Scheme	  9.	  Base	  induced	  β-­‐amino	  elimination	  of	  intermediate	  β-­‐haloenones.	  
	  
	  
In	  conclusion,	  depending	  on	  the	  exact	  nature	  of	  the	  substitution	  of	  the	  starting	  material,	  Georg	  and	  
co-­‐workers	  have	  provided	  methodology	   that	  gives	   the	  desired	  substituted	  2,3-­‐dihydro-­‐4-­‐pyridones	  
12	   in	   yields	   ranging	   from	   50	   to	   99%.	   The	   products	   were	   isolated	   with	   diastereomeric	   ratios	   or	  




























































1.2.2.3	  Gouault	  and	  co-­‐workers	  
	  
In	  2011,	  Gouault	  and	  co-­‐workers	  reported	  a	  gold(I)-­‐catalysed	  cyclisation	  of	  a	  range	  of	  α-­‐amino	  acid	  
derived	   ynones	   15	   to	   give	   2,6-­‐disubstituted	   2,3-­‐dihydro-­‐4-­‐pyridones	   16	   in	   good	   yields	   (Scheme	  
10).14	  
	  
Scheme	  10.	  Gold(I)-­‐catalysed	  cyclisation	  of	  amino	  ynones	  15	  to	  give	  2,3-­‐dihydro-­‐4-­‐pyridones	  16.	  
	  
	  
This	  methodology	  was	  used	  to	  synthesise	  both	  enantiomers	  of	  the	  natural	  product	  241D	  (Figure	  11)	  
by	   removal	   of	   the	   protecting	   group	   and	   stereoselective	   hydrogenation	   of	   both	   the	   alkene	   and	  
ketone	  functional	  groups.15	  
	  
Figure	  11.	  Both	  enantiomers	  of	  natural	  product	  241D	  synthesised	  by	  Gouault	  and	  co-­‐workers.	  
	  
	  
Gouault	   and	   co-­‐workers	   have	   recently	   published	   an	   extension	   of	   this	   methodology	   involving	   the	  
synthesis	   of	   6-­‐substituted	   4-­‐hydroxypipecolates.16	   As	   before	   the	   key	   step	   was	   a	   gold(I)-­‐catalysed	  
cyclisation,	   in	   this	   case	  performed	  on	   L-­‐aspartic	   acid	  derived	   ynones	  17	   (Scheme	  11).	   For	   internal	  
alkynes	  17a	  and	  17b,	  very	  good	  yields	  of	  the	  desired	  2,3-­‐dihydro-­‐4-­‐pyridones	  were	  achieved	  using	  
Ph3PAuNTf2	   as	   the	   catalyst.	   However,	   the	   cyclisation	   of	   terminal	   alkyne	   17c	   proved	   much	   more	  

















R1 = H, Me, iBu, Bn, CH2OBn, sBu
R2 = Ph, nPr, nC9H19














Scheme	  11.	  Gold(I)-­‐catalysed	  cyclisation	  of	  amino	  ynones	  17	  to	  give	  2,3-­‐dihydro-­‐4-­‐pyridones	  18.	  
	  
	  
Due	   to	   the	   low	   yield	   obtained	   in	   the	   gold-­‐catalysed	   cyclisation	   of	   the	   terminal	   alkyne	   17c,	   the	  
authors	  instead	  applied	  the	  conditions	  reported	  by	  Georg	  and	  co-­‐workers.13	  These	  conditions	  proved	  
effective,	   and	   after	   Boc	   protection	   the	   desired	   2,3-­‐dihydro-­‐4-­‐pyridone	  18c	   was	   isolated	   in	   a	   75%	  
yield	  (Scheme	  12).	  
	  
Scheme	  12.	  Application	  of	  Georg	  and	  co-­‐workers’	  conditions	  to	  enable	  the	  cyclisation	  of	  alkyne	  17c.	  
	  
	  
With	   the	   desired	   2,3-­‐dihydro-­‐4-­‐pyridones	   in	   hand,	   Gouault	   and	   co-­‐workers	   then	   went	   on	   to	  
investigate	   the	   chemoselective	   and	   diastereoselective	   reductions	   of	   these	   compounds	   in	   order	   to	  
access	  6-­‐substituted	  4-­‐hydroxypipecolates.	  Through	  careful	  choice	  of	  conditions	  for	  the	  reductions,	  
they	  were	  able	  to	  synthesise	  both	  epimers	  of	  the	  resulting	  cis	  2,6-­‐disubstituted	  4-­‐hydroxypiperidines	  
19	  and	  20	  in	  good	  yields	  (Scheme	  13).	  All	  of	  these	  reductions	  proceeded	  to	  give	  the	  products	  with	  
diastereomeric	   ratios	   of	   90:10	   or	   greater,	  with	   the	   exception	   of	   the	   synthesis	   of	   compound	  20b,	  











R = nPr, X = NTf2, 18a, 97%
R = Ph, X = NTf2, 18b, 95%
R = H, X = OTf, 18c, 33%
R = nPr, 17a 
R = Ph, 17b








i) 3 M HCl/EtOAc
ii) K2CO3, MeOH
iii) (Boc)2O, iPr2NEt






Scheme	  13.	  Synthesis	  of	  two	  sets	  of	  epimeric	  6-­‐substituted	  4-­‐hydroxypipecolates	  by	  reduction	  of	  the	  
corresponding	  2,3-­‐dihydro-­‐4-­‐pyridones	  18.	  
	  
	  
In	   order	   to	   access	   trans	   2,6-­‐disubstituted	   4-­‐hydroxypiperidines,	   the	   authors	   next	   investigated	   the	  
reactivity	   of	   unsubstituted	   compound	   18c	   (Scheme	   14).	   Copper-­‐catalysed	   conjugate	   addition	   of	  
nPrMgCl	  yielded	  the	  trans	  6-­‐disubstituted	  4-­‐oxopipecolate	  21	  as	  a	  single	  diastereoisomer.	  Following	  
this,	  reduction	  of	  the	  ketone	  with	  NaBH4	  at	  −90	  °C	  favoured	  production	  of	  epimer	  22,	  whereas	  the	  
use	  of	  NaBH4	  in	  combination	  with	  CeCl3	  gave	  an	  excess	  of	  the	  other	  diastereoisomer	  23.	  
	  















R = nPr, Ph
1.) NaBH4, MeOH
2.) H2, Pd/C, MeOH
1.) H2, Pd/C, MeOH
2.) NaBH4, MeOH, 0 °C
1.) NaBH4, CeCl3
     MeOH, 0 °C
2.) H2, Pd/C, MeOH
or
R = nPr, 19a, 66–71%
R = Ph, 19b, 68–77%
R = nPr, 20a, 86%






















reducing agent = NaBH4, 65%, 22:23 = 66:34
22 23







1.2.2.4	  Davis	  and	  co-­‐workers	  
	  
Davis	   and	   co-­‐workers	   have	   also	   used	   a	   1,6	   disconnection	   to	   synthesise	   a	   number	   of	   4-­‐
hydroxypiperidine	   containing	   natural	   products	   from	   N-­‐sulfinyl	   δ-­‐amino	   β-­‐keto	   esters	  24	   (Scheme	  
15).17-­‐19	   The	   important	   chiral	   amine	   functionality	   present	   in	   these	   molecules	   was	   installed	   by	   a	  
diastereoselective	  addition	  of	  an	  enolate	  to	  the	  required	  N-­‐sulfinyl	  imines	  25,	  directed	  by	  the	  chiral	  
sulfinyl	   group	   (Scheme	   15).17-­‐21	   The	   diastereomeric	   ratio	   of	   the	   products	   from	   this	   addition	   was	  
greater	  than	  98:2	  in	  all	  cases.	  
	  
Scheme	  15.	  Some	  N-­‐sulfinyl	  δ-­‐amino	  β-­‐keto	  esters	  24	  synthesised	  by	  Davis	  and	  co-­‐workers.	  
	  
	  
Compound	   (+)-­‐24a	   was	   used	   to	   synthesise	   trans-­‐4-­‐hydroxy-­‐D-­‐pipecolic	   acid	   D-­‐26	   (Scheme	   18).17	  
Zn(BH4)2	  was	  used	  to	  reduce	  compound	   (+)-­‐24a	  to	  give	  syn	  alcohol	  27	   in	  a	  77:23	  mixture	  with	   its	  
diastereoisomer,	  the	  anti	  alcohol.	  After	  separation	  of	  these	  compounds	  by	  column	  chromatography,	  
removal	   of	   the	   sulfinyl	   group	   from	   syn	   alcohol	   27	   and	   base	   mediated	   cyclisation	   gave	   trans-­‐6-­‐
phenyl-­‐4-­‐hydroxypiperidin-­‐2-­‐one	  28.	   Subsequent	   reduction	  of	   the	  amide	  using	   LiAlH4,	   followed	  by	  


































Scheme	  16.	  Synthesis	  of	  trans-­‐4-­‐hydroxy-­‐D-­‐pipecolic	  acid	  D-­‐26	  from	  compound	  (+)-­‐24a.	  
	  
	  
The	  reduction	  of	  N-­‐sulfinyl	  δ-­‐amino	  β-­‐keto	  ester	  (+)-­‐24a	  is	  stereoselective	  because	  of	  the	  influence	  
of	  the	  existing	  amino	  stereocentre.	  The	  zinc	  coordinates	  to	  both	  the	  amine	  and	  the	  carbonyl	  groups,	  
giving	   two	   possible	   half-­‐chair	   conformations	   (Figure	   12).	   Hydride	   delivery	   in	   these	   half-­‐chair	  
conformations	  comes	   from	  the	   top	   face,	   so	  as	   to	  proceed	  via	   the	  more	   stable	  chair-­‐like	   transition	  
state,	   compared	   to	   the	   twist	   boat	   transition	   state	   that	  would	   occur	   if	   the	   hydride	  were	   delivered	  
from	   the	   bottom	   face.	   External	   hydride	   delivery	   occurs	   preferentially	   to	   conformer	   29-­‐eq,	   as	   in	  
conformer	   29-­‐ax	   the	   incoming	   hydride	   experiences	   a	   steric	   clash	   with	   the	   pseudo-­‐axial	   phenyl	  



















































Figure	  12.	  Rationale	  for	  the	  observed	  diastereoselective	  reduction	  of	  compound	  (+)-­‐24a.	  
	  
	  
The	  alkaloid	   (−)-­‐SS	  20846	  A	  was	  also	   synthesised	  by	  Davis	  and	  co-­‐workers	  using	   this	  methodology	  
(Scheme	  17).18	   This	   synthesis	   involved	   the	  diastereoselective	   reduction	  of	   the	   related	  N-­‐sulfinyl	  δ-­‐
amino	  β-­‐keto	  ester	  (−)-­‐24c	  using	  Zn(BH4)2.	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i) Separation of 
   diastereoisomers
ii) CF3CO2H, MeOH
iii) NaHCO3 (aq), THF
LiAlH4
THF, −78 °C to r.t.






Davis	   and	   co-­‐workers	   have	   also	   synthesised	   cis-­‐4-­‐hydroxy-­‐D-­‐pipecolic	   acid	   D-­‐1	   from	   N-­‐sulfinyl	   δ-­‐
amino	  β-­‐keto	  ester	  (+)-­‐24a	  by	  reversing	  the	  order	  of	  the	  ketone	  reduction	  and	  cyclisation	  steps	   in	  
the	  synthetic	  strategy	  (Scheme	  18).17	  After	  removal	  of	  the	  sulfinyl	  group,	  ammonium	  salt	  30a	  was	  
cyclised	   using	   NaHCO3,	   resulting	   in	   6-­‐phenylpiperidin-­‐2,4-­‐one	   31.	   The	   ketone	   was	   then	   reduced	  
stereoselectively	   using	   NaBH4	   to	   give	   cis-­‐6-­‐phenyl-­‐4-­‐hydroxypiperidin-­‐2-­‐one	   32,	   with	   a	  
diastereomeric	   ratio	   of	   97:3.	   The	   amide	   was	   reduced	   using	   LiAlH4,	   with	   diastereomerically	   pure	  
product	  33	  being	  isolated	  after	  column	  chromatography.	  This	  compound	  was	  converted	  into	  cis-­‐4-­‐
hydroxy-­‐D-­‐pipecolic	   acid	  D-­‐1	   in	   the	   same	  manner	   as	   previously	   described	   for	   compound	  28	   (see	  
Scheme	  16,	  p16).	  
	  
Scheme	  18.	  Synthesis	  of	  cis-­‐4-­‐hydroxy-­‐D-­‐pipecolic	  acid	  D-­‐1	  from	  compound	  (+)-­‐24a.	  
	  
	  
By	  applying	  the	  previously	  described	  chemistry	  to	  the	  other	  enantiomer	  of	  the	  starting	  material,	  N-­‐
sulfinyl	   δ-­‐amino	   β-­‐keto	   ester	   (−)-­‐24a,	   Davis	   and	   co-­‐workers	  were	   also	   able	   to	   synthesise	   cis-­‐	  and	  
trans-­‐4-­‐hydroxy-­‐L-­‐pipecolic	  acid	  L-­‐1	  and	  L-­‐26.17	  
	  
	  
1.2.3	  Previous	  Syntheses	  using	  a	  5,6	  Disconnection	  
	  
Davis	  and	  co-­‐workers	  have	  also	  adapted	  their	  strategy	  outlined	  above	  to	  produce	  2,6-­‐disubstituted	  

















































Figure	  13.	  A	  5,6	  disconnection	  used	  to	  construct	  substituted	  4-­‐hydroxypiperidines.	  
	  
	  
Since	  5-­‐10%	  of	  N-­‐sulfinyl	  δ-­‐amino	  β-­‐keto	  ester	  (+)-­‐24b	  exists	  in	  its	  enol	  form,	  the	  authors	  proposed	  
that	  it	  would	  be	  possible	  to	  perform	  an	  intramolecular	  Mannich	  reaction	  between	  this	  enol	  and	  the	  
iminium	   ion	  34,	   formed	   by	   the	   condensation	   of	   acetaldehyde	  with	   compound	  30b	   (Scheme	   19).	  
This	   did	   indeed	   occur,	   and	   the	   cyclised	   product	   35	   was	   isolated	   in	   good	   yield	   as	   a	   single	  
diastereoisomer.	  
	  




The	  stereoselectivity	  of	   this	  Mannich	   reaction	  arises	   from	  the	   relative	  stability	  of	   the	   two	  possible	  
transition	  states	  that	  place	  both	  the	  large	  R	  group	  and	  the	  carbomethoxy	  group	  in	  pseudo-­‐equatorial	  
positions	   (Figure	  14).	  These	  differ	   in	   the	  orientation	  of	   the	  methyl	   substituent	  of	   the	   iminium	   ion:	  
the	  more	   stable	   transition	   state	  34-­‐enol-­‐eq	   also	   places	   the	  methyl	   group	   in	   a	   pseudo-­‐equatorial	  



















































axial	  position.	  Reaction	  through	  the	  more	  stable	  transition	  state	  34-­‐enol-­‐eq	   leads	  to	  the	  observed	  
product	  35.	  
	  
Figure	  14.	  Rationale	  for	  the	  diastereoselectivity	  of	  the	  Mannich	  reaction.	  
	   	  
	  
Subsequent	  hydrogenation,	  decarboxylation	  and	  reduction	  of	  compound	  35	  gave	  alkaloid	  (+)-­‐241	  D	  
(Scheme	  20).	  
	  
































































1.2.4	  Previous	  Syntheses	  using	  a	  2,3	  Disconnection	  
	  
1.2.4.1	  Troin,	  Canet	  and	  co-­‐workers	  
	  
A	   similar	   intramolecular	  Mannich	   type	   reaction	   has	   been	   used	   by	   Troin,	   Canet	   and	   co-­‐workers	   to	  
synthesise	  a	  wide	   variety	  of	   4-­‐hydroxypiperidines	   via	   the	   corresponding	  4-­‐oxopiperidines	   (Scheme	  
21).22-­‐28	  Due	  to	  the	  position	  of	  the	  substituents,	  this	  is	  classed	  as	  a	  2,3	  disconnection	  (Figure	  15).	  
	  
Scheme	  21.	  General	  synthesis	  of	  4-­‐hydroxypiperidines	  by	  Troin,	  Canet	  and	  co-­‐workers.	  
	  
	  
Figure	  15.	  A	  2,3	  disconnection	  used	  to	  construct	  substituted	  4-­‐hydroxypiperidines.	  
	  
	  
In	   this	   reaction	   an	   acetal	   protected	   4-­‐oxo	   amine	   36	   reacts	   with	   an	   aldehyde	   to	   form	   imine	   38	  
(Figure	  16).22-­‐25	  Under	  the	  acidic	  reaction	  conditions	  the	  imine	  is	  protonated	  and	  the	  acetal	  group	  is	  
converted	   to	  enol	   ether	  39,	  which	   then	   cyclises	  onto	   the	   iminium	   ion.	   Finally,	   reformation	  of	   the	  















































Figure	  16.	  Mechanism	  of	  the	  Mannich	  type	  reaction	  between	  compounds	  36	  and	  an	  aldehyde.	  
	  
	  
If	   there	   is	   a	   substituent	   in	   the	   α-­‐position	   of	   the	   starting	   amine	   36	   (i.e.	   R4	   ≠	   H),	   then	   the	  
stereochemistry	  of	  the	  R1	  group	  at	  the	  2-­‐position	  of	  the	  piperidine	  is	  induced	  during	  the	  cyclisation.	  
There	  are	  two	  possible	  transition	  states	  that	  place	  the	  R1	  group	  in	  the	  more	  stable	  pseudo-­‐equatorial	  
position:	   39a	   and	   39b	   (Figure	   17).	   Conformer	   39b	   is	   disfavoured	   due	   to	   the	   1,3-­‐diaxial	   strain	  
between	  the	  R4	  group	  and	  the	  hydrogen	  from	  the	  aldehyde.22	  For	  this	  reason	  conformer	  39a,	  where	  
the	  R4	  group	  is	  in	  a	  pseudo-­‐equatorial	  position,	  is	  favoured,	  which	  leads	  to	  the	  cis-­‐2,6-­‐disubstituted	  
piperidine.	   The	   stereochemistry	   of	   the	   remaining	   two	   stereocentres	   (R2	   and	   R3)	   is	   set	   during	   the	  
acidic	   acetal	   deprotection	   step,	   where	   equilibration	   occurs	   to	   give	   the	   more	   thermodynamically	  














































Figure	  17.	  Rationale	   for	  the	  stereochemistry	   induced	  at	  the	  2-­‐position	  of	   the	  piperidine	  during	  the	  
Mannich-­‐type	  reaction	  (substituents	  R2	  and	  R3	  omitted	  for	  clarity).	  
	   	  
	  
Since	   this	   cyclisation	  process	   is	   diastereoselective,	   beginning	  with	   an	  enantiomerically	  pure	  amine	  
leads	   to	   an	   enantiomerically	   enriched	   product.	   Troin	   and	   co-­‐workers	   have	   synthesised	   both	  
enantiomers	  of	   the	  natural	  alkaloid	  241	  D	  using	   this	  methodology,24	  as	  well	  as	  cis,cis-­‐4-­‐hydroxy-­‐6-­‐
trifluoromethyl	  -­‐L-­‐pipecolic	  acid	  (Figure	  18).25	  
	  
Figure	  18.	  Some	  alkaloids	  prepared	  by	  Troin	  and	  co-­‐workers.	  
	  
	  
In	   a	   related	  method,	   Troin,	   Canet	   and	   co-­‐workers	   used	   chiral,	   non-­‐racemic	   iron	   tricarbonyl	   diene	  


























major product 37 - cis





























The	  iron	  tricarbonyl	  group	  acts	  as	  a	  directing	  group	  for	  the	  cyclisation,26-­‐27	  since	  it	  blocks	  one	  face	  of	  
the	  imine	  formed	  during	  the	  reaction.	  There	  are	  two	  possible	  conformations	  in	  which	  this	  imine	  can	  
exist,	  which	  differ	  in	  the	  orientation	  of	  the	  imine	  with	  respect	  to	  the	  diene	  (Figure	  19).	  The	  transoid	  
conformation	   is	  more	  stable	  than	  the	  cisoid	  conformation,	  since	   in	  conformer	  41-­‐cisoid	   there	   is	  a	  
steric	  clash	  between	  the	   iminium	  hydrogen	  and	  one	  of	   the	  hydrogen	  atoms	  on	  the	  diene.	  For	   this	  
reason	  the	  major	  product	  is	  the	  (2S)-­‐isomer.	  	  
	  



















































minor product - (2R) major product - (2S)
n = 1, 2
	  	  
	  25	  
This	  methodology	  has	  been	  used	  to	  prepare	  the	  natural	  products	  (+)-­‐	  and	  (−)-­‐dienomycin	  and	  (−)-­‐SS	  
20846	  A	  (Figure	  20).27-­‐28	  
	  





1.2.5	  Previous	  Syntheses	  using	  an	  External	  Disconnection	  
	  
All	   of	   the	   previous	   syntheses	   reviewed	   so	   far	   have	   constructed	   the	   piperidine	   ring	   during	   the	  
synthesis.	   However,	   there	   have	   been	   a	   number	   of	   syntheses	   of	   substituted	   4-­‐hydroxpiperdines	  
where	   the	   6-­‐membered	   ring	   is	   already	   present	   in	   the	   starting	  material,	   and	   the	   substituents	   are	  
added	  during	  the	  synthesis.	  For	  the	  purposes	  of	  this	  review	  this	  methodology	  has	  been	  classified	  as	  
an	  external	  disconnection	  (Figure	  21).	  	  
	  
Figure	  21.	  An	  external	  disconnection	  used	  to	  construct	  substituted	  4-­‐hydroxypiperidines.	  
	  
	  
1.2.5.1	  Comins	  and	  co-­‐workers	  
	  
All	   of	   the	   syntheses	  of	   4-­‐hydroxypiperidines	   reviewed	   that	   employ	   the	   external	   disconnection	   are	  
based	  on	  Comins	  and	  co-­‐workers’	  methodology.	  In	  1986,	  Comins	  and	  co-­‐workers	  were	  first	  to	  report	  
the	  synthesis	  of	  2-­‐substituted	  2,3-­‐dihydro-­‐4-­‐pyridones	  42	  by	  the	  addition	  of	  Grignard	  reagents	  to	  N-­‐






























Comins	  and	  co-­‐workers	  also	  published	  a	  stereoselective	  variant	  of	  this	  reaction.30-­‐31	  They	  found	  that	  
the	   (−)-­‐8-­‐phenylmenthylcarbonyl	   auxiliary	   gave	   good	   to	   excellent	   diastereoselectivities,30-­‐32	   when	  
there	  was	  a	  bulky	  triisopropylsilyl	  group	   installed	  at	  carbon	  5	  to	  block	  attack	  of	   the	  nucleophile	  at	  
carbon	  6	  (Scheme	  24).	  Both	  the	  auxiliary	  and	  the	  blocking	  group	  could	  be	  subsequently	  removed	  to	  
give	  the	  free	  2,3-­‐dihydro-­‐4-­‐pyridone.	  
	  
Scheme	  24.	  Diastereoselective	  synthesis	  of	  2,3-­‐dihydro-­‐4-­‐pyridones,	  using	  a	  triisopropylsilyl	  blocking	  
group	  and	  a	  (−)-­‐8-­‐phenylmenthylcarbonyl	  auxiliary.	  
	  
	  
Comins	   and	   co-­‐workers	   also	   reported	   that	   the	   related	   auxiliary	   containing	   (−)-­‐8-­‐(4-­‐
phenoxyphenyl)menthol	   (Figure	   22)	   gave	   excellent	   diastereoselectivities	   in	   this	   reaction	   (d.r.	   ≥	  
89:11).30,33	  Changing	  the	  chiral	  group	  to	  trans-­‐2-­‐(α-­‐cumyl)cyclohexanol,	  which	  can	  be	  synthesised	  as	  
either	   enantiomer,	   gave	   access	   to	   both	   enantiomers	   of	   the	   desired	   products,	   with	   similarly	   high	  


































80:20 ≤ d.r. ≤ 97:3
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  27	  
Figure	  22.	  Other	  chiral	  auxiliaries	  used	  by	  Comins	  and	  co-­‐workers.	  
	  
	  
Comins	   and	   co-­‐workers	   have	   synthesised	   a	   number	   of	   4-­‐hydroxypiperidine	   containing	   natural	  
products	   through	  reduction	  of	  both	   the	  alkene	  and	  ketone	   functional	  groups	   in	   the	  2,3-­‐dihydro-­‐4-­‐
pyridones	  (Figure	  23).32-­‐38	  During	  this	  process	  they	  extended	  the	  range	  of	  nucleophiles	  that	  could	  be	  
added	   to	   the	   N-­‐acylpyridinium	   ion	   to	   include	   lithium	   acetylides,36	   zinc	   enolates37	   and	   alkyl	  
organocuprates.38	  
	  





























































1.2.5.2	  Charette	  and	  co-­‐workers	  
	  
Comins	   and	   co-­‐workers’	   work	   has	   been	   expanded	   by	   various	   authors,	   giving	   complementary	  
methods	  to	  make	  chiral	  2-­‐substitued	  2,3-­‐dihydro-­‐4-­‐pyridones.	  Charette	  and	  co-­‐worker	  reported	  the	  
use	  of	   L-­‐valine	  derived	  chiral	   auxiliary	  44	   that	  enabled	   the	  diastereoselective	  addition	  of	  Grignard	  
reagents	  to	  pyridinium	  salt	  45,	  without	  the	  use	  of	  a	  blocking	  group	  on	  the	  pyridine	  (Scheme	  25).39	  
Instead	   the	   phenyl	   group	   in	   the	   auxiliary	   acts	   as	   a	   blocking	   group	   preventing	   attack	   of	   the	  
nucleophile	   at	   carbon	   6,	   whilst	   the	   lone	   pair	   of	   the	   imidate	   nitrogen	   can	   coordinate	   to	   the	  
organometallic	  reagent	  aiding	  attack	  at	  carbon	  2.40	  A	  range	  of	  alkyl,	  alkenyl,	  alkynyl	  and	  aryl	  Grignard	  
reagents	  were	  used	  in	  this	  reaction.	  
	  
Scheme	   25.	   Use	   of	   chiral	   auxiliary	   44	   in	   the	   diastereoselective	   addition	   of	   Grignard	   reagents	   to	  
pyridinium	  	  salt	  45.	  
	  
	  
1.2.5.3	  Minnaard,	  Feringa	  and	  co-­‐workers	  
	  
In	  2009,	  Minnaard,	  Feringa	  and	  co-­‐workers	  published	  the	  first	  catalytic,	  enantioselective	  synthesis	  of	  
2,3-­‐dihydro-­‐4-­‐pyridones	   using	   this	   methodology,	   making	   use	   of	   the	   copper-­‐catalysed	   addition	   of	  
diorganozinc	   reagents	   to	   achiral	  N-­‐acylpyridinium	   salt	  43a	   (Scheme	  26).41	   The	   authors	   found	   that	  
chiral	  phosphoramidite	   ligand	  46a	   generally	  allowed	  the	  products	   to	  be	   formed	   in	  good	  yield	  and	  


















83:17 ≤ d.r. ≤ >95:5
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Scheme	   26.	   Enantioselective,	   copper-­‐catalysed	   addition	   of	   diorganozinc	   reagents	   to	   N-­‐
acylpyridinium	  salt	  43a.	  
	  
	  
1.2.5.4	  Doyle	  and	  co-­‐workers	  
	  
Recently,	  Doyle	  and	  co-­‐workers	  have	  developed	  a	  related	  nickel-­‐catalysed	  enantioselective	  addition	  
of	   aryl	   organozinc	   reagents	   to	   N-­‐acylpyridinium	   salt	  43b	   (Scheme	   27).42	   After	   optimisation,	   they	  
found	  that	  ligand	  46b	  gave	  the	  products	  with	  good	  enantiomeric	  excesses.	  The	  best	  excesses	  were	  
seen	   for	  aryl	   zinc	   reagents	  with	  electron-­‐withdrawing	  substituents,	  while	  electron	  neutral	  aryl	   zinc	  
reagents	   gave	  modest	   enantiomeric	   excesses.	   Electron	   rich	   aryl	   zinc	   reagents	   generally	   gave	   poor	  
enantiomeric	  excesses	  due	  to	  the	  competing	  background	  reaction	  between	  the	  organozinc	  reagent	  
and	  the	  pyridinium	  ion,	  without	  the	  involvement	  of	  the	  chiral	  catalyst.	  This	  was	  also	  found	  to	  be	  the	  
case	  for	  alkyl	  zinc	  reagents,	  which	  is	  why	  the	  reaction	  was	  limited	  to	  the	  use	  of	  aryl	  zinc	  reagents.	  
	  
Scheme	   27.	   Enantioselective,	   nickel-­‐catalysed	   addition	   of	   aryl	   organozinc	   reagents	   to	   N-­‐
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1.3	  Retrosynthetic	  Analysis	  of	  Target	  Molecules	  
	  
The	  target	  molecules	  for	  this	  project	  are	  2-­‐substituted	  4-­‐hydroxypiperidines	  47	  (Scheme	  28).	  These	  
are	  of	  interest	  as	  small,	  chiral	  pharmaceutical	  building	  blocks,	  as	  well	  as	  being	  present	  in	  a	  number	  
of	  natural	  products	   (see	  Chapter	  1.1,	  p1).	  Retrosynthetic	   analysis	  of	   these	   compounds	   shows	   that	  
they	   could	   be	   synthesised	   via	   the	   reduction	   of	   2-­‐substituted	   4-­‐oxopiperidines	   48.	   These	   in	   turn	  
could	   be	   made	   by	   cyclising	   intermediates	   49,	   which	   could	   result	   from	   the	   palladium-­‐catalysed	  
Negishi	  cross	  coupling	  reaction	  of	  acryloyl	  chloride	  with	  a	  variety	  of	  α-­‐amino	  acid	  derived	  organozinc	  
reagents	  50.	  
	  



































1.4	  Organozinc	  Reagents	  
	  
1.4.1	  Reaction	  of	  Organozinc	  Reagents	  with	  Acid	  Chlorides	  
	  
The	   key	   step	   in	   the	   retrosynthetic	   analyses	   of	   2-­‐substituted	   4-­‐hydroxypiperidines	   47	   is	   the	  
palladium-­‐catalysed	  Negishi	   cross	   coupling	   reaction	   of	   an	   organozinc	   reagent	  with	   a	   suitable	   acid	  
chloride	  (see	  Scheme	  28,	  p30).	  
	  
There	  are	  three	  key	  steps	  in	  the	  (simplified)	  catalytic	  cycle	  for	  the	  Negishi	  cross	  coupling	  reaction	  of	  
an	  organozinc	  reagent	  with	  an	  acid	  chloride	  (Figure	  24).43	  The	  first	  step	  is	  the	  oxidative	  addition	  of	  
the	  active	  catalyst,	  a	  fourteen	  electron	  bis-­‐ligated	  palladium(0)	  species,	  to	  the	  acid	  chloride.	  This	   is	  
followed	   by	   transmetallation	   of	   the	   R1	   group	   from	   the	   zinc	   to	   the	   palladium.	   Finally,	   reductive	  
elimination	  occurs	  to	  yield	  the	  cross	  coupled	  product,	  reforming	  the	  active	  catalyst.	  	  
	  
Figure	  24.	  Simplified	  catalytic	  cycle	  for	  the	  Negishi	  cross	  coupling	  reaction	  of	  an	  organozinc	  reagent	  



























The	  first	  example	  of	  a	  reaction	  between	  an	  organozinc	  reagent	  and	  an	  acid	  chloride	  was	  reported	  by	  
Freund	  in	  1861.44-­‐45	  He	  reacted	  diethylzinc	  and	  dimethylzinc	  with	  simple	  acid	  chlorides	  and	  observed	  
the	  formation	  of	  the	  corresponding	  ketones.	  
	  
In	  1981,	  Fujisawa	  and	  co-­‐workers	  discovered	  that	  benzyl	  bromide	  could	  be	  reductively	  coupled	  with	  
acid	   chlorides	   in	   the	   presence	   of	   two	   equivalents	   of	   zinc	   and	   a	   sub-­‐stoichiometric	   amount	   of	   a	  
palladium	   phosphine	   catalyst.46	   They	   suggested	   that	   the	   benzyl	   organozinc	   reagent	   was	   being	  
formed	  in	  situ	  before	  reacting	  with	  the	  acid	  chloride,	  with	  the	  palladium	  species	  acting	  as	  a	  catalyst	  
for	  the	  reaction	  (Scheme	  29).	  
	  




This	  discovery	  of	  palladium	  phosphine	  complexes	  as	  good	  catalysts	   for	   the	  acylation	  of	  organozinc	  
reagents	  was	  supplemented	  by	  work	  published	  independently	  by	  Negishi	  and	  co-­‐workers	  in	  1983,47	  
and	   Grey	   in	   1984.48	   An	   example	   of	   a	   reaction	   reported	   by	   each	   of	   the	   authors	   is	   shown	   below	  
(Scheme	  30	  and	  Scheme	  31).	  
	  
Scheme	  30.	  An	  example	   from	  the	  work	  of	  Negishi	  and	  co-­‐workers	   showing	   the	  use	  of	  a	  palladium	  























Scheme	   31.	   An	   example	   from	   the	   work	   of	   Grey	   showing	   the	   use	   of	   a	   palladium	   catalyst	   for	   the	  
acylation	  of	  an	  alkyl	  organozinc	  reagent.	  
	  
	  
The	  Negishi	  cross	  coupling	  reaction	  of	  organozinc	  reagents	  with	  acid	  chlorides	  has	  been	  used	  by	  a	  
number	  of	  researchers	  to	  construct	  ketones.43	  An	  example	  of	  this	  is	  seen	  in	  the	  reaction	  of	  the	  zinc	  
homoenolate	  derived	  from	  iodide	  51	  with	  a	  number	  of	  acid	  chlorides,	  reported	  by	  Yoshida	  and	  co-­‐
workers	  (Scheme	  32).49	  
	  
Scheme	  32.	  The	  Negishi	  cross	  coupling	  reaction	  of	  zinc	  homoenolate	  derived	  from	  iodide	  51	  with	  a	  
variety	  of	  acid	  chlorides.	  
	  
	  
A	  more	   recent	  example	  was	  published	  by	   Iwai,	  Ohno	  and	  co-­‐workers,	  who	  used	   the	  Negishi	   cross	  
coupling	  reaction	  to	  synthesise	  pyridyl	  ketones	  (Scheme	  33).50	  
	  
Scheme	   33.	   Synthesis	   of	   pyridyl	   ketones	   using	   the	   Negishi	   cross	   coupling	   reaction	   of	   various	  
organozinc	  reagents	  52.	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1.4.2	  Amino	  Acid	  Derived	  Organozinc	  Reagents	  
	  
1.4.2.1	  Negishi	  Cross	  Coupling	  Reactions	  with	  Acid	  Chlorides	  
	  
Jackson	  and	  co-­‐workers	  have	  also	  used	  the	  reactivity	  of	  organozinc	  reagents	  towards	  acid	  chlorides	  
to	  construct	  ketones.	  Specifically,	  they	  have	  synthesised	  a	  variety	  of	  oxygenated	  α-­‐,	  β-­‐	  and	  γ-­‐amino	  
acids	  using	  amino	  acid	  derived	  organozinc	  reagents.51-­‐54	  For	  example,	  L-­‐aspartic	  acid	  and	  L-­‐glutamic	  
acid	  derived	  organozinc	  reagents	  53a	  and	  54	  were	  cross	  coupled	  with	  various	  acid	  chlorides	  to	  yield	  
5-­‐oxo-­‐3-­‐amino	  acids	  55	  and	  6-­‐oxo-­‐4-­‐amino	  acids	  56	  (Scheme	  34)	  in	  moderate	  yields	  (Table	  1).51	  The	  
presence	   of	   DMA	   was	   necessary	   to	   stabilise	   the	   organozinc	   reagent.	   Although	   DMF	   is	   the	   usual	  
solvent	  of	  choice	  for	  these	  reactions,	  it	  was	  not	  a	  suitable	  solvent	  in	  this	  case,	  as	  it	  is	  known	  to	  react	  
with	  acid	  chlorides.	  
	  
Scheme	  34.	  Synthesis	  of	  5-­‐oxo-­‐3-­‐amino	  acids	  and	  6-­‐oxo-­‐4-­‐amino	  acids	  via	  the	  Negishi	  cross	  coupling	  




Table	  1.	  Yields	  for	  the	  Negishi	  cross	  coupling	  reaction	  of	  L-­‐aspartic	  acid	  and	  L-­‐glutamic	  acid	  derived	  
organozinc	  reagents	  53a	  and	  54	  with	  various	  acid	  chlorides.	  	  
Entry	   R	   Yield	  of	  compound	  55	  (%)	   Yield	  of	  compound	  56	  (%)	  
1	   Ph	   59	   51	  
2	   CH2=CH	   46	   48	  
3	   AcOCH2	   49	   52	  
4	   CH3(CH2)4	   20	   –	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Similarly,	  L-­‐serine	  derived	  organozinc	  reagent	  57a	  was	  cross	  coupled	  with	  a	  number	  of	  acid	  chlorides	  
to	  give	  4-­‐oxo-­‐2-­‐amino	  acids	  58a	  (Scheme	  35)	  in	  moderate	  to	  good	  yields	  (Table	  2).52-­‐53	  
	  
Scheme	   35.	   Synthesis	   of	   4-­‐oxo-­‐2-­‐amino	   acids	   via	   the	   Negishi	   cross	   coupling	   reaction	   of	   L-­‐serine	  
derived	  organozinc	  reagent	  57a	  with	  various	  acid	  chlorides.	  
	  
Table	   2.	   Yields	   for	   the	  Negishi	   cross	   coupling	   reaction	  of	   L-­‐serine	  derived	  organozinc	   reagent	  57a	  
with	  various	  acid	  chlorides.	  	  
Entry	   R	   Yield	  of	  compound	  58a	  (%)	  
1	   Ph	   70	  
2	   2-­‐Furyl	   90	  
3	   Me	   80	  
4	   Et	   83	  
5	   iPrCH2	   76	  
6	   tBuCH2	   84	  
7	   Bn	   41	  
8	   trans-­‐PhCH=CH	   72	  
9	   4-­‐MeO-­‐C6H4	   43	  
10	   4-­‐AcO-­‐C6H4	   63	  
11	   ClCH2	   a39a	  
12	   AcOCH2	   64	  
13	   PhthNCH2	   53	  
14	   CH2=CH	   b58b	  
a	  Reaction	  stirred	  without	  sonication.	  
b	  1.5	  eq.	  HMPA	  used	  in	  place	  of	  DMA.55	  
	  
The	   differently	   protected	   L-­‐serine	   derived	   organozinc	   reagent	   57b	   was	   also	   cross	   coupled	   with	  




















Scheme	  36.	  Synthesis	  of	  4-­‐oxo-­‐2-­‐amino	  acids	  58b	  via	  the	  Negishi	  cross	  coupling	  reaction	  of	  L-­‐serine	  
derived	  organozinc	  reagent	  57b	  with	  various	  acid	  chlorides.	  
	  
Table	   3.	   Yields	   for	   the	  Negishi	   cross	   coupling	   reaction	  of	   L-­‐serine	  derived	  organozinc	   reagent	  57b	  
with	  various	  acid	  chlorides.	  
Entry	   R	   Yield	  of	  compound	  58b	  (%)	  
1	   AcOCH2	   47	  
2	   Et	   47	  
3	   (S)-­‐N-­‐Trifluoroacetylpyrrolidin-­‐2-­‐yl	   46	  
4	   PhthNCH2	   43	  
5	   CH2=CH	   42	  
	  
Of	   particular	   interest	   are	   the	   cross	   coupling	   reactions	   of	   L-­‐serine	   derived	   organozinc	   reagents	  57	  
with	   acryloyl	   chloride	   (Table	   2,	   entry	   14	   and	   Table	   3,	   entry	   5),	   as	   these	   provide	   access	   to	   amino	  
enones.	   Subsequent	   treatment	   of	   amino	   enone	   59a	   with	   1	   M	   hydrogen	   chloride	   in	   Et2O	   was	  
reported	   by	   Jackson	   and	   co-­‐workers	   to	   give	   benzyl	   4-­‐oxopipecolate	   60a	   in	   a	   quantitative	   yield	  
(Scheme	  37).52	  This	  work	  was	  based	  on	  a	  very	  similar	  acidic	  cyclisation	  of	  the	  racemic	  amino	  acid	  (±)-­‐
59b	   carried	   out	   by	   Obrecht	   and	   co-­‐workers,	   which	   was	   reported	   to	   give	   4-­‐oxo-­‐pipecolic	   acid	  
hydrochloride	  (±)-­‐60b	  in	  similarly	  high	  yields	  (Scheme	  38).56-­‐57	  These	  reactions	  give	  a	  precedent	  for	  
the	   proposed	   cyclisation	   of	   intermediates	   49	   to	   give	   4-­‐oxopiperidines	   48,	   shown	   earlier	   in	   the	  
retrosynthetic	  analysis	  of	  2-­‐substituted	  4-­‐hydroxypiperidines	  47	  (see	  Scheme	  28,	  p30).	  
	  
Scheme	   37.	   Previously	   reported	   acid	   mediated	   Boc	   deprotection	   and	   subsequent	   cyclisation	   of	  



































Scheme	   38.	   Previously	   reported	   acid	   mediated	   Boc	   deprotection	   and	   subsequent	   cyclisation	   of	  
compound	  (±)-­‐59b	  to	  give	  4-­‐oxopipecolate	  (±)-­‐60b.	  
	  
	  
1.4.2.2	  Negishi	  Cross	  Coupling	  Reactions	  with	  Aromatic	  Iodides	  
	  
Other	   amino	   acid	   derived	   organozinc	   reagents	   have	   been	   synthesised	   in	   the	   literature,	   although	  
their	   Negishi	   cross	   coupling	   reaction	   with	   acid	   chlorides	   has	   not	   been	   investigated.	   Instead,	   they	  
have	   generally	   been	   used	   in	   the	  Negishi	   cross	   coupling	   reaction	  with	   aromatic	   halides	   to	   yield	   β-­‐
arylethylamine	   derivatives.	   This	   thesis	   is	   going	   to	   concentrate	   on	   the	   use	   of	   organozinc	   reagents	  
derived	  from	  L-­‐valine	  and	  L-­‐alanine,	  as	  these	  are	  of	  particular	  interest	  to	  this	  project.	  
	  
Jackson	  and	  co-­‐workers	  have	  reported	  the	  palladium-­‐catalysed	  Negishi	  cross	  coupling	  reaction	  of	  L-­‐
valine	  derived	  organozinc	  reagent	  62a	  in	  the	  synthesis	  of	  a	  range	  of	  β-­‐phenylethylamine	  derivatives	  
63a	  (Scheme	  39)	  in	  moderate	  to	  good	  yields	  (Table	  4).58	  
	  
Scheme	   39.	   The	   Negishi	   cross	   coupling	   reaction	   of	   L-­‐valine	   derived	   organozinc	   reagent	  62a	   with	  


































Table	   4.	   Yields	   for	   the	  Negishi	   cross	   coupling	   reaction	   of	   L-­‐valine	   derived	   organozinc	   reagent	  62a	  
with	  various	  aromatic	  iodides.	  
Entry	   Ar	   Yield	  of	  compound	  63a	  (%)	  
1	   Ph	   71	  
2	   1-­‐Naphthyl	   63	  
3	   4-­‐NO2-­‐C6H4	   79	  
4	   4-­‐MeO-­‐C6H4	   53	  
	  
In	  a	  similar	  manner,	  Jackson	  and	  co-­‐workers	  have	  used	  reported	  the	  Negishi	  cross	  coupling	  reactions	  
of	   both	   organozinc	   reagent	   62a	   and	   L-­‐alanine	   derived	   organozinc	   reagent	   65a	   with	   2-­‐
bromoiodobenzene	  in	  the	  synthesis	  of	  enantiomerically	  pure	  2-­‐substituted	  N-­‐Boc	  indolines	  66	  and	  
67	   (Scheme	   40).59	   In	   these	   reactions	   the	   zinc	   insertion	   step	   was	   conducted	   at	   0	   °C,	   due	   to	   the	  
instability	  of	  organozinc	  reagents	  62a	  and	  65a	  (see	  Chapter	  1.4.2.3,	  p40).	  
	  
Scheme	  40.	  Synthesis	  of	  2-­‐substituted	  N-­‐Boc	   indolines	  66	  and	  67	  using	  the	  Negishi	  cross	  coupling	  
reaction	  of	  organozinc	  reagents	  62a	  and	  65a	  with	  2-­‐bromoiodobenzene.	  
	  
	  
More	  recently,	  the	  synthesis	  of	  various	  β-­‐phenylethylamine	  derivatives	  63	  has	  been	  revisited.60	  The	  
synthesis	   of	   compounds	   63a	   had	   already	   been	   achieved	   by	   the	   reaction	   of	   N-­‐Boc	   protected	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The	   corresponding	   N-­‐TFA	   protected	   organozinc	   reagent	   62b	   was	   prepared	   by	   Jackson	   and	   co-­‐
workers	  and	  reacted	  with	  a	  variety	  of	  aromatic	  iodides	  to	  yield	  β-­‐phenylethylamine	  derivatives	  63b	  
(Scheme	  41).60	  Moderate	  to	  good	  yields	  were	  obtained	  when	  using	  5	  mol%	  of	  the	  palladium	  catalyst	  
(Table	  5,	  Method	  A).	   In	   some	  cases	   it	  was	   found	   that	  a	   tenfold	  decrease	   in	  catalyst	   loading	   to	  0.5	  
mol%	  still	  gave	  acceptable	  yields	  of	  product	  (Table	  5,	  Method	  B).	  
	  
Scheme	   41.	   Synthesis	   of	   β-­‐phenylethylamine	   derivatives	   63b	   using	   L-­‐valine	   derived	   organozinc	  
reagent	  62b.	  	  
	  
Table	   5.	   Yields	   for	   the	   palladium-­‐catalysed	   cross	   coupling	   reaction	   organozinc	   reagent	   62b	   with	  
various	  aromatic	  iodides.	  
Entry	   Ar	  
Yield	  of	  compound	  63b	  (%)	  
Method	  Aa	   Method	  Bb	  
1	   Ph	   63	   58	  
2	   4-­‐Me-­‐C6H4	   70	   42	  
3	   4-­‐CO2Me-­‐C6H4	   51	   –	  
4	   4-­‐F-­‐C6H4	   61	   60	  
5	   4-­‐MeO-­‐C6H4	   57	   37	  
6	   3-­‐MeO-­‐C6H4	   74	   –	  
7	   2-­‐MeO-­‐C6H4	   42	   –	  
a	  2.5	  mol%	  Pd2(dba)3,	  5	  mol%	  SPhos	  
b	  0.25	  mol%	  Pd2(dba)3,	  0.5	  mol%	  SPhos	  
	  
The	   major	   difference	   in	   reaction	   conditions	   used	   for	   these	   reactions	   was	   the	   improved	   catalyst	  





















ligand	  for	  the	  palladium-­‐catalysed	  Negishi	  cross	  coupling	  reaction	  of	  aromatic	  halides	  with	  L-­‐serine	  
derived	  organozinc	  reagent	  57c	  (Scheme	  42).62	  The	  TFA	  protecting	  group	  was	  chosen	  as	  a	  result	  of	  
studies	   on	   the	   stability	   of	   various	   β-­‐amino	   organozinc	   reagents	   (see	   Chapter	   1.4.2.3,	   below).	  
However,	  it	  was	  also	  noted	  that	  the	  iodide	  61b	  was	  more	  stable	  than	  its	  N-­‐Boc	  protected	  analogue	  
61a,60	  and	  that	  the	  yield	  for	  the	  iodination	  of	  N-­‐TFA-­‐L-­‐valinol	  was	  higher	  than	  that	  of	  N-­‐Boc-­‐L-­‐valinol	  
(70%	  cf.	  56%).58,60	  
	  
Scheme	  42.	  Synthesis	  of	  phenylalanine	  derivatives	  69	  using	  a	  Pd2(dba)3/SPhos	  catalyst	  system.62	  
	  
	  
1.4.2.3	  Stability	  of	  Organozinc	  Reagents	  
	  
The	   stability	   of	   amino	   acid	   derived	   organozinc	   reagents	   53a,	   54	   and	   57c	   has	   been	   studied	   by	  
Jackson	  and	  co-­‐workers.51,63-­‐66	  The	  main	  decomposition	  route	  for	  these	  compounds	  is	  β-­‐elimination,	  
which	   leads	  to	  the	  corresponding	  alkenes	  70	   (Scheme	  43).	   Jackson	  and	  co-­‐workers	  have	  proposed	  
that	  this	  a	  syn	  elimination	  process,	  as	  opposed	  to	  the	  more	  commonly	  encountered	  anti	  elimination.	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When	   13C	   NMR	   spectra	   were	   collected	   for	   organozinc	   reagents	   53a,	   54	   and	   57c	   in	   THF-­‐d8,	   a	  
significant	  downfield	  shift	  was	  seen	  in	  the	  carbonyl	  peak	  of	  the	  carbamate	  group,	  when	  compared	  to	  
the	  same	  peak	  in	  the	  starting	  iodides	  (Table	  6).63-­‐64	  This	  was	  taken	  as	  evidence	  of	  the	  coordination	  of	  
the	   carbonyl	   oxygen	   to	   the	   electron	   deficient	   zinc	   atom,	   which	   sets	   up	   the	   molecule	   for	   a	   syn	  
elimination.	  This	  downfield	  shift	  did	  not	  occur	  when	  the	  same	  zinc	  reagents	  were	  analysed	  in	  DMF-­‐
d7,	  suggesting	  that	  DMF	  can	  disrupt	  this	  interaction	  by	  coordinating	  to	  the	  zinc	  atom	  itself.	  In	  fact,	  as	  
more	  equivalents	  of	  DMF	  were	  added	  to	  organozinc	  reagent	  57c	  in	  THF-­‐d8,	  the	  downfield	  shift	  was	  
seen	  to	  decrease	  (Table	  7).51	  
	  
Table	   6.	   Change	   in	   the	   13C	   NMR	   chemical	   shift	   of	   the	   carbamate	   carbonyl	   group	   of	   organozinc	  
reagents	  53a,	  54	  and	  57c,	  upon	  zinc	  insertion	  in	  THF-­‐d8	  and	  DMF-­‐d7.	  
Entry	   Organozinc	  Reagent	  
Δδ	  carbamate	  /	  ppma	  
THF-­‐d8	   DMF-­‐d7	  
1	   57c	   +2.711	   −0.868	  
2	   53a	   +3.747	   −0.535	  
3	   54	   +3.923	   −0.687	  
a	  The	  reference	  was	  taken	  as	  the	  chemical	  shift	  of	  the	  carbamate	  carbonyl	  in	  the	  starting	  iodides.	  
	  
Table	   7.	   Change	   in	   the	   13C	   NMR	   chemical	   shift	   of	   the	   carbamate	   carbonyl	   group	   of	   organozinc	  
reagent	  57c	  in	  THF-­‐d8,	  upon	  titration	  with	  DMF.	  
Entry	   Eq.	  of	  DMF	   Δδ	  carbamate	  /	  ppma	  
1	   0	   +2.711	  
2	   0.5	   +2.180	  
3	   1	   +1.785	  
4	   2	   +1.045	  
5	   4	   +0.526	  
a	  The	  reference	  was	  taken	  as	  the	  chemical	  shift	  of	  the	  carbamate	  carbonyl	  in	  the	  starting	  iodide	  68.	  
	  
These	   proposals	   are	   supported	   by	   kinetic	   data,	   which	   showed	   that	   organozinc	   reagent	   53a	  
decomposed	  with	  a	  rate	  constant	  of	  0.26	  ×	  10-­‐4	  s-­‐1	  in	  DMF	  at	  298	  K,	  approximately	  four	  times	  slower	  
than	   in	  THF,	  when	  the	  rate	  constant	  was	  1.02	  ×	  10-­‐4	  s-­‐1.51	  These	  decompositions	  were	  found	  to	  be	  
first	   order.	   Further	   evidence	   for	   a	   syn	   elimination	   came	   from	   analysis	   of	   the	   kinetic	   activation	  
parameters	  of	  organozinc	   reagent	  53a.	  The	  entropy	  of	  activation	  ΔS‡	  was	   found	  to	  be	  negative	   in	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both	  THF	  and	  DMF.	  In	  the	  transition	  state	  of	  an	  anti	  elimination,	  three	  molecules	  would	  be	  forming	  
from	  one	  single	  molecule	  of	  organozinc	  reagent,	  anticipating	  a	  positive	  value	  of	  ΔS‡	  (see	  Scheme	  43,	  
p40).	  However,	  in	  order	  for	  a	  syn	  elimination	  to	  occur,	  the	  molecule	  first	  has	  to	  organise	  itself	  into	  
the	  required	  cyclic	  transition	  state.	  The	  observed	  negative	  ΔS‡	  values	  are	  therefore	  better	  explained	  
by	  a	  syn	  elimination	  process,	  with	  its	  highly	  ordered	  transition	  state.	  
	  
Jackson	  and	  co-­‐workers	  also	  observed	  that	  the	  carbonyl	  of	  the	  ester	  in	  organozinc	  reagents	  53a,	  54	  
and	  57c	  was	  able	  to	  coordinate	  to	  the	  zinc	  atom,	   in	  both	  THF	  and	  DMF,	  as	   judged	  by	  a	  downfield	  
shift	  in	  the	  13C	  NMR	  spectra	  (Table	  8).63-­‐64	  The	  ester	  coordination	  depended	  on	  the	  proximity	  of	  the	  
ester	  to	  the	  zinc	  atom,	  as	  different	  ring	  sizes	  were	  formed	  in	  each	  case.	  Serine	  derived	  zinc	  reagent	  
57c	  showed	  the	  largest	  downfield	  shift,	  and	  forms	  a	  five	  membered	  ring	  upon	  coordination	  of	  the	  
ester	  to	  the	  zinc	  atom	  (Figure	  25).	  Aspartic	  acid	  derived	  zinc	  reagent	  53a	  had	  a	  lower	  downfield	  shift	  
in	  the	  NMR	  spectrum,	  and	  forms	  a	  six	  membered	  ring.	  Finally	  the	  seven	  membered	  ring	  that	  forms	  
in	  the	  case	  of	  glutamic	  derived	  zinc	  reagent	  54	  correlates	  to	  the	  very	  small	  downfield	  shift	  observed.	  
This	  ester	  coordination	  has	  been	  proposed	  to	  compete	  with	  carbamate	  coordination,	  and	  has	  been	  
used	  to	  explain	  the	  observed	  order	  of	  stability	  for	  these	  three	  compounds,	  with	  organozinc	  reagent	  
57c	  being	  the	  most	  stable	  to	  β-­‐elimination,	  and	  organozinc	  reagent	  54	  being	  the	  least	  stable.	  
	  
Table	  8.	  Change	   in	   the	   13C	  NMR	  chemical	   shift	  of	   the	  ester	   carbonyl	  group	  of	  organozinc	   reagents	  
53a,	  54	  and	  57c,	  upon	  zinc	  insertion	  in	  THF-­‐d8	  and	  DMF-­‐d7.	  
Entry	   Organozinc	  Reagent	  
Δδ	  ester	  /	  ppma	  
THF-­‐d8	   DMF-­‐d7	  
1	   57c	   +5.347	   +5.786	  
2	   53a	   +1.464	   +0.872	  
3	   54	   +0.675	   +0.115	  
a	  The	  reference	  was	  taken	  as	  the	  chemical	  shift	  of	  the	  ester	  carbonyl	  in	  the	  starting	  iodides.	  
	  
Figure	  25.	  Different	   ring	   sizes	   formed	  upon	  coordination	  of	   the	  ester	   carbonyl	   to	   the	   zinc	  atom	   in	  























Given	  that	  the	  interaction	  between	  the	  carbonyl	  of	  the	  Boc	  group	  and	  the	  zinc	  atom	  seemed	  to	  be	  
key	   in	   the	   β-­‐elimination	   process,	   Jackson	   and	   co-­‐workers	   investigated	   the	   effect	   of	   choosing	   a	  
protecting	  group	  with	  a	   less	   coordinating	   carbonyl	   group,	  namely	   the	   trifluoroacetyl	   group.	  N-­‐TFA	  
protected	   organozinc	   reagent	   53b	   was	   synthesised,	   and	   its	   decomposition	   was	   studied	   and	  
compared	  to	  that	  of	  its	  N-­‐Boc	  protected	  analogue	  53a	  (Scheme	  44).65-­‐66	  
	  
Scheme	  44.	  Major	  product	  of	  the	  decomposition	  of	  organozinc	  reagents	  53a	  and	  53b	  in	  DMF-­‐d7.	  
	  
	  
The	  major	  product	  of	  each	  decomposition	  pathway	  was	  methyl	  but-­‐3-­‐enoate	  70a.	  The	  rate	  constant	  
for	   the	   first-­‐order	   elimination	   of	   organozinc	   reagent	  53a	  was	   found	   to	   be	   9.0	   ×	   10-­‐6	   s-­‐1.66	   This	   is	  
smaller	  than	  the	  previously	  determined	  value	  (see	  p41),	  a	  difference	  taken	  to	  be	  due	  to	  a	  change	  in	  
the	  zinc	  activation	  procedure.	  1H	  NMR	  analysis	  of	  compound	  53b	  showed	  that	  it	  decomposed	  by	  a	  
second-­‐order	  β-­‐elimination	  process,	  with	  a	  rate	  constant	  of	  2.8	  ±	  0.5	  ×	  10-­‐6	  M-­‐1	  s-­‐1,	  more	  than	  three	  
times	   slower	   than	   the	   elimination	   of	   compound	  53a.	   Jackson	   and	   co-­‐workers	   suggested	   that	   the	  
electron-­‐withdrawing	   trifluoromethyl	   group	   reduces	   the	   coordination	   of	   the	   carbonyl	   of	   the	  
protecting	  group	  to	  the	  zinc	  atom,	  which	  in	  turn	  suppresses	  the	  syn	  elimination	  that	  is	  observed	  for	  
the	  corresponding	  N-­‐Boc	  protected	  organozinc	  reagent	  53a.	   Instead,	  they	  proposed	  that	  a	  Schlenk	  
pre-­‐equilibrium	   forms	   between	   two	   molecules	   of	   organozinc	   iodide	   53b	   and	   one	   molecule	   of	  
diorganozinc	  reagent	  71,	  which	  then	  undergoes	  an	  anti	  elimination	  (Scheme	  45).	  Although	  in	  theory	  
organozinc	  reagent	  53b	   itself	  can	  undergo	  an	  anti	  elimination,	  it	  was	  suggested	  that	  this	  would	  be	  
disfavoured,	   because	   the	   electron	   density	   in	   the	   carbon-­‐zinc	   bond	   would	   be	   reduced	   by	   the	  
electron-­‐withdrawing	  iodide	  attached	  to	  the	  zinc.	  However,	  anti	  elimination	  of	  diorganozinc	  reagent	  
71	   would	   be	   favoured,	   as	   there	   is	   no	   longer	   an	   electron-­‐withdrawing	   group	   attached	   to	   the	   zinc	  
atom.	   This	  mechanism	   accounts	   for	   the	   observed	   second	   order	   nature	   of	   the	   elimination,	   as	   the	  
concentration	   of	   diorganozinc	   reagent	  71	   formed	   in	   the	   Schlenk	   pre-­‐equilibrium	  depends	   on	   the	  
square	  of	  the	  concentration	  of	  organozinc	  iodide	  53b.	  
	  





PG = Boc, 53a








Scheme	  45.	  Proposed	  mechanism	  for	  the	  second-­‐order	  elimination	  of	  organozinc	  reagent	  53b.	  
	  





















1.5	  Project	  Aims	  
	  
This	  project	  aims	  to	  develop	  a	  synthetic	  route	  to	  various	  small,	  enantiomerically	  pure	  2-­‐substituted	  
4-­‐hydroxypiperdines	  47	   (Scheme	   46).	   The	   key	   step	   will	   be	   the	   palladium-­‐catalysed	   Negishi	   cross	  
coupling	  reaction	  of	  an	  amino	  acid	  derived	  organozinc	  reagent	  50	  with	  a	  suitable	  acid	  chloride.	  The	  
stereochemistry	   in	   the	   final	   products	   will	   be	   controlled	   through	   the	   choice	   of	   chiral	   starting	  
materials	  and	  a	  final	  diastereoselective	  reduction.	  
	  
Scheme	  46.	  Proposed	  synthesis	  of	  2-­‐substituted	  4-­‐hydroxypiperidines	  47.	  
	  
	  

































2.	  Results	  and	  Discussion	  
	  
2.1	  Synthesis	  of	  Amino	  Acid	  Derived	  Iodides	  
	  
The	   key	   intermediates	   required	   for	   the	   proposed	   synthesis	   of	   various	   2-­‐substituted	   4-­‐
hydroxypiperidines	  (see	  Scheme	  46,	  p45)	  are	  the	  amino	  acid	  derived	  organozinc	  reagents	  57c,	  62a,	  
62b,	  65a	  and	  65b	  (Figure	  26).	  In	  order	  to	  access	  these	  compounds,	  the	  corresponding	  iodides	  61a,	  
61b,	  64a,	  64b	  and	  68	  needed	  to	  be	  synthesised	  from	  the	  appropriate	  α-­‐amino	  acids.	  
	  
Figure	  26.	  Key	  amino	  acid	  derived	  organozinc	  intermediates	  57c,	  62a,	  62b,	  65a	  and	  65b	  and	  the	  
corresponding	  iodides	  61a,	  61b,	  64a,	  64b	  and	  68.	  
	  
	  
All	   five	   iodide	   compounds	   had	   been	   previously	   synthesised,58,60,67-­‐69	   and	   so	   these	   syntheses	   were	  
repeated	  starting	  from	  the	  commercially	  available	  amino	  acids	  or	  amino	  alcohols.	  
	  
	  
2.1.1	  L-­‐Serine	  Derived	  Iodide	  
	  
L-­‐Serine	   was	   converted	   to	   its	   methyl	   ester	   hydrochloride	   salt	   72	   by	   treatment	   with	   methanolic	  
hydrogen	  chloride,	  as	  reported	  by	  Dondoni	  and	  Perrone	  (Scheme	  47).70	  Boc	  protection	  of	  compound	  
72	   using	   (Boc)2O	   in	  water	  with	  K2CO3	  as	   the	  base71	   gave	  N-­‐Boc-­‐L-­‐serine	  methyl	  ester	  73	   in	  a	  96%	  
crude	  yield	  over	  two	  steps.	  Tosylation	  of	  alcohol	  73,	  followed	  by	  iodination	  of	  the	  resulting	  tosylate	  
74	  were	  carried	  out	  using	  the	  method	  reported	  by	  Jackson	  and	  co-­‐workers,69	  giving	  iodide	  68	   in	  a	  

















68PG = Boc, R = iPr, 62a
PG = TFA, R = iPr, 62b
PG = Boc, R = Me, 65a
PG = TFA, R = Me, 65b
PG = Boc, R = iPr, 61a
PG = TFA, R = iPr, 61b
PG = Boc, R = Me, 64a
PG = TFA, R = Me, 64b
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2.1.2	  L-­‐Valine	  Derived	  Iodides	  
	  
In	  order	  to	  access	  iodide	  61a,	  L-­‐valine	  was	  first	  reduced	  with	  NaBH4/I2	  to	  give	  L-­‐valinol	  75	  (Scheme	  
48),	   using	   Meyers	   and	   co-­‐workers’	   procedure.72	   The	   crude	   amino	   alcohol	   was	   Boc	   protected	  
following	  the	  procedure	  described	  by	  Jackson	  and	  co-­‐workers,58	  to	  yield	  N-­‐Boc-­‐L-­‐valinol	  76a	  in	  69%	  
yield	  over	  the	  two	  steps.	  Finally,	  iodination	  of	  the	  alcohol	  using	  PPh3/I2/imidazole	  gave	  iodide	  61a	  in	  
a	   56%	   yield.	   Alternatively,	   crude	   L-­‐valinol	   was	   TFA	   protected	   using	   trifluoroacetic	   anhydride,	  
according	  to	  the	  procedure	  recently	  reported	  by	  Jackson	  and	  co-­‐workers.60	  This	  gave	  N-­‐TFA-­‐L-­‐valinol	  
76b	   in	   a	   59%	   yield	   over	   two	   steps	   (TFA	   protection	   of	   commercially	   available	   L-­‐valinol	   gave	  
compound	  76b	   in	   an	   80%	   yield).	   Iodination	   of	   alcohol	  76b	  using	   I2/PPh3/imidazole60	   gave	   iodide	  










































Scheme	  48.	  Synthesis	  of	  iodides	  61a	  and	  61b	  from	  L-­‐valine.	  
	  
a	  Yield	  calculated	  from	  1H	  NMR	  spectrum	  due	  to	  the	  presence	  of	  (Boc)2O.	  
	  
	  
2.1.3	  L-­‐Alanine	  Derived	  Iodides	  
	  
The	  L-­‐alanine	  derived	  N-­‐Boc	  protected	  iodide	  64a	  proved	  to	  be	  more	  challenging	  to	  synthesise	  than	  
its	  L-­‐valine	  derived	  counterpart	  61a,	  due	  to	   low	  yields	  for	  the	  reduction	  of	  L-­‐alanine.	  Although	  the	  
literature	  reports	  that	  NaBH4/I2	  can	  be	  used	  to	  reduce	  this	  amino	  acid,	  with	  yields	  varying	  from	  60	  to	  
≥88%,73-­‐77	   this	   reaction	   proved	   difficult	   to	   repeat.	   The	   yield	   of	   the	   reduction	   was	   somewhat	  
improved	  by	  changing	  the	  reducing	  agent	  to	  LiAlH4,	  following	  the	  procedure	  set	  out	  by	  Hegedus	  and	  
Hsiao,78	  but	  was	  still	   lower	  than	  the	  yields	  reported	   in	  the	   literature.	  One	  possible	  reason	  that	  the	  
yields	   achieved	   for	   the	   reduction	   of	   L-­‐alanine	   were	   lower	   than	   those	   reported	   is	   the	   high	   water	  
solubility	  of	  the	  product	  L-­‐alaninol,	  which	  may	  make	  its	  isolation	  during	  an	  aqueous	  workup	  difficult.	  
	  
As	   a	   result	   of	   the	   low	   yields	   achieved	   for	   the	   reduction	   of	   L-­‐alanine,	   it	  was	   decided	   to	   adapt	   the	  
synthetic	   strategy.	   Accordingly,	   the	   carboxylic	   acid	   group	   in	   L-­‐alanine	   was	   protected	   as	   a	   methyl	  
ester,	  followed	  by	  Boc	  protection	  of	  the	  amine	  group	  to	  give	  N-­‐Boc-­‐L-­‐alanine	  methyl	  ester	  77	  in	  an	  
86%	  crude	  yield	  (Scheme	  49).	  The	  ester	  in	  compound	  77	  was	  then	  reduced	  using	  LiBH4,	  which	  was	  
formed	   in	   situ	   from	   NaBH4	   and	   LiCl,	   as	   reported	   by	   Shioiri	   and	   co-­‐workers.79	   The	   reduction	  
proceeded	   to	  give	  N-­‐Boc-­‐L-­‐alaninol	  78a	   in	  a	  yield	  of	  81%.	  The	   iodination	  of	  alcohol	  78a	  was	   then	  
carried	  out	  using	  I2/PPh3/imidazole,	  as	  previously	  reported	  by	  Jackson	  and	  co-­‐workers.67	  The	  product	  
















PG = Boc, 76a, 69% over 2 stepsa
PG = TFA, 76b, 59% over 2 steps
PG = Boc, 61a, 56%
PG = TFA, 61b, 68%













In	   order	   to	   synthesise	   TFA	   protected	   iodide	   64b	   it	   was	   decided	   to	   purchase	   the	   amino	   alcohol	  
directly,	   as	   the	   protecting	   group	   would	   not	   be	   compatible	   with	   a	   LiBH4	   reduction.	   Therefore	   L-­‐
alaninol	  was	  TFA	  protected	  using	  a	  modified	  version	  of	  Kihlberg	  and	  co-­‐workers’	  procedure,68	  which	  
yielded	  the	  protected	  alcohol	  78b	   in	  a	  71%	  yield	  (Scheme	  50).	  This	  compound	  was	  iodinated	  using	  
I2/PPh3/imidazole	  to	  produce	  iodide	  64b	  in	  a	  71%	  yield.	  
	  
Scheme	  50.	  Synthesis	  of	  iodide	  64b	  from	  L-­‐alaninol.	  













































2.2	  Formation	  of	  Organozinc	  Reagents	  and	  Cross	  Coupling	  Reactions	  
	  
With	   iodides	   61a,	   61b,	   64a,	   64b	   and	   68	   in	   hand,	   attention	   was	   turned	   to	   the	   key	   palladium-­‐
catalysed	  Negishi	  cross	  coupling	  reaction	  of	  the	  corresponding	  organozinc	  reagents	  57c,	  62a,	  62b,	  
65a	  and	  65b	  with	  acryloyl	  chloride.	  
	  
	  
2.2.1	  Reaction	  Optimisation	  
	  
Optimisation	  was	   initially	  carried	  out	  on	  the	  reaction	  between	  L-­‐serine	  derived	  organozinc	  reagent	  
57c	   and	   acryloyl	   chloride	   (Scheme	   51).	   Although	   previous	   cross	   coupling	   reactions	   with	   acid	  
chlorides	   carried	   out	   in	   the	   Jackson	   group	   used	   a	   zinc/copper	   couple	   or	   zinc	   activated	   with	  
trimethylsilyl	   chloride	   to	   form	   the	   organozinc	   reagent,51-­‐54	   it	   was	   initially	   decided	   to	   use	   zinc	  
activated	  with	  iodine.	  This	  method	  of	  zinc	  activation	  was	  developed	  by	  Huo,80	  and	  recently	  Jackson	  
and	   co-­‐workers	   have	   shown	   it	   to	   be	   successful	   in	   forming	   α-­‐amino	   acid	   derived	   organozinc	  
reagents.60,62	   DMA	   was	   the	   polar	   aprotic	   solvent	   chosen	   to	   stabilise	   the	   organozinc	   reagent,	   in	  
combination	  with	  toluene	  as	  a	  co-­‐solvent,	  as	  previously	  used	  within	  the	  Jackson	  group.51,54	  Just	  over	  
four	  equivalents	  of	  DMA	  were	  used,	  because	  1H	  NMR	  studies	  of	  organozinc	  reagent	  57c	  in	  DMF/THF	  
suggested	   that	   four	   equivalents	   was	   the	   minimum	   amount	   of	   a	   polar	   aprotic	   solvent	   needed	   to	  
stabilise	  the	  organozinc	  reagent.51	  (Ph3P)2PdCl2	  was	  chosen	  as	  the	  catalyst	  for	  this	  reaction,	  as	  it	  has	  
previously	  been	  shown	  to	  be	  an	  effective	  catalyst	  for	  the	  Negishi	  cross	  coupling	  reaction	  of	  α-­‐amino	  
acid	  derived	  organozinc	  reagents	  with	  acid	  chlorides.53-­‐54	  
	  
Scheme	  51.	  Initial	  conditions	  for	  the	  reaction	  of	  organozinc	  reagent	  57c	  with	  acryloyl	  chloride.	  
	  
	  
Initial	  attempts	  to	  perform	  this	  reaction	  gave	  the	  product	  59c	  in	  a	  25-­‐28%	  yield	  (Scheme	  51).	  As	  well	  
as	  the	  desired	  product,	  a	  number	  of	  by-­‐products	  were	  also	  observed,	  which	  have	  been	  identified	  as	  






















Scheme	  52.	   By-­‐products	   formed	   in	   the	   reaction	   of	   organozinc	   reagent	  57c	  with	   acryloyl	   chloride,	  
and	  probable	  routes	  to	  their	  formation.	  
	  
	  
Protonation	  of	  organozinc	  reagents	  is	  a	  well-­‐known	  side	  reaction,	  and	  it	  was	  unsurprising	  to	  see	  the	  
protonated	   product	   77	   as	   a	   by-­‐product.	   However,	   the	   observation	   of	   the	   ester	   79	   was	   more	  
unusual.	  The	  most	   likely	  explanation	   for	   the	   formation	  of	   this	   compound	   is	   that	   small	   amounts	  of	  
oxygen	  present	  in	  the	  reaction	  were	  able	  to	  oxidise	  the	  organozinc	  reagent	  to	  form	  the	  zinc	  alkoxide	  
81,	   which	   then	   reacted	  with	   acryloyl	   chloride	   to	   form	   ester	  79.	   The	   presence	   of	   this	   compound	  
shows	   that	   the	   initial	   conditions	   for	   the	   cross	   coupling	   reaction	  were	   not	   optimum	   as	   a	   result	   of	  
oxygen	   in	   the	   reaction,	  which	  may	   have	   entered	   the	   system	  either	  while	   the	   solid	   reagents	  were	  
being	  added	  to	  the	  reaction,	  or	  as	  an	  impurity	  in	  the	  nitrogen	  supply.	  
	  
Another	  minor	   by-­‐product	   seen	   by	   1H	  NMR	  was	   compound	  80.	   This	   compound	   is	   a	   dimer	   of	   the	  
starting	   iodide	  68,	   and	  has	  been	  previously	  observed	  within	   the	   Jackson	  group	  during	   the	  Negishi	  
reaction	  of	  organozinc	  reagent	  57c	  with	  aromatic	  halides.81	  It	  is	  not	  yet	  conclusively	  known	  how	  this	  
product	  forms,	  although	  one	  possibility	  is	  that	  the	  zinc	  mediates	  a	  Wurtz-­‐type	  coupling	  between	  two	  
















































As	  seen	  from	  the	  combined	  yield	  of	  product,	  protonated	  product	  and	  oxidised	  product	  (Scheme	  52),	  
the	   initial	  mass	  balance	  for	  this	  reaction	  was	   low,	  at	   less	  than	  50%.	  Even	  considering	  that	  some	  of	  
iodide	  68	  has	  undergone	  dimerisation	  to	  form	  compound	  80,	  a	  significant	  amount	  of	  the	  organozinc	  
reagent	   remained	   unaccounted	   for.	   Although	   later	   reaction	   optimisation	   improved	   the	   mass	  
balance,	   the	   disappearance	   of	   the	   organozinc	   reagent	   remained	   a	   problem	   when	   trying	   to	  
understand	  what	  was	  occurring	  in	  the	  reaction	  mixture.	  
	  
One	  further	  by-­‐product	  that	  was	  identified	  from	  this	  reaction	  was	  compound	  82	  (Scheme	  53).	  This	  
compound	  must	  have	  arisen	  from	  the	  reduction	  of	  an	  alkene:	  either	   in	  the	  acid	  chloride	  prior	  to	   it	  
reacting	  with	  the	  organozinc	  reagent,	  or	  in	  the	  product	  59c	  after	  a	  successful	  cross	  coupling	  reaction	  
had	  occurred.	  This	   reduction	  may	  have	  been	  mediated	  by	   zinc	  and	  a	   small	   amount	  of	   acid,	  which	  
would	   have	   formed	   if	   any	   of	   the	   acid	   chloride	  were	   hydrolysed	   by	  water	   present	   in	   the	   reaction	  
mixture	  or	  during	  the	  aqueous	  workup.	  The	  formation	  of	  by-­‐product	  82	  was	  minimised	  by	  removing	  
the	   organozinc	   reagent	   from	   the	   excess	   zinc	   dust	   after	   the	   zinc	   insertion	   had	   occurred,	   and	  
performing	  the	  cross	  coupling	  reaction	  in	  a	  second	  flask.	  
	  
Scheme	  53.	  Possible	  routes	  to	  by-­‐product	  82.	  
	  
	  
Next,	   a	   number	   of	   the	   reaction	   conditions	   were	   changed	   in	   an	   attempt	   to	   increase	   the	   yield	   of	  
product	  59c	  (Scheme	  54	  and	  Table	  9).	  However,	  most	  of	  these	  variations	  failed	  to	  improve	  the	  yield	  




























Scheme	  54.	  Initial	  conditions	  for	  the	  reaction	  of	  organozinc	  reagent	  59c	  with	  acryloyl	  chloride.	  
	  
	  
Table	  9.	  Variables	  changed	  in	  an	  attempt	  to	  increase	  the	  yield	  of	  cross	  coupled	  product	  59c.	  
Entry	   Variable	   Yield	  of	  compound	  59c	  (%)	  
1	   Zn	  activated	  with	  BrCH2CH2Br/Me3SiCl	  in	  DMA/toluene.	   27	  
2	   3	  eq.	  acid	  chloride	  were	  used.	   25	  
3	   The	  reaction	  was	  run	  at	  50	  °C	  after	  the	  zinc	  insertion.	   25	  
4	   1.8	  eq.	  of	  LiCl	  were	  added	  after	  the	  zinc	  insertion.	   29	  
5	   Initial	  reaction	  conditions	  performed	  on	  a	  3	  mmol	  scale.	   38	  
	  
Firstly,	   the	   zinc	  was	   activated	  with	   1,2-­‐dibromoethane	   and	   trimethylsilyl	   chloride	   instead	   of	   using	  
iodine.	   However,	   this	   change	   in	   the	   zinc	   activation	   procedure	   failed	   to	   improve	   the	   yield	   of	   the	  
product	  (Table	  9,	  entry	  1).	  The	  iodine	  activation	  method	  was	  used	  thereafter,	  as	  it	  was	  quicker	  and	  
easier	  to	  perform.	  
	  
It	  was	  thought	  that	  a	  possible	  side	  reaction	  could	  be	  the	  polymerisation	  of	  the	  acid	  chloride,	  since	  
acryloyl	   residues	  are	  common	  monomers	  used	   in	   the	  production	  of	  polymers.	   In	  order	   to	   test	   this	  
theory,	  the	  amount	  of	  acid	  chloride	  was	  increased	  from	  1.3	  to	  3	  equivalents	  (entry	  2).	  However,	  this	  
also	  failed	  to	  increase	  the	  yield	  of	  the	  product.	  
	  
The	   previously	   reported	   reaction	   between	   the	   differently	   protected	   organozinc	   reagent	  57b	   and	  
acryloyl	   chloride	   was	   conducted	   at	   50	   °C,	   rather	   than	   at	   room	   temperature	   (see	   Scheme	   36	   and	  
Table	  3,	  entry	  5,	  p36).52	  However,	  increasing	  the	  temperature	  for	  the	  reaction	  of	  organozinc	  reagent	  
57c	  with	  acryloyl	  chloride	  to	  50	  °C	  had	  no	  effect	  on	  the	  yield	  of	  the	  product	  (Table	  9,	  entry	  3).	  
	  
One	   further	   attempt	   to	   optimise	   the	   yield	   involved	   the	   addition	   of	   1.8	   equivalents	   of	   LiCl	   to	   the	  






















improve	   the	   yield	   of	   the	   Negishi	   cross	   coupling	   reaction	   between	   nBuZnBr	   and	   3-­‐bromo-­‐1-­‐
phenylpropane.85	  They	  proposed	  that	  the	  role	  of	  the	  anion	  from	  the	  Lewis	  acid	  was	  to	  form	  higher	  
order	   zincates,	   which	   were	   more	   reactive	   towards	   transmetallation	   than	   the	   corresponding	  
organozinc	  halide.85-­‐86	  Recent	  work	  within	   the	   Jackson	  group	  work	  has	   shown	   that	   these	  additives	  
can	  be	  used	  to	  improve	  the	  yield	  of	  the	  Negishi	  cross	  coupling	  reaction	  between	  organozinc	  reagent	  
57c	   and	   unreactive	   electrophiles,	   including	   some	   cycloalkenyl	   triflates87	   and	   2-­‐iodothiophene.88	  
Even	  though	  acryloyl	  chloride	  is	  a	  very	  reactive	  electrophile,	  the	  addition	  of	  LiCl	  was	  investigated	  on	  
one	  occasion.	  However,	  no	  significant	  improvement	  in	  yield	  was	  observed.	  
	  
Pleasingly,	  increasing	  the	  scale	  of	  the	  reaction	  from	  1	  mmol	  to	  3	  mmol	  showed	  approximately	  a	  10%	  
improvement	  in	  the	  yield,	  resulting	  in	  38%	  of	  the	  desired	  product	  59c	  (entry	  5).	  One	  possible	  reason	  
for	   this	   increase	   in	   yield	   is	   the	  aforementioned	   sensitivity	  of	   the	  organozinc	   reagent	   to	  water	  and	  
oxygen	   impurities	   (see	  Scheme	  52	  and	  Scheme	  53,	  p51).	  On	  a	   larger	   scale,	   the	   relative	  amount	  of	  
any	  water	  or	  oxygen	  impurities	  compared	  to	  the	  amount	  of	  organozinc	  reagent	  present	  will	  be	  less,	  
and	  therefore	  the	  amount	  of	  undesired	  by-­‐products	  arising	  from	  these	  impurities	  will	  be	  reduced.	  
	  
It	   was	   also	   discovered	   that	   the	   length	   of	   time	   allowed	   for	   the	   zinc	   insertion	   was	   important,	   and	  
needed	   to	  be	  minimised.	  Careful	  monitoring	  of	   the	   zinc	   insertion	   to	  completion	  by	  TLC	   (≥10	  min),	  
followed	   by	   immediate	   addition	   of	   the	   remaining	   reagents	   to	   the	   same	   flask	   (i.e.	   no	   longer	  
transferring	   the	   organozinc	   reagent	   away	   from	   the	   excess	   zinc)	   resulted	   in	   yields	   of	   the	   product	  
ranging	  from	  36	  to	  49%.	  
	  
Finally,	   it	   was	   noted	   that	   the	   addition	   of	   the	   acid	   chloride	   caused	   an	   exotherm	   to	   occur.	   It	   was	  
thought	   that	   an	   increase	   in	   temperature	   might	   cause	   degradation	   of	   the	   sensitive	   organozinc	  
reagent,	   and	   so	  precautions	  were	   taken:	   the	   reaction	   flask	  was	  placed	   in	  a	  water	  bath	  before	   the	  
acid	  chloride	  was	  added,	  and	  the	  acid	  chloride	  was	  added	  slowly	  over	  a	  period	  of	  5	  minutes.	  
	  
All	   of	   these	   adaptations	   taken	   together	   make	   up	   the	   optimised	   conditions	   for	   the	   reaction	   of	  
organozinc	  reagent	  57c	  with	  acryloyl	  chloride,	  which	  have	  reproducibly	  given	  yields	  of	  the	  desired	  
product	  59c	  between	  51	  and	  66%	  on	  a	  3	  mmol	  scale	  (Scheme	  55).	  Scaling	  up	  the	  reaction	  to	  a	  10	  
mmol	  scale	  gave	  yields	  of	  up	  to	  53%	  of	  the	  product,	  although	  the	  consistency	  of	  the	  reaction	  yield	  









2.2.2	  N-­‐Boc	  Protected	  Organozinc	  Reagents	  
	  
With	  a	  set	  of	  optimised	  conditions	  in	  hand,	  attention	  was	  turned	  to	  the	  other	  Boc	  protected	  amino	  
acid	  derived	  organozinc	  reagents	  of	  interest.	  The	  L-­‐valine	  and	  L-­‐alanine	  derived	  organozinc	  reagents	  
62a	  and	  65a	  were	  reacted	  with	  acryloyl	  chloride	  under	  the	  optimised	  reaction	  conditions,	  namely	  
performing	  the	  reaction	  on	  a	  3	  mmol	  scale,	  carefully	  monitoring	  the	  zinc	  insertion	  to	  completion	  by	  
TLC	  and	  adding	  the	  acid	  chloride	  slowly	  with	  the	  reaction	  flask	  placed	  in	  a	  water	  bath	  (Scheme	  56).	  It	  
should	   be	   noted	   that	   the	   yields	   quoted	   for	   the	   cross	   coupling	   reactions	   reported	   from	   this	   point	  
forward	  are	  the	  best	  yields	  achieved	  in	  each	  case;	  however,	  the	  efficiency	  of	  these	  reactions	  proved	  
to	   be	   somewhat	   erratic,	   and	   a	   large	   variability	   in	   the	   yield	   of	   the	   desired	   products	  was	   generally	  
observed.	  
	  
Scheme	   56.	   Application	   of	   the	   optimised	   cross	   coupling	   conditions	   to	   the	   reaction	   of	   acryloyl	  
chloride	   with	   the	   L-­‐valine	   and	   L-­‐alanine	   derived	   organozinc	   reagents	  62a	   and	  65a,	   formed	   from	  
iodides	  61a	  and	  64a.	  
	  
a	  Yield	  calculated	  from	  1H	  NMR	  spectrum	  due	  to	  presence	  of	  compound	  85a	  (see	  Figure	  27,	  p57).	  
	  
Pleasingly,	   for	   L-­‐valine	   derived	   organozinc	   reagent	  62a	   the	   product	  83a	   was	   formed,	   albeit	   in	   a	  




i) 3 eq. Zn, 16 mol% I2 







ii) 5 mol% (Ph3P)2PdCl2, toluene














iii)                  over 5 min
R = iPr, 83a, 46%a
R = Me, 84a, 0%
R = iPr, 61a, 2.9 mmol scale
R = Me, 64a, 3.0 mmol scale then o/n
	  	  
	  56	  
84a	  was	  observed.	  When	  organozinc	  reagent	  65a	  was	  previously	  synthesised,	  the	  zinc	  insertion	  was	  
performed	  at	  0	  °C	  due	  to	  the	   instability	  of	  the	  organozinc	  reagent	  (see	  Scheme	  40,	  p38).59	  For	  this	  
reason,	  the	  reaction	  was	  repeated,	  with	  the	  formation	  of	  the	  organozinc	  reagent	  and	  the	  addition	  of	  
the	   acid	   chloride	  being	   carried	  out	   at	   0	   °C,	   before	   the	   reaction	  was	   allowed	   to	  warm	  up	   to	   room	  
temperature	  overnight	  (Scheme	  57).	  1H	  NMR	  analysis	  of	  the	  crude	  reaction	  mixture	  showed	  that	   it	  
consisted	   of	   an	   approximately	   4:1	   mixture	   of	   the	   iodide	   64a	   and	   the	   desired	   product	   84a,	  
suggesting	   that	   the	  zinc	   insertion	  reaction	  had	  not	  gone	  to	  completion.	   1H	  NMR,	   13C	  NMR	  and	  MS	  
analysis	   of	   the	   fractions	   collected	   after	   column	   chromatography	   confirmed	   the	   presence	   of	   the	  
desired	  product,	  albeit	  in	  a	  very	  low	  yield	  (<6%).	  
	  
Scheme	   57.	   Adaptation	   of	   the	   optimised	   cross	   coupling	   conditions	   to	   the	   reaction	   of	   acryloyl	  
chloride	  with	  organozinc	  reagent	  65a,	  formed	  from	  iodide	  64a.	  
	  
	  
In	   both	   of	   the	   cross	   coupling	   reactions	   of	   N-­‐Boc	   amino	   organozinc	   reagents	   62a	   and	   65a,	   an	  
unexpected	   by-­‐product	   85a	   was	   observed	   by	   1H	   NMR	   spectroscopy	   (Figure	   27).	   A	   plausible	  
mechanism	   for	   the	   formation	   of	   this	   by-­‐product	   involves	   syn	   β-­‐elimination	   of	   the	   organozinc	  
reagents,	   initiated	   by	   an	   interaction	   between	   the	   carbonyl	   of	   the	   carbamate	   and	   the	   electron	  
deficient	  zinc	  atom.	  This	  is	  known	  to	  be	  a	  major	  decomposition	  pathway	  for	  this	  class	  of	  molecules	  
(see	  Chapter	  1.4.2.3,	  p40).	  Once	  formed,	  zinc	  enolate	  86	  could	  then	  react	  with	  acryloyl	  chloride	  to	  
produce	  the	  observed	  compound	  85a.	   It	  may	  be	  that	  not	  all	  of	  compound	  86	  reacts	  with	  the	  acid	  
chloride,	   and	   some	   of	   it	   is	   protonated	   upon	   workup	   to	   give	   tert-­‐butyl	   carbamate.	   The	   possible	  
formation	  of	  this	  compound,	  coupled	  with	  the	  loss	  of	  the	  volatile	  alkene	  by-­‐product	  produced	  during	  
β-­‐elimination,	   goes	   some	  way	   to	  explaining	   the	  poor	  mass	  balance	  observed	   for	   the	  Negishi	   cross	  


















3 mmol scale then 0 °C to r.t. o/n
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Figure	  27.	  Plausible	  route	  to	  by-­‐product	  85a	  via	  β-­‐elimination	  of	  organozinc	  reagents	  62a	  and	  65a,	  
and	  possibility	  of	  the	  production	  of	  tert-­‐butyl	  carbamate	  as	  another	  by-­‐product.	  
	  
	  
The	  fact	  that	  by-­‐product	  85a	  was	  formed	  for	  L-­‐valine	  and	  L-­‐alanine	  derived	  organozinc	  reagents	  62a	  
and	  65a,	   but	  was	   not	   observed	   during	   the	   cross	   coupling	   reaction	   of	   L-­‐serine	   derived	   organozinc	  
reagent	  57c,	  highlights	  the	  comparative	  stability	  of	  organozinc	  reagent	  57c	  to	  β-­‐elimination.	  This	  is	  
thought	  to	  be	  due	  to	  a	  stabilising	  interaction	  between	  the	  ester	  carbonyl	  and	  the	  electron	  deficient	  
zinc	   atom	   (Figure	   28,	   see	   also	   Table	   8,	   p42),	   which	   can	   compete	   with	   the	   key	   carbamate-­‐zinc	  
interaction.	  This	  ester-­‐zinc	  interaction	  is	  not	  present	  in	  compounds	  62a	  and	  65a,	  and	  therefore	  β-­‐
elimination	   is	  expected	  to	  occur	  more	  quickly.	  Although	  the	  decomposition	  of	  organozinc	  reagents	  
62a	   and	   65a	   has	   not	   been	   studied	   kinetically,	   the	   rate	   of	   β-­‐elimination	   for	   the	   analogous	   L-­‐
phenylalanine	   derived	   zinc	   reagent	  87	   (Figure	   28,	   R	   =	   CH2Ph)	   has	   previously	   been	   determined.89	  
Compound	   87	  was	   found	   to	   undergo	   elimination	   almost	   five	   times	   faster	   than	   L-­‐serine	   derived	  
organozinc	  reagent	  57c	  (k	  =	  9.7	  ×	  10-­‐6	  s-­‐1	  cf.	  k	  =	  2.0	  ×	  10-­‐6	  s-­‐1),	  a	  difference	  that	  is	  consistent	  with	  the	  
proposed	  stabilisation	  of	  compound	  57c	  as	  the	  result	  of	  an	  ester-­‐zinc	  interaction.	  
	  
Figure	  28.	  Stabilising	  ester-­‐zinc	  interaction	  in	  organozinc	  reagent	  57c,	  which	  can	  compete	  with	  the	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R = CO2Me, 57c 
R = iPr, 62a
R = Me, 65a





2.2.3	  N-­‐TFA	  Protected	  Organozinc	  Reagents	  
	  
In	  order	   to	   try	  and	  avoid	   the	  problem	  of	  β-­‐elimination,	  attention	  was	  next	   turned	   to	   the	  nitrogen	  
protecting	  group.	  The	  trifluoroacetyl	  protecting	  group	  has	  previously	  been	  employed	  by	  Jackson	  and	  
co-­‐workers,	  who	  used	  it	  to	  slow	  down	  the	  elimination	  of	  β-­‐amido	  organozinc	  reagents	  (see	  Chapter	  
1.4.2.3,	  p40).66	  Therefore,	  the	  reactions	  of	  N-­‐TFA	  protected	  organozinc	  reagents	  62b	  and	  65b	  with	  
acryloyl	   chloride	  were	   attempted	   (Scheme	  58).	   L-­‐Valine	   derived	  organozinc	   reagent	  62b	   gave	   the	  
product	  83b	   in	   a	   similar	   yield	   to	   its	   Boc	   protected	   analogue	   (41%	   cf.	   46%,	   see	   Scheme	   56,	   p55).	  
However,	   in	   contrast	   to	   its	   Boc	   protected	   analogue	  65a	   (see	   Scheme	   57,	   p56),	   L-­‐alanine	   derived	  
organozinc	   reagent	  65b	   reacted	   with	   acryloyl	   chloride	   to	   give	   the	   product	  84b	   in	   a	  much	  more	  
respectable	  yield	  of	  48%.	  
	  
Scheme	   58.	   Application	   of	   the	   optimised	   cross	   coupling	   conditions	   to	   the	   reaction	   of	   acryloyl	  
chloride	   with	   the	   L-­‐valine	   and	   L-­‐alanine	   derived	   organozinc	   reagents	  62b	   and	  65b,	   formed	   from	  
iodides	  61b	  and	  64b.	  
	  
a	  Best	  yield	  achieved	  at	  3	  mmol	  scale	  was	  16%.	  
	  
In	   these	   reactions,	   the	   analogous	   elimination	   by-­‐product	   85b	   was	   not	   observed	   (Figure	   29).	  
However,	  this	  does	  not	  rule	  out	  the	  possibility	  of	  β-­‐elimination.	  Assuming	  that	  organozinc	  reagents	  
62b	  and	  65b	  underwent	  an	  anti	  elimination	  as	  proposed	  by	  Jackson	  and	  co-­‐workers66	  (see	  Scheme	  
45,	   p44),	   the	   product	   would	   be	   the	   trifluoroacetamide	   anion	   88.	   This	   species	   may	   not	   be	  
nucleophilic	  enough	  to	  react	  with	  acryloyl	  chloride,	  because	  of	  the	  electron-­‐withdrawing	  nature	  of	  
the	   CF3	   group.	   Therefore,	   the	   absence	   of	   by-­‐product	  85b	  does	   not	   prove	   that	   elimination	   is	   not	  
occurring.	  However,	  the	  fact	  that	  TFA	  protected	  organozinc	  reagent	  65b	  succeeded	  in	  forming	  the	  
desired	  cross	  coupled	  product	  84b,	  where	  its	  Boc	  protected	  analogue	  65a	  struggled,	  suggests	  that	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Figure	   29.	   Speculations	   as	   to	   the	   nucleophilicity	   of	   anion	   88,	   which	   would	   form	   if	   organozinc	  
reagents	  62b	  and	  65b	  underwent	  an	  anti	  β-­‐elimination.	  
	  
	  
In	  summary,	  the	  Negishi	  cross	  coupling	  reaction	  of	  various	  amino	  acid	  derived	  organozinc	  reagents	  
with	  acryloyl	  chloride	  proved	  successful	  in	  providing	  access	  to	  four	  key	  amino	  enone	  intermediates	  
59c,	   83a,	   83b	   and	   84b	   (Figure	   30),	   enabling	   the	   cyclisation	   of	   these	   intermediates	   to	   be	  
investigated.	  
	  
Figure	   30.	   Four	   key	   amino	   enone	   intermediates	   59c,	   83a,	   83b	   and	   84b	   synthesised	   using	   the	  
Negishi	   cross	   coupling	   reaction	   of	   various	   amino	   acid	   derived	   organozinc	   reagents	   with	   acryloyl	  
chloride.	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2.3	  Attempted	  Hydrogen	  Chloride	  Mediated	  Cyclisations	  
	  
The	  next	   step	   in	   the	  proposed	  synthetic	   route	   towards	  2-­‐substituted	  4-­‐hydroxypiperidines	  47	  was	  
the	  cyclisation	  of	  the	  cross	  coupled	  intermediates	  49	  to	  form	  4-­‐oxopiperidines	  48	  (see	  Scheme	  46,	  
p45).	  For	  the	  Boc	  protected	  compounds	  59c	  and	  83a,	  an	  acid	  mediated	  cyclisation	  was	  envisaged	  
based	  on	  very	  similar	  cyclisations	  previously	  reported	  in	  the	  literature.52,56-­‐57	  
	  
	  
2.3.1	  Literature	  Cyclisations	  
	  
The	   first	   authors	   to	   report	   such	  a	   cyclisation	  were	  Obrecht	   and	   co-­‐workers	   (Scheme	  59).56-­‐57	   They	  
claimed	   that	   by	   treating	   racemic	   protected	   4-­‐oxoamino	   acid	   (±)-­‐59b	   with	   saturated	   hydrogen	  
chloride	   in	  diethyl	  ether	   they	  were	  able	   to	  affect	  a	  global	  deprotection	  and	  carry	  out	  a	  cyclisation	  
reaction	  to	  yield	  compound	  (±)-­‐60b.	  	  
	  




Based	   on	   this	   work,	   Jackson	   and	   co-­‐workers	   synthesised	   the	   closely	   related	   substrate	   59a	   and	  


















Scheme	  60.	  The	  apparent	  cyclisation	  of	  compound	  59a	  to	  give	  compound	  60a	  reported	  by	  Jackson	  
and	  co-­‐workers.	  	  
	  
	  
The	   proposed	  mechanism	   for	   this	   reaction	   is	   based	   on	   the	   observation	  made	   by	   Jackson	   and	   co-­‐
workers	  that	  the	  Boc	  deprotection	  for	  compound	  59a	   is	  slow,	  and	  that	  the	  hydrogen	  chloride	  first	  
reacts	   with	   the	   double	   bond	   to	   form	   an	   intermediate	   β-­‐chloroketone	   89	   (Scheme	   61).	   This	  
compound	   then	  was	   proposed	   to	   react	   further	   to	   give	   cyclised	   product	  60a,	   presumably	   through	  
removal	  of	  the	  nitrogen	  protecting	  group,	  followed	  by	  an	  SN2	  reaction	  between	  the	  small	  percentage	  
of	  free	  amine	  present	  in	  solution	  (in	  equilibrium	  with	  its	  ammonium	  salt)	  and	  the	  alkyl	  chloride.	  
	  
Scheme	  61.	   The	   proposed	  mechanism	   for	   the	   reported	  hydrogen	   chloride	  mediated	   cyclisation	   of	  










































2.3.2	  Cyclisation	  Attempts	  and	  Further	  Reactions	  
	  
Given	  the	  literature	  precedent,	  the	  obvious	  first	  step	  was	  to	  treat	  compounds	  59c	  and	  83a	  with	  HCl	  
in	   Et2O.	   These	   reactions	   did	   indeed	   appear	   to	   yield	   the	   target	   compounds	   60c	   and	   90	   as	   their	  
hydrochloride	  salts	  (Scheme	  62),	  and	  the	  1H	  NMR	  data	  for	  compound	  60c	  were	  very	  similar	  to	  the	  
data	  reported	  by	  Obrecht	  for	  compound	  (±)-­‐60b	  (Table	  10).	  However,	  the	  yields	  for	  these	  reactions	  
were	  each	  greater	  than	  100%	  despite	  the	  products	  appearing	  clean	  by	  1H	  NMR	  spectroscopy,	  raising	  
doubts	  about	  the	  structure	  of	  the	  products.	  
	  
Scheme	  62.	  Presumed	  cyclisation	  of	  compounds	  59c	  and	  83a.	  	  
	  
	  
Table	  10.	  Comparison	  of	  the	  1H	  NMR	  data	  for	  compound	  60c	  with	  Obrecht’s	  data	  for	  compound	  (±)-­‐
60b.	  
1H	  NMR	  Data	  for	  
Compound	  60c	  (CD3OD)	  
Obrecht’s	  1H	  NMR	  Data	  for	  	  
Compound	  (±)-­‐60b	  (CD3OD)56-­‐57	  
3.06	  (2H,	  t,	  J	  =	  6.4)	   3.05	  (2H,	  dt,	  J	  =	  6,	  2)	  
	  
3.21–3.30	  (2H,	  m)	   3.20	  (1H,	  dd,	  J	  =	  7,	  20)	  
–	   3.29	  (1H,	  dd,	  J	  =	  4,	  20)	  
3.80	  (2H,	  t,	  J	  =	  6.4)	   3.79	  (2H,	  t,	  J	  =	  6)	  
3.84	  (3H,	  s)	   –	  































Analysis	  of	  compound	  60c	  by	  mass	  spectrometry	  showed	  the	  presence	  of	  a	  mass	   ion	  at	  158.0812,	  
consistent	  with	  the	  desired	  formula	  C7H12NO3+.	  However,	  there	  were	  also	  a	  pair	  of	  mass	  ions	  in	  a	  3:1	  
ratio	  at	  194.0577	  and	  196.0546	  that	  corresponded	  to	  the	  molecular	  formula	  C7H13ClNO3+,	  suggesting	  
that	  the	  product	  may	  contain	  one	  extra	  hydrogen	  atom	  and	  one	  extra	  chlorine	  atom.	  
	  
Further	   suspicions	   were	   aroused	   when	   the	   Boc	   protection	   of	   compounds	   60c	   and	   90	   was	  
attempted.	  After	  treatment	  with	  (Boc)2O	  and	  Et3N,	  1H	  NMR	  analysis	  of	  the	  crude	  mixtures	  showed	  
that	   the	  major	  products	  were	  actually	  compounds	  59c	  and	  83a,	   rather	   than	  the	  desired	  N-­‐Boc	  4-­‐
oxopiperidines	  91a	  and	  92a	  (Scheme	  63).	  
	  
Scheme	   63.	   Presumed	   structures	   of	   compounds	   60c	   and	   90,	   which	   were	   Boc	   protected	   to	   give	  
enones	  59c	  and	  83a	  rather	  than	  the	  expected	  piperidines	  91a	  and	  92a.	  
	  
	  
Although	  an	  E1cB	  elimination	  of	  the	  4-­‐oxopiperidines	  could	  in	  theory	  lead	  to	  the	  observed	  products	  
59c	  and	  83a,	  this	  seems	  unlikely	  as	  the	  successful	  Boc	  protection	  of	  ethyl	  4-­‐oxopipecolate	  93a	  has	  
previously	  been	  reported	  under	  very	  similar	  conditions	  (Scheme	  64).90	  
	  




















































Another	  unexpected	  result	  was	  obtained	  upon	  attempting	  the	  acidic	  ester	  hydrolysis	  of	  compound	  
60c	   (Scheme	  65).	  Two	  products	  were	  observed	  by	   1H	  NMR	  spectroscopy	   in	  a	  4:1	   ratio.	  The	  minor	  
product	  was	  identified	  as	  hydrated	  4-­‐oxopipecolic	  acid	  hydrochloride	  94a·∙H2O	  by	  comparison	  with	  
the	   literature	   1H	   NMR	   data	   for	   this	   compound,	   which	   is	   known	   to	   predominate	   over	   the	   non-­‐
hydrated	  ketone	  94a	  in	  D2O.91-­‐92	  However,	  the	  identity	  of	  the	  major	  product	  remained	  unknown.	  
	  
Scheme	  65.	  Presumed	  structure	  of	  compound	  60c	  and	  the	  products	  of	  its	  acidic	  ester	  hydrolysis.	  
	  
	  
Although	   the	   13C	  NMR	  data	   for	   this	   unknown	   compound	   are	   similar	   to	   the	   literature	   data	   for	   the	  
non-­‐hydrated	  ketone	  94a	  (Table	  11),91-­‐92	  they	  do	  not	  match	  exactly.	  This	  is	  seen	  most	  clearly	  for	  the	  
signal	   in	   the	  unknown	   compound	   at	   48.4	   ppm,	  which	   corresponds	   to	   carbon	  2	   in	   compound	  94a	  
(highlighted	  in	  red),	  which	  has	  a	  chemical	  shift	  of	  57.4	  ppm.	  Given	  this	  discrepancy,	  and	  the	  fact	  that	  
ketone	  94a	   should	   only	   be	   present	   in	   very	   small	   amounts	   due	   to	   the	   hydration	   equilibrium	   lying	  
heavily	   towards	   the	   hydrate	  94a·∙H2O,	   it	   seems	   likely	   that	   the	  major	   product	   of	   the	   acidic	   ester	  
hydrolysis	  is	  in	  fact	  another	  compound.	  
	  
Table	  11.	  Comparison	  of	  the	  13C	  NMR	  data	  for	  the	  unknown	  compound	  and	  the	  literature	  13C	  NMR	  
data	  given	  for	  the	  ketone	  94a.	  
13C	  NMR	  Data	  for	  	  
Unknown	  Compound	  (D2O)	  
Literature	  13C	  NMR	  Data	  for	  	  
Compound	  94a	  (D2O)91-­‐92	  
38.0	   37.9	  
	  
41.6	   41.2	  
44.1	   42.8	  
48.4	   57.4	  
171.1	   171.1	  

























2.3.3	  Proposed	  Structural	  Revisions	  
	  
All	   of	   these	  unexpected	   results	  brought	   the	   structure	  of	   compounds	  60c	  and	  90	   into	  question.	   It	  
was	   decided	   to	   propose	   a	   revision	   of	   the	   structures	   of	   these	   compounds	   to	   the	   β-­‐chloroketones	  
shown	  below	  (Scheme	  66),	  as	  these	  structures	  seem	  to	  better	  fit	  the	  data.	  	  
	  
Scheme	  66.	  Proposals	  for	  the	  revised	  structures	  of	  compounds	  60c	  and	  90	   in	  order	  to	  explain	  the	  
unexpected	  results.	  
	  
a	  See	  below	  for	  clarification	  about	  the	  yield	  of	  these	  reactions	  upon	  repetition.	  
	  
Firstly,	  this	  proposed	  structural	  revision	  solves	  the	  problem	  of	  the	  greater	  than	  100%	  yields	  seen	  in	  
the	  acidic	  deprotection	  of	  compounds	  59c	  and	  83a	  (see	  Scheme	  62,	  p62).	  Taking	  into	  account	  the	  
extra	   mass	   gained	   through	   addition	   of	   HCl	   to	   the	   enones,	   the	   resulting	   yields	   are	   much	   more	  
reasonable	  at	  94%	  and	  96%.	  
	  
It	   should	  be	  noted	   that	   for	  both	   reactions	   there	  were	  a	   few	  cases	  upon	   repetition	  when	   the	  yield	  
was	  calculated	  to	  be	  >100%,	  even	  after	  adjusting	   the	  molecular	  weight	  of	   the	  product	   in	   line	  with	  
the	  proposed	  structural	  revision.	  Although	  this	  appears	  problematic,	  there	  are	  a	  few	  points	  that	  help	  
to	  explain	  how	  the	  mass	  of	  the	  product	  may	  have	  been	  inflated:	  firstly,	   if	  they	  were	  any	  remaining	  
starting	  material	   (or	   intermediate	  N-­‐Boc	  β-­‐chloroketone)	  present,	   this	  would	   increase	   the	  mass	  of	  
the	  sample	  while	  perhaps	  not	  being	  visible	  in	  the	  NMR	  spectrum	  when	  D2O	  was	  used	  to	  prepare	  the	  


























Obrecht’s	  Organic	   Syntheses	  paper	   for	   a	   very	   similar	   compound,57	   the	   samples	  were	   found	   to	   be	  
hygroscopic	   while	   they	   still	   contained	   hydrogen	   chloride,	   and	   so	   extra	   mass	   may	   arise	   from	   the	  
absorption	  of	  water	  from	  the	  atmosphere;	  finally,	  if	  the	  sample	  still	  contained	  Et2O	  the	  mass	  would	  
be	  increased,	  but	  all	  of	  the	  diethyl	  ether	  may	  not	  be	  visible	  in	  the	  NMR	  spectrum,	  as	  again	  it	  is	  not	  
very	  soluble	  in	  D2O.	  As	  a	  result	  of	  the	  extensive	  evidence	  that	  the	  products	  of	  this	  type	  of	  reaction	  
are	  β-­‐chloroketones	  (see	  below),	  the	  few	  examples	  where	  the	  yield	  proved	  to	  be	  greater	  than	  100%	  
were	   put	   down	   to	   unknown	   factors	   such	   as	   those	   previously	   mentioned,	   and	   the	   yield	   of	   the	  
reactions	  of	  compounds	  60c	  and	  90	  with	  ethereal	  hydrogen	  chloride	  were	  quoted	  as	  88–98%	  and	  
96%,	  based	  on	  the	  examples	  of	  these	  reactions	  which	  gave	  product	  with	  yields	  of	  less	  than	  100%.	  
	  
The	   newly	   proposed	   structures	   explain	   the	   mass	   spectrometry	   data	   for	   compound	   60c.	   The	   β-­‐
chloroketone	   structure	   corresponds	   to	   the	  mass	   ion	  194.0577	   (with	   its	   corresponding	   37Cl	   isotope	  
196.0546),	  and	  loss	  of	  HCl	  from	  this	  compound	  during	  analysis	  would	  lead	  to	  the	  formation	  of	  enone	  
95a,	   which	   corresponds	   to	   the	   other	   mass	   ion	   158.0812	   (Scheme	   67).	   It	   should	   be	   noted	   that	  
compound	  95a	  has	  the	  same	  molecular	  formula	  as	  the	  desired	  cyclic	  product,	  explaining	  why	  there	  
initially	  seemed	  to	  be	  mass	  spectrometry	  evidence	  that	  the	  cyclisation	  had	  occurred.	  
	  
Scheme	  67.	  Proposed	  loss	  of	  HCl	  from	  compound	  60c	  during	  mass	  spectrometry.	  
	  
	  
The	  results	  of	  the	  Boc	  protections	  (see	  Scheme	  63,	  p63)	  are	  also	  consistent	  with	  these	  structures,	  as	  
loss	  of	  HCl	  from	  the	  β-­‐chloroketones	  under	  the	  basic	  reaction	  conditions	  seems	  very	  plausible,	  and	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Scheme	  68.	  Proposed	  loss	  of	  HCl	  during	  Boc	  protection	  of	  compounds	  60c	  and	  90	  leading	  to	  enones	  
59c	  and	  83a.	  
	  
	  
Finally,	  the	  results	  of	  the	  acidic	  ester	  hydrolysis	  of	  compound	  60c	  are	  also	  explained	  by	  revising	  its	  
structure.	   Under	   the	   harsh	   reaction	   conditions	   it	   seems	   reasonable	   that	   a	   small	   amount	   of	   the	  
starting	  material	   could	  undergo	  an	  SN2	   cyclisation	   reaction	  as	  well	   as	   the	  desired	  ester	  hydrolysis,	  
leading	   to	   cyclised	   compound	  94a·∙H2O	   (Scheme	   69).	   In	   line	  with	   these	   proposals,	   the	   previously	  
unknown	  structure	  of	   the	  major	  product	   can	  be	  assigned	  as	   the	  uncyclised	  β-­‐chloroketone	   shown	  
below.	  
	  


















































2.3.4	  Repetition	  of	  Literature	  Cyclisation	  
	  
Given	  the	  evidence	  outlined	  above	  that	  the	  products	  of	  the	  acidic	  deprotection	  reactions	  appear	  to	  
be	   uncyclised	   β-­‐chloroketones	   rather	   than	   cyclised	   4-­‐oxopiperidines,	   the	   results	   of	   the	   cyclisation	  
reported	  previously	  by	  Jackson	  and	  co-­‐workers	  (Scheme	  60)52	  and	  ultimately	  the	  original	  cyclisation	  
reported	   by	   Obrecht	   and	   co-­‐workers	   (Scheme	   59)56-­‐57	   were	   also	   brought	   into	   question.	   It	   was	  
decided	   to	   attempt	   to	   repeat	   the	   original	   cyclisation	   reported	   by	   Obrecht.	   To	   this	   end,	  
enantiomerically	   pure	   starting	   material	   59b	   was	   synthesised	   in	   two	   steps	   from	   commercially	  
available	  N-­‐Boc-­‐L-­‐serine	  tert-­‐butyl	  ester	  (Scheme	  70).	  
	  
Scheme	  70.	  Synthesis	  of	  compound	  59b.	  
	  
	  
Once	   synthesised,	   compound	  59b	  was	   subjected	   to	   the	   exact	   cyclisation	   conditions	   described	   by	  
Obrecht	   and	   co-­‐workers,	   namely	   treatment	   with	   saturated	   hydrogen	   chloride	   in	   diethyl	   ether	  
(Scheme	  71).57	  As	  previously	  observed,	  the	  yield	  of	  the	  reaction	  provided	  some	  useful	   information:	  
from	   the	  mass	   of	   product	   isolated,	   if	   the	   cyclised	   structure	  were	   correct	   then	   the	   yield	  would	   be	  
105%,	   whereas	   if	   the	   uncyclised	   structure	   is	   assumed	   the	   yield	   would	   be	   87%.	   At	   this	   point	   the	  
product	   was	   subjected	   to	   extensive	   analysis	   to	   try	   and	   determine	   whether	   it	   was	   indeed	   4-­‐
oxopipecolic	  acid	  hydrochloride	  as	  reported,	  or	  whether	  it	  was	  actually	  the	  β-­‐chloroketone	  instead.	  
	  
Scheme	  71.	  Treatment	  of	  compound	  59b	  with	  saturated	  HCl	  in	  Et2O,	  and	  the	  two	  possible	  structures	  










































The	  characterisation	  data	  collected	  for	  the	  product	  of	  this	  reaction	  were	  first	  compared	  to	  the	  data	  
provided	   by	   Obrecht	   and	   co-­‐workers.	   The	   published	   data	  were	   limited	   to	   a	   1H	   NMR	   spectrum	   in	  
methanol-­‐d4,	   an	   IR	   spectrum	   collected	   as	   a	   Nujol	   mull	   and	   a	   melting	   point	   range.	   Given	   that	  
enantiomerically	   pure	   amino	   acid	   59b	   had	   been	   used,	   whereas	   Obrecht	   synthesised	   a	   racemic	  
compound,	   there	   was	   no	   guarantee	   that	   the	   melting	   points	   would	   match.	   However,	   the	   values	  
proved	  to	  be	  similar,	  with	  the	  product	  decomposing	  slowly	  above	  temperatures	  of	  ~145	  °C,	  whereas	  
Obrecht	   and	   co-­‐workers	   reported	   a	   decomposition	   at	   139–142	   °C.57	   The	   IR	   spectrum	  also	  broadly	  
matched	  Obrecht’s	  data,	  after	  discounting	  the	  reported	  signals	  arising	  from	  the	  use	  of	  Nujol.57	  
	  
The	  most	  important	  characterisation	  data	  reported	  were	  the	  1H	  NMR	  data.	  Comparison	  of	  the	  data	  
given	  by	  Obrecht56-­‐57	  with	  those	  collected	  for	  the	  compound	  of	  interest	  showed	  a	  good	  match	  (Table	  
12),	   giving	   confidence	   that	   the	   same	  product	  had	   indeed	  been	  made.	  The	   signal	   corresponding	   to	  
the	   doublet	   of	   doublets	   reported	   at	   3.29	   ppm	  was	   partially	   overlapping	  with	   the	   CD3OH	   residual	  
solvent	  signal	  (Figure	  31),	  but	  the	  chemical	  shift	  and	  remaining	  coupling	  constant	  of	  this	  signal	  were	  
inferred	  by	  analysis	  of	  the	  coupling	  constants	  of	  the	  other	  double	  doublet	  in	  the	  ABX	  spin	  system	  at	  
3.19	  ppm.	  
	  
Table	   12.	   Comparison	   of	   Obrecht’s	   1H	   NMR	   data	   for	   compound	   (±)-­‐60b	   and	   the	   1H	   NMR	   data	  
collected	  for	  compound	  60b.	  
1H	  NMR	  Data	  for	  
Compound	  60b	  (CD3OD)	  
Obrecht’s	  1H	  NMR	  Data	  for	  
Compound	  (±)-­‐60b	  (CD3OD)56-­‐57	  
3.06	  (2H,	  td,	  J	  =	  6.4,	  1.9)	   3.05	  (2H,	  dt,	  J	  =	  6,	  2)	  
	  
3.19	  (1H,	  dd,	  J	  =	  7.1,	  19.0)	   3.20	  (1H,	  dd,	  J	  =	  7,	  20)	  
3.29	  (1H,	  dd,	  J	  =	  3.8,	  19.0)a	   3.29	  (1H,	  dd,	  J	  =	  4,	  20)	  
3.81	  (2H,	  t,	  J	  =	  6.4)	   3.79	  (2H,	  t,	  J	  =	  6)	  
4.31	  (1H,	  dd,	  J	  =	  3.8,	  7.1)	   4.30	  (1H,	  dd,	  J	  =	  4,	  7)	  














Figure	  31.	  Overlap	  of	  double	  doublet	  of	   the	  ABX	   spin	   system	  with	   the	   residual	   solvent	  peak	   in	   1H	  
NMR	  spectrum	  of	  compound	  60b.	  
	  
	  
Given	  that	  the	  1H	  NMR	  data	  for	  the	  product	  were	  almost	  identical	  to	  those	  reported	  by	  Obrecht	  and	  
co-­‐workers,	   attention	   was	   next	   turned	   to	   the	   other	   characterisation	   data	   provided	   for	   cyclic	  
compound	  94a	   in	  the	   literature.	  This	  compound	  was	  synthesised	  independently	  by	  Burger	  and	  co-­‐
workers	   in	   1996,	   using	   a	   related	   conjugate	   addition	   reaction	   on	   the	   protected	   amino	   acid	   97	  
(Scheme	  72).91-­‐92	  The	  authors	  reported	  13C	  NMR	  data	  for	  the	  hydrate	  94a·∙H2O,	  which	  predominates	  
in	   D2O	   (97.4%	   by	   1H	   NMR	   spectroscopy).	   They	   also	   stated	   that	   the	   1H	   NMR	   data	   for	   compound	  
94a·∙H2O	   were	   essentially	   the	   same	   as	   those	   reported	   for	   the	   racemic	   hydrobromide	   salt	   of	   4-­‐




Scheme	  72.	  Synthesis	  of	  4-­‐oxo-­‐L-­‐pipecolic	  acid	  94a	  by	  Burger	  and	  co-­‐workers.	  
	  
	  
Comparison	   of	   the	   1H	   NMR	   data	   for	   compound	   60b	   and	   Herdeis’s	   data	   for	   compound	   98·∙D2O	  
showed	   significant	   differences	   (Table	   13),	  with	   the	   clearest	   difference	   being	   in	   the	  most	   shielded	  
signals	  (highlighted	  in	  red).	  	  
	  
Table	   13.	   Comparison	   of	   Herdeis’s	   1H	   NMR	   data	   for	   compound	   98·∙D2O	   and	   the	   1H	   NMR	   data	  
collected	  for	  compound	  60b.	  
1H	  NMR	  Data	  for	  
Compound	  60b	  (HCl	  salt,	  D2O)	  
Herdeis’s	  1H	  NMR	  Data	  for	  	  
Compound	  98·∙D2O	  (HBr	  salt,	  D2O)93	  
2.97	  (2H,	  t,	  J	  =	  6.1)	   1.86–2.14	  (3H,	  m)	  
	  
3.21	  (1H,	  br.	  s)	   –	  
3.23	  (1H,	  br.	  s)	   2.41	  (1H,	  ddd,	  J	  =	  2.2,	  4.0,	  14.3)	  
3.65	  (2H,	  t,	  J	  =	  6.1)	   3.23	  (1H,	  ddd,	  J	  =	  4.3,	  11.3,	  13.0)	  
–	   3.51	  (1H,	  td,	  J	  =	  13.0,	  4.3)	  
4.22	  (1H,	  t,	  J	  =	  5.1)	   4.16	  (1H,	  dd,	  J	  =	  4.0,	  11.5)	  
	  
Herdeis	  reported	  three	  protons	  giving	  a	  signal	  at	  1.86–2.14	  ppm	  and	  another	  single	  proton	  at	  2.41	  





































indicative	  of	  protons	  α	  to	  a	  hydrated	  ketone.	  The	  corresponding	  signals	  in	  the	  compound	  of	  interest	  
are	  much	  less	  shielded,	  at	  2.97,	  3.21	  and	  3.23	  ppm	  respectively.	  These	  chemical	  shifts	  are	  indicative	  
of	  protons	  α	  to	  a	  non-­‐hydrated	  ketone.	  
	  
Comparison	  of	  the	  13C	  NMR	  data	  collected	  for	  compound	  60b	  with	  the	  data	  reported	  by	  Burger	  and	  
co-­‐workers	   showed	   further	   differences,	   the	   clearest	   being	   the	   signal	   corresponding	   to	   carbon	   4	  
(highlighted	   in	   red).	   Burger	   and	   co-­‐workers	   reported	   that	   this	   signal	   has	   a	   chemical	   shift	   of	   92.4	  
ppm,	  consistent	  with	  the	  shift	  of	  a	  hydrated	  ketone.	  The	  corresponding	  signal	   in	  compound	  60b	   is	  
very	  different	  with	  a	  chemical	  shift	  of	  207.8	  ppm,	  again	  indicative	  of	  a	  non-­‐hydrated	  ketone.	  
	  
Table	  14.	  Comparison	  of	  Burger’s	  data	  13C	  NMR	  data	  for	  compound	  94a·∙D2O	  and	  the	  13C	  NMR	  data	  
collected	  for	  compound	  60b.	  
13C	  NMR	  Data	  for	  
Compound	  60b	  (D2O)	  
Burger’s	  13C	  NMR	  Data	  for	  
Compound	  94a·∙D2O	  (D2O)91-­‐92	  
38.0	   35.2	  
	  
41.6	   38.7	  
44.1	   42.5	  
48.6	  and	  48.9	   56.5	  
–	   92.4	  
171.2	   172.6	  
207.8	   –	  
	  
Analysis	   of	   the	   compound	   of	   interest	   by	  mass	   spectrometry	   again	   showed	   possible	  mass	   ions	   for	  
both	  potential	  products,	  with	  a	  signal	  at	  144.0663	  and	  pair	  of	  signals	  in	  a	  3:1	  ratio	  at	  180.0429	  and	  
182.0409.	  However,	  as	  previously	  described	  for	  compound	  60c	  (Scheme	  67),	  if	  compound	  60b	  is	  a	  
β-­‐chloroketone,	  it	  could	  easily	  lose	  HCl	  during	  the	  analysis	  to	  produce	  compound	  95b,	  which	  has	  the	  
same	  exact	  mass	  as	  the	  cyclic	  product	  reported	  (Scheme	  73).	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Although	  it	  proved	  very	  difficult	  to	  establish	  the	  structure	  of	  the	  product	  of	  the	  literature	  cyclisation	  
conclusively	  using	  mass	  spectrometry,	  it	  was	  thought	  that	  elemental	  analysis	  might	  be	  a	  more	  useful	  
tool,	   as	   this	   technique	   should	  be	   able	   to	  distinguish	  between	   the	  possible	   cyclised	  and	  uncyclised	  
structures,	  on	  the	  basis	  of	  their	  differing	  numbers	  of	  chlorine	  atoms	  (Scheme	  74).	  
	  
Scheme	  74.	  Possible	  structures	  and	  molecular	  formulae	  of	  compound	  60b.	  
	  
	  
Table	   15.	   Comparison	   of	   the	   calculated	   and	   experimental	   elemental	   compositions	   for	   compound	  
60b.	  
Formula	   Carbon	  (%)	   Hydrogen	  (%)	   Nitrogen	  (%)	   Chlorine	  (%)	  
C6H10ClNO3	   40.12	   5.61	   7.80	   19.74	  
C6H12ClNO4	   36.47	   6.12	   7.09	   17.94	  
C6H11Cl2NO3	   33.35	   5.13	   6.48	   32.82	  
Experimental	  Values	   33.80	   4.59	   6.14	   31.67	  
	  
Although	   the	   absolute	   percentage	   difference	   between	   the	   experimental	   values	   for	   the	   elemental	  
composition	   and	   the	   calculated	   values	   are	   relatively	   large	   in	   all	   cases,	   it	   is	   very	   clear	   that	   the	   β-­‐
chloroketone	   structure	   fits	   the	  experimental	  data	   the	   closest,	  with	   the	   starkest	  difference	   seen	   in	  
the	  percentage	  of	  chlorine	  (Table	  15	  and	  Graph	  1).	   	  It	   is	  interesting	  to	  note	  that	  elemental	  analysis	  
provided	   the	  most	   conclusive	  evidence	  as	   to	   the	   identity	  of	   compound	  60b,	   despite	   the	   fact	   that	  
over	  180	  years	  have	  passed	  since	  Liebig	  developed	  the	  capability	  to	  easily	  perform	  the	  technique	  in	  
the	   laboratory.94	   This	   shows	   the	   continuing	   value	   of	   elemental	   analysis	   to	   the	   organic	   chemist,	  





















Graph	  1.	   The	  absolute	  difference	  between	   the	   calculated	  elemental	   compositions	   for	   the	  possible	  
structures	  of	  compound	  60b	  and	  the	  experimentally	  determined	  elemental	  composition.	  
	  
	  
	   	  
2.3.5	  Analysis	  of	  Yields	  for	  Literature	  Cyclisations	  
	  
It	   has	   already	   been	   observed	   that	   the	   yields	   for	   the	   reaction	   of	   amino	   enones	   with	   hydrogen	  
chloride	  in	  diethyl	  ether	  were	  found	  to	  be	  greater	  than	  100%	  when	  a	  cyclic	  structure	  of	  the	  product	  
was	  assumed	  (see	  Scheme	  62,	  p62	  and	  Scheme	  71,	  p68).	  However,	  when	  Obrecht	  and	  co-­‐workers	  
reported	   the	   reaction	   of	   amino	   enone	   (±)-­‐59b	   with	   hydrogen	   chloride	   in	   diethyl	   ether,	   they	  
reported	  yields	  of	  100%	  and	  99%	  for	  their	  cyclic	  product.56-­‐57	  It	  was	  decided	  to	  re-­‐examine	  these	  two	  
papers,	  paying	  careful	  attention	  to	  the	  yields	  that	  were	  reported	  and	  the	  calculations	  that	  were	  used	  
to	  work	  out	  these	  yields.	  
	  
The	  earlier	  of	  the	  two	  papers	  of	  interest	  was	  published	  in	  Synthetic	  Communications	  in	  1988.56	  In	  it,	  
Obrecht	   and	   co-­‐worker	   reported	   the	   reaction	   of	   amino	   enone	   (±)-­‐59b	   with	   ethereal	   hydrogen	  














































Scheme	   75.	   Reaction	   of	   amino	   enone	   (±)-­‐59b	   with	   ethereal	   hydrogen	   chloride,	   as	   reported	   by	  
Obrecht	  and	  co-­‐worker	  in	  Synthetic	  Communications.56	  	  
	  
	  
By	  calculating	  the	  yield	  using	  the	  masses	  of	  starting	  material	   (SM)	  and	  product	  (P)	  recorded	   in	  the	  
paper,	   a	   slightly	   lower	   yield	   of	   95%	   is	   obtained	   (Equation	   1).	   It	   is	   unclear	   why	   there	   is	   a	   small	  
discrepancy	   between	   the	   yield	   reported	   in	   the	   paper	   and	   the	   yield	   calculated	   from	   the	   recorded	  
data;	  however,	  this	  difference	   is	  unimportant	  for	  the	  current	  discussion,	  as	  both	  values	  are	  ≤100%	  
and	  therefore	  are	  feasible	  yields	  for	  the	  synthesis	  of	  the	  claimed	  cyclic	  product	  (±)-­‐60b.	  
	  
Equation	  1:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑎𝑠𝑠!/𝑀!!𝑚𝑎𝑠𝑠!"/𝑀!!" = 170/179.60298/299.36×100 = 0.946547880.99545697×100 = 95%	  
	  
The	  second	  paper	  of	  interest	  by	  Obrecht	  was	  published	  in	  Organic	  Syntheses	  in	  1993.57	  The	  reaction	  
of	   amino	   enone	   (±)-­‐59b	  with	   hydrogen	   chloride	   was	   reported	   to	   be	   performed	   on	   a	   30.8	  mmol	  
scale,	  and	  the	  yield	  was	  quoted	  to	  be	  99%	  (Scheme	  76).	  
	  
Scheme	   76.	   Reaction	   of	   amino	   enone	   (±)-­‐59b	   with	   ethereal	   hydrogen	   chloride,	   as	   reported	   by	  
Obrecht	  and	  co-­‐workers	  in	  Organic	  Syntheses.57	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The	  reported	  yield	   is	  based	  on	  the	  claim	  that	   the	  reaction	  was	  carried	  out	  upon	  30.8	  mmol	  of	   the	  
starting	  material	   (which	   is	   the	   limiting	   reagent);	   using	   this	   value	   in	   the	   yield	   calculation	   gives	   the	  
yield	  to	  be	  99%,	  the	  same	  value	  as	  the	  paper	  (Equation	  2).	  
	  
Equation	  2:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑎𝑠𝑠!/𝑀!!𝑚𝑜𝑙𝑒𝑠!" = 5.48/179.600.0308 ×100 = 0.030512250.0308 ×100 = 99%	  
	  
However,	  when	   the	   number	   of	  moles	   of	   the	   starting	  material	   is	   calculated	   using	   the	  mass	   of	   the	  
compound	  and	   its	  molecular	  weight,	   the	  smaller	  value	  of	  29.2	  mmol	   is	  obtained	  (Equation	  3).	  This	  
has	  the	  consequence	  that	  when	  this	  new	  (corrected)	  value	  for	  the	  molar	  amount	  of	  starting	  material	  
is	  introduced	  into	  the	  yield	  calculation,	  the	  corrected	  yield	  is	  found	  to	  be	  105%	  (Equation	  4).	  
	  
Equation	  3:	   	  𝑚𝑜𝑙𝑒𝑠!" = 𝑚𝑎𝑠𝑠!"𝑀!!" = 8.73299.36 = 0.02916221  𝑚𝑜𝑙 ≈ 29.2  𝑚𝑚𝑜𝑙	  
Equation	  4:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑎𝑠𝑠!/𝑀!!𝑚𝑎𝑠𝑠!"/𝑀!!" = 5.48/179.608.73/299.36×100 = 0.030512250.02916221×100 = 105%	  
	  
If	   the	   yield	   is	   calculated	   for	   this	   reaction	   assuming	   the	   product	   is	   actually	   the	   uncyclised	   β-­‐
chloroketone	  (Mr	  =	  216.06	  gmol-­‐1),	  a	  yield	  of	  87%	  is	  now	  obtained	  (Equation	  5).	  	  
	  
Equation	  5:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑎𝑠𝑠!/𝑀!!𝑚𝑎𝑠𝑠!"/𝑀!!" = 5.48/216.068.73/299.36×100 = 0.025363330.02916221×100 = 87%	  
	  
Therefore,	  if	  the	  product	  of	  the	  reaction	  reported	  by	  Obrecht	  and	  co-­‐workers	  in	  Organic	  Syntheses	  is	  
the	   cyclic	   4-­‐oxopiperidine	   then	   the	   yield	   is	   105%,	   whereas	   if	   the	   product	   is	   the	   acyclic	   β-­‐
chloroketone	  then	  the	  yield	  is	  87%	  (Scheme	  77).	  This	  anomaly	  in	  the	  yield	  of	  the	  product	  as	  reported	  
by	  Obrecht	  and	  co-­‐workers	  appears	  to	  have	  gone	  unnoticed	  due	  to	  an	  error	  in	  calculating	  the	  molar	  
amount	   of	   starting	  material	   used	   in	   the	   reaction.	   It	   is	   noteworthy	   that	   the	   corrected	   yields	   now	  
match	  the	  yields	  achieved	  when	  the	  current	  author	  repeated	  this	  reaction	  (see	  Scheme	  71,	  p68).	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Scheme	   77.	   Possible	   structures	   and	   yields	   of	   compound	   (±)-­‐60b,	   based	   on	   the	   data	   reported	   by	  
Obrecht	  and	  co-­‐workers	  in	  Organic	  Syntheses.57	  
	  	  
	  
Of	  course,	   it	   is	  possible	  that	  of	  the	  two	  pieces	  of	   inconsistent	   information	  provided	  by	  Obrecht	  for	  
the	  starting	  material	  (±)-­‐59b	  (mass	  =	  8.73	  g,	  molar	  amount	  =	  30.8	  mmol)	  the	  mistake	  has	  actually	  
been	  made	  in	  recording	  the	  mass,	  and	  30.8	  mmol	  of	  compound	  (±)-­‐59b	  were	  used	  in	  the	  reaction.	  
However,	  this	  seems	  unlikely	  when	  the	  preceding	  reaction	  is	  considered,	  in	  which	  amino	  enone	  (±)-­‐
59b	  was	  synthesised	   from	  protected	  glycine	  99,	  with	   the	   reported	  yields	   ranging	   from	  33	   to	  36%	  
(Scheme	  78).57	  
	  
Scheme	  78.	  Synthesis	  of	  amino	  enone	  (±)-­‐59b	  from	  protected	  glycine	  99.57	  
	  
	  
If	  these	  yields	  are	  calculated	  using	  the	  masses	  given	  in	  the	  paper,	  the	  lower	  limit	  of	  33%	  is	  found	  to	  
be	   correct	   (Equation	   6),	   but	   the	   upper	   limit	   of	   36%	   is	   wrong;	   the	   correct	   yield	   for	   8.73	   g	   of	  
compound	  (±)-­‐59b	   is	  actually	  34%,	  as	  this	  mass	  of	  compound	  corresponds	  to	  29.2	  mmol	  (Equation	  
7).	   A	   yield	   of	   36%	   would	   have	   resulted	   if	   30.8	   mmol	   of	   compound	   (±)-­‐59b	   had	   been	   produced	  
(Equation	  8).	  It	  is	  this	  same	  incorrect	  molar	  amount	  that	  is	  quoted	  for	  the	  reaction	  of	  compound	  (±)-­‐
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number	  of	  moles	  of	  compound	  (±)-­‐59b	  produced	  from	  protected	  glycine	  99	  was	  then	  responsible	  
for	   the	  mistake	  made	   in	  calculating	   the	  yield	  of	   the	  product	  of	   the	   reaction	  of	  compound	   (±)-­‐59b	  
with	  hydrogen	  chloride.	  
	  
Equation	  6:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑎𝑠𝑠!/𝑀!!𝑚𝑎𝑠𝑠!"/𝑀!!" = 8.44/299.3620.0/231.29×100 = 0.028193480.08647153×100 = 33%	  
Equation	  7:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑎𝑠𝑠!/𝑀!!𝑚𝑎𝑠𝑠!"/𝑀!!" = 8.73/299.3620.0/231.29×100 = 0.029162210.08647153×100 = 34%	  
Equation	  8:	   	  𝑦𝑖𝑒𝑙𝑑 = 𝑚𝑜𝑙𝑒𝑠!𝑚𝑎𝑠𝑠!"/𝑀!!" = 0.030820.0/231.29×100 = 0.03080.08647153×100 = 36%	  
	  
Unfortunately,	  Jackson	  and	  co-­‐workers’	  previous	  paper	  reporting	  a	  very	  similar	  cyclisation52	  (based	  
heavily	  on	  the	  precedent	  set	  by	  Obrecht	  and	  co-­‐workers)	  was	  published	  in	  Tetrahedron	  Letters	  and	  
contained	  no	  experimental	  data.	  A	  careful	  search	  of	  the	  relevant	  laboratory	  notebooks	  also	  failed	  to	  
yield	   enough	   useful	   information	   to	   enable	   an	   analysis	   of	   the	   yield	   for	   this	   reaction,	   which	   was	  
quoted	  to	  be	  100%	  in	  the	  paper.	  However,	  it	  is	  now	  believed	  that	  the	  product	  of	  this	  reaction	  60a	  is	  
actually	  the	  β-­‐chloroketone	  rather	  than	  the	  4-­‐oxopipecolate	  (Scheme	  79),	  in	  line	  with	  the	  evidence	  
outlined	  above	  for	  related	  reactions.	  
	  
Scheme	   79.	   The	   reaction	   of	   amino	   enone	   59a	   with	   ethereal	   hydrogen	   chloride,	   which	   is	   now	  
believed	   to	   have	   given	   the	   β-­‐chloroketone	   product,	   rather	   than	   the	   4-­‐oxopipecolate	   previously	  
reported	  by	  Jackson	  and	  co-­‐workers.	  
	  
	  
To	   summarise,	   an	   analysis	   of	   the	   yield	   of	   the	   supposedly	   cyclised	   product	   (±)-­‐60b	   reported	   by	  




















the	  checkers)	  shows	  that	  a	  mistake	  was	  made	  in	  the	  mole	  calculations,	  and	  in	  fact	  the	  yield	  of	  the	  
product	  as	  stated	  in	  the	  paper	  would	  have	  been	  105%.	  This	  unreasonable	  value	  for	  the	  reaction	  yield	  
provides	   further	   evidence	   that	   the	   product	   of	   this	   reaction	   is	   not	   the	   claimed	   4-­‐oxopiperidine.	  
However,	  if	  the	  product	  were	  actually	  the	  β-­‐chloroketone	  (as	  proposed	  by	  the	  current	  author)	  then	  





All	  of	  the	  evidence	  outlined	  above	  points	  towards	  the	  conclusion	  that	  the	  treatment	  of	  4-­‐oxoamino	  
acids	  100	  with	  hydrogen	   chloride	   in	  diethyl	   ether	   leads	   to	   the	   formation	  of	  β-­‐chloroketones	  101	  
rather	  than	  the	  previously	  reported	  4-­‐oxopiperidines	  102	  (Scheme	  80).	  
	  
Scheme	  80.	  Product	  of	  the	  treatment	  of	  4-­‐oxoamino	  acids	  100	  with	  HCl	  in	  Et2O.	  
	  
	  
This	  conclusion	  is	  supported	  by	  analysis	  of	  the	  reaction	  mechanism.	  The	  first	  step	  in	  the	  reaction	  is	  
the	   previously	   observed	   addition	   of	   hydrogen	   chloride	   to	   enone	   100	   to	   give	   intermediate	   103	  
(Scheme	  81).	  This	  is	  presumably	  followed	  by	  deprotection	  of	  the	  Boc	  group	  to	  form	  ammonium	  salt	  
101.	   It	   was	   previously	   believed	   that	   the	   small	   percentage	   of	   free	   amine	  104	  present	   in	   solution	  
then	   underwent	   an	   intramolecular	   SN2	   cyclisation	   to	   form	   the	   desired	   piperidinium	   salt	  102	   (see	  
Scheme	  61,	  p61).	  However,	  under	  the	  strongly	  acidic	  reaction	  conditions	  the	  concentration	  of	   free	  
amine	  will	  be	  very	  small,	  as	  the	  equilibrium	  will	  lie	  heavily	  towards	  the	  protonated	  amine.	  As	  such,	  it	  
seems	  entirely	  reasonable	  that	  the	  reaction	  stops	  at	  this	  point,	  yielding	  the	  β-­‐chloroketone	  101	  as	  























Scheme	  81.	  Proposed	  mechanism	  for	  the	  treatment	  of	  4-­‐oxoamines	  100	  with	  hydrogen	  chloride	  in	  
diethyl	  ether.	  	  
	  
	  





























2.4	  Alternative	  Cyclisation	  Strategies	  
	  
Given	   that	   the	   hydrogen	   chloride	   mediated	   reactions	   were	   failing	   to	   yield	   cyclised	   products,	   an	  
alternative	   cyclisation	   strategy	   was	   sought.	   There	   were	   a	   number	   of	   potential	   challenges	   to	   be	  
overcome	  in	  achieving	  the	  desired	  cyclisation	  (Scheme	  82):	  the	  high	  electrophilicity	  of	  the	  terminal	  
enone;	  the	  low	  nucleophilicity	  of	  the	  protected	  amine;	  and	  the	  potentially	  high	  acidity	  of	  the	  protons	  
α	  to	  the	  ketone	  in	  both	  the	  starting	  material	  and	  the	  product,	  which	  could	  facilitate	  unwanted	  retro-­‐
Michael	  reactions	  (Scheme	  83).	  
	  
Scheme	  82.	  Potential	  challenges	  to	  overcome	  in	  the	  cyclisation	  of	  protected	  amino	  enones	  49.	  
	  
	  
Scheme	  83.	  An	  example	  of	  a	  deprotonation-­‐induced	  retro-­‐Michael	  reaction	  for	  compounds	  105.	  
	  
	  
Three	   distinct	   cyclisation	   strategies	   were	   envisaged,	   which	   aimed	   to	   overcome	   the	   potential	  
reactivity	  issues	  of	  amino	  enones	  49:	  activation	  of	  the	  enone	  with	  a	  Lewis	  (or	  Brønsted)	  acid	  in	  order	  
to	  increase	  its	  electrophilicity	  even	  further;	  deprotonation	  of	  the	  protected	  amine	  to	  make	  it	  more	  









































2.4.1	  Electrophile	  Activation	  Strategy	  
	  
2.4.1.1	  Trimethyl	  Orthoformate/Tosic	  Acid	  Activation	  
	  
The	  inspiration	  for	  activating	  the	  already	  reactive	  enone	  in	  order	  to	  allow	  addition	  of	  the	  relatively	  
non-­‐nucleophilic	   protected	   amine	   came	   from	   a	   paper	   published	   by	   Troin	   and	   co-­‐workers.95	   They	  
reported	   the	   cyclisation	   of	   Cbz	   protected	   amino	   enone	   106	   in	   excellent	   yield,	   using	   trimethyl	  
orthoformate	  and	  tosic	  acid	  to	  activate	  the	  enone,	  presumably	  via	   intermediate	  107	   (Scheme	  84).	  
The	  product	  was	  isolated	  as	  the	  ethylene	  glycol	  acetal	  108.	  
	  






















































When	   trying	   to	   apply	   these	   conditions,	   TFA	   protected	   amino	   enone	   83b	   was	   chosen	   as	   the	  
substrate,	  as	   it	  was	   thought	   that	   tosic	  acid	  might	  be	  able	   remove	  a	  Boc	  protecting	  group,	   causing	  
complications.	  An	  initial	  attempt	  at	  cyclising	  TFA	  protected	  compound	  83b	  under	  these	  conditions	  
gave	  rise	  to	  compounds	  109	  and	  110,	  instead	  of	  the	  desired	  cyclised	  product	  (Scheme	  85).	  
	  
Scheme	  85.	  Attempted	  cyclisation	  of	  compound	  83b.	  
	  
	  
Upon	  reflection	  this	   is	  perhaps	  unsurprising,	  as	  a	  trifluoroacetamide	  will	  be	  much	   less	  nucleophilic	  
than	  a	  benzyl	  carbamate	  due	  to	  the	  highly	  electron-­‐withdrawing	  nature	  of	   the	  CF3	  group.	  As	  such,	  
both	  the	  ethylene	  glycol	  in	  the	  reaction	  and	  the	  methanol	  formed	  during	  the	  reaction	  have	  added	  to	  
the	  enone	   in	  preference	  to	  the	  protected	  amine,	   leading	  to	  the	  observed	  products.	   In	  order	  to	  try	  
and	   avoid	   this	   problem,	   compound	  83b	  was	   reacted	   with	   tosic	   acid	   in	   dichloromethane	  without	  
trimethyl	   orthoformate	   or	   ethylene	   glycol,	   to	   try	   and	   remove	   competing	   nucleophiles	   from	   the	  
reaction	  (Scheme	  86).	  However,	  no	  cyclisation	  occurred,	  with	  compound	  111	  being	  isolated	  instead.	  
This	   appears	   to	   have	   resulted	   from	   addition	   of	  water	   to	   enone	  83b,	   followed	   by	   addition	   of	   the	  
resulting	   alcohol	  112	   to	   another	  molecule	   of	   starting	  material.	   Although	   the	   tosic	   acid	   used	  was	  
monohydrated,	   only	   10	   mol%	   of	   this	   compound	   was	   used,	   implying	   that	   there	   must	   have	   been	  
another	  source	  of	  water	  in	  the	  reaction	  to	  allow	  60%	  of	  the	  product	  to	  have	  formed.	  Given	  that	  dry	  
dichloromethane	   was	   used	   as	   the	   solvent,	   it	   may	   be	   that	   the	   product	  111	   was	   actually	   formed	  
during	  the	  aqueous	  reaction	  workup.	  
	  







































Given	  the	  intrinsic	  low	  nucleophilicity	  of	  the	  TFA	  protected	  amines	  and	  the	  susceptibility	  of	  the	  Boc	  
protected	   amines	   to	   deprotection	   under	   acidic	   conditions,	   it	   was	   decided	   to	   synthesise	   Cbz	  
protected	  amino	  enone	  59d	   in	  order	  to	  have	  a	  substrate	  more	  similar	  to	  the	   literature	  precedent.	  
The	  required	  enone	  was	  synthesised	  from	  commercially	  available	  N-­‐Cbz-­‐L-­‐serine	  methyl	  ester,	  using	  
the	   already	   established	   methodology	   involving	   iodination	   of	   the	   alcohol	   followed	   by	   organozinc	  
reagent	   formation	   and	   palladium-­‐catalysed	   Negishi	   cross	   coupling	   with	   acryloyl	   chloride	   (Scheme	  
87).	  This	  cross	  coupling	  reaction	  proceeded	  in	  54%	  yield,	  comparable	  to	  the	  yields	  achieved	  for	  Boc	  
protected	  organozinc	  reagent	  57c	   (see	  Scheme	  55,	  p55),	  suggesting	  that	   the	  Cbz	  group	   is	  another	  
viable	  choice	  of	  nitrogen	  protecting	  group	  for	  these	  cross	  coupling	  reactions.	  
	  	  
Scheme	  87.	  Synthesis	  of	  Cbz	  protected	  amino	  enone	  59d	  from	  N-­‐Cbz-­‐L-­‐serine	  methyl	  ester.	  
	  
	  
With	  Cbz	  protected	  amino	  enone	  59d	  in	  hand,	  the	  trimethyl	  orthoformate	  mediated	  cyclisation	  was	  
attempted.	  However,	  despite	  the	  similarity	  of	  compound	  59d	  to	  compound	  106,	  which	  was	  cyclised	  
using	   this	  methodology	   (see	   Scheme	   84,	   p82),95	   the	   only	   product	   isolated	   from	   this	   reaction	  was	  
methanol	  adduct	  114	  (Scheme	  88).	  
	   	  
Scheme	  88.	  Attempted	  cyclisation	  of	  compound	  59d	  using	  Troin	  and	  co-­‐workers’	  conditions.	  
	  
	  
One	  possible	  explanation	  for	  the	  formation	  of	  compound	  114	  rather	  than	  the	  desired	  piperidine	  is	  
that	   the	   methyl	   ester	   present	   in	   compound	   59d	   is	   more	   electron-­‐withdrawing	   than	   the	   phenyl	  



































that	   addition	   of	   the	   methanol	   produced	   during	   the	   reaction	   is	   more	   favourable	   than	   an	  
intramolecular	  aza-­‐Michael	  reaction.	  
	  
2.4.1.2	  Palladium(II)	  Activation	  
	  
One	  further	  attempt	  to	  encourage	  cyclisation	  involved	  the	  use	  of	  a	  palladium(II)	  catalyst	  to	  try	  and	  
activate	  the	  enone.	  This	  approach	  drew	  inspiration	  from	  the	  cyclisation	  of	  the	  related	  amino	  enone	  
115	   (Scheme	   89),	   an	   unpublished	   result	   from	   the	   Jackson	   lab,96	   based	   on	   the	   work	   reported	   by	  
Young	  and	  co-­‐workers.97	  
	  
Scheme	  89.	  Palladium(II)-­‐catalysed	  6-­‐exo-­‐trig	  cyclisation	  of	  compound	  115.96	   	  
	  
	  
However,	   despite	   the	   apparent	   similarities	  between	   compound	  115	  and	   compound	  59c,	   reacting	  
the	  latter	  with	  10	  mol%	  (MeCN)2PdCl2	  in	  CH2Cl2	  at	  room	  temperature	  or	  reflux	  for	  extended	  periods	  
of	   time	   resulted	   in	   no	   reaction,	   returning	   only	   unreacted	   starting	   material	   (Scheme	   90).	   This	  
difference	   in	   the	   ease	   of	   performing	   these	   very	   similar	   6-­‐endo-­‐trig	   and	   6-­‐exo-­‐trig	   cyclisations	   is	  
interesting	   given	   that	   both	   are	   favoured	  by	  Baldwin’s	   rules.98	   It	  may	  be	   the	   result	   of	   the	   reduced	  
flexibility	  of	  compound	  59c,	  due	  to	  the	  presence	  of	  two	  sp2	  atoms	  (carbons	  4	  and	  5,	  highlighted	  in	  
red)	   between	   the	   nitrogen	   and	   carbon	   atoms	   that	   need	   to	   interact	   in	   order	   for	   the	   cyclisation	   to	  
occur.	  
	  
Scheme	  90.	  Unsuccessful	  attempt	  to	  cyclise	  compound	  59c	  using	  Pd(II)	  catalysis.	  

























2.4.2	  Deprotonation	  Strategy	  
	  
2.4.2.1	  Deprotonation	  Using	  Sodium	  Hydride	  
	  
Given	   the	   lack	  of	   success	  achieving	   cyclisation	  by	  activating	   the	  electrophile,	   another	  method	  was	  
sought.	  A	  deprotonation	  of	   the	  protected	  amine	  was	  envisaged,	  based	  on	  unpublished	  work	   from	  
the	   Jackson	   group	   involving	   the	   deprotonation	   and	   subsequent	   cyclisation	   of	   a	   number	   of	   amino	  
allylic	  chlorides	  116	  to	  yield	  5-­‐methylenepiperidines	  117	  (Scheme	  91).99	  
	  
Scheme	  91.	  Base	  mediated	  cyclisation	  of	  amino	  alkenes	  116.	  
	  
	  
Although	  the	  previous	  work	  showed	  that	  sodium	  hydride	  was	  basic	  enough	  to	  deprotonate	  both	  Boc	  
and	  TFA	  protected	  amines,	  TFA	  protected	  amino	  enone	  83b	  was	  chosen	  as	  the	  substrate,	  since	  the	  
trifluoroacetamide	   proton	   should	   be	   significantly	   more	   acidic	   than	   the	   corresponding	   tert-­‐butyl	  
carbamate	  proton.	  Accordingly,	  compound	  83b	  was	  treated	  with	  sodium	  hydride	  in	  DMF,	  before	  the	  
reaction	  was	  quenched	  with	  water	  (Scheme	  92).	  	  
	  	  
Scheme	  92.	  Attempted	  base-­‐promoted	  cyclisation	  of	  compound	  83b.	  
	  
	  
It	  was	  difficult	  to	  determine	  whether	  cyclisation	  had	  occurred	  due	  to	  the	  broad	  nature	  of	  the	  peaks	  
in	   the	   1H	   NMR	   spectrum,	   although	   the	   lack	   of	   alkene	   protons	   looked	   promising.	   Analysis	   of	   the	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molecules	   of	   product	   (and/or	   starting	   material),	   suggesting	   an	   oligomerisation	   process.	   One	  
plausible	  possibility	  is	  that	  the	  base	  remaining	  in	  the	  reaction	  mixture	  after	  the	  cyclisation	  promotes	  
an	  aldol	  self-­‐condensation	  of	  4-­‐oxopiperidine	  92b,	  leading	  to	  oligomeric	  material	  118	  (Scheme	  93).	  	  
	  
Scheme	  93.	  Possible	  aldol	  oligomerisation	  of	  compound	  92b.	  
	  
	  
Alternatively,	  the	  initial	  enolate	  119	  formed	  after	  conjugate	  addition	  could	  add	  to	  another	  molecule	  
of	  starting	  material	  (Scheme	  94).	  This	  would	  form	  another	  enolate	  120,	  allowing	  the	  oligomerisation	  
process	  to	  continue.	  
	  
Scheme	  94.	  Possible	  oligomerisation	  process	  involving	  sequential	  conjugate	  addition	  reactions.	  
	  
	  
In	  the	  previous	  group	  work,	  one	  of	  the	  products	  117a	  (PG	  =	  Boc,	  R	  =	  CO2Me,	  see	  Scheme	  91,	  p86)	  
was	  no	  longer	  enantiomerically	  pure	  after	  a	  standard	  aqueous	  workup.99	  This	  is	  because	  the	  sodium	  















n = 1, observed m/z =  734.3.
n = 2, observed m/z =  971.4
n = 3, observed m/z = 1208.5





















relatively	   acidic	   stereocentre.	   This	   racemisation	   process	   was	   avoided	   by	   using	   a	   pH	   7	   phosphate	  
buffer	   solution	   in	   the	  workup.	   In	   order	   to	   test	  whether	   the	   oligomerisation	   process	   observed	   for	  
compound	   83b	   was	   caused	   by	   sodium	   hydroxide	   formed	   during	   the	   workup,	   the	   reaction	   was	  
repeated	  using	  a	  pH	  7	  phosphate	  buffer	  workup.	  Although	  analysis	  of	  the	  crude	  reaction	  mixture	  by	  
mass	  spectrometry	  showed	  no	  mass	  ions	  consistent	  with	  oligomeric	  products,	  the	  1H	  NMR	  spectrum	  
proved	   to	  be	  complicated,	  and	   showed	   little	  evidence	   that	   the	  desired	  cyclic	  product	  was	  present	  
either.	  
	  
Another	  potential	  solution	  to	  the	  problem	  of	  oligomerisation	  would	  be	  to	  trap	  the	  enolate	   initially	  
formed	  after	  the	  conjugate	  addition	  as	  its	  silyl	  enol	  ether	  (Scheme	  95).	  However,	  when	  this	  reaction	  
was	   attempted	   with	   all	   the	   reagents	   added	   at	   the	   same	   time,	   only	   the	   starting	   material	   was	  
observed	  after	  the	  reaction	  (Scheme	  96).	  
	  
Scheme	  95.	  Proposed	  trapping	  of	  enolate	  119	  to	  prevent	  oligomerisation.	  
	  
	  
Scheme	  96.	  Attempted	  trapping	  of	  enolate	  formed	  after	  cyclisation	  of	  compound	  83b.	  
	  
	  
Attempting	   to	   perform	   the	   cyclisation	   and	   then	   to	   subsequently	   quench	   the	   reaction	   with	  
trimethylsilyl	   chloride	   also	   failed	   to	   yield	   the	   desired	   silyl	   enol	   ether,	   instead	   again	   forming	  
































2.4.2.2	  Deprotonation	  Using	  Milder	  Bases	  
	  
It	  was	   thought	   that	   the	  problems	  detailed	  above	  were	  due	   to	   the	  strongly	  basic	  nature	  of	   sodium	  
hydride,	   and	   so	   a	  milder	   base	  was	   looked	   for.	  Attempts	   at	   cyclising	   compound	  83b	  using	  DBU	   in	  
toluene	  proved	  unsuccessful,	  with	  no	  identifiable	  products	  being	  isolated,	  suggesting	  decomposition	  
of	   the	   starting	   material.	   Encouraged	   by	   a	   report	   of	   DABCO	   being	   used	   to	   deprotonate	   a	  
trifluoroacetamide	  to	  allow	  it	  to	  undergo	  an	  aza-­‐Michael	  reaction,100-­‐101	  this	  was	  chosen	  as	  the	  next	  
base	   to	   attempt	   the	   cyclisation.	   However,	  when	   this	   reaction	  was	   attempted	   no	   cyclised	   product	  
was	   observed.	   Instead,	   the	   unusual	   dimeric	   product	  122	  was	   formed	   in	   a	   fairly	   low	   yield	   of	   27%	  
(Scheme	  98).	  
	  




It	   is	   thought	   that	   this	   product	   was	   the	   result	   of	   a	   Baylis-­‐Hillman	   type	  mechanism,	   where	   DABCO	  
added	   to	   the	   enone	   to	   form	   zwitterion	  123	   (Scheme	  99).	   The	   enolate	   then	   reacted	  with	   another	  
molecule	   of	   starting	   material	   to	   form	   intermediate	   124,	   which,	   upon	   tautomerisation	   and	  

























Scheme	  99.	  Proposed	  Baylis-­‐Hillman	  type	  mechanism	  for	  the	  formation	  of	  compound	  122.	  
	  
	  
This	  proposal	  seems	  reasonable,	  as	  DABCO	  is	  well	  known	  to	  catalyse	  Baylis-­‐Hillman	  reactions.	  In	  fact,	  
this	   type	   of	   dimerisation	   of	   enones	   is	   known	   in	   the	   literature,	   and	   is	   called	   the	   Rauhut-­‐Currier	  
reaction	  (or	  the	  vinylogous	  Baylis-­‐Hillman	  reaction).102	  Although	  this	  reaction	  is	  usually	  mediated	  by	  
trialkylphosphines,	   DABCO	   has	   also	   been	   shown	   be	   a	   suitable	   catalyst,	   for	   example	   in	   the	  
dimerisation	  of	  methyl	  vinyl	  ketone.103	  
	  
	  
2.4.3	  Deprotection	  Strategy	  
	  
2.4.3.1	  Trifluoroacetic	  Acid	  Mediated	  Boc	  Deprotection	  
	  
The	  third	  strategy	  adopted	  to	  try	  and	  cyclise	  amino	  enones	  49	   involved	  removal	  of	   the	  protecting	  
group	  to	  yield	  the	  more	  nucleophilic	  free	  amine.	  In	  fact,	  this	  was	  the	  original	  synthetic	  plan,	  before	  

















































	  Trifluoroacetic	   acid	   proved	   able	   to	   remove	   the	   Boc	   group	   from	   compound	   59c	   to	   produce	  
ammonium	  salt	  125,	  although	  if	  the	  reaction	  was	  left	  for	  too	  long	  the	  trifluoroacetic	  acid	  was	  also	  
found	   to	   add	   to	   the	   enone	   to	   form	   trifluoroacetate	  126	   (Scheme	   100).	   This	   highlights	   the	   highly	  
electrophilic	   nature	   of	   the	   terminal	   enone	   in	   compound	   59c	   as	   trifluoroacetate	   is	   a	   very	   poor	  
nucleophile,	   highlighted	   by	   the	   fact	   that	   the	   pKa	   of	   trifluoroacetic	   acid	   is	   3.45	   in	   DMSO.104	   This	  
unwanted	  side	  reaction	  could	  be	  avoided	  by	  stopping	  the	  reaction	  as	  soon	  as	  the	  deprotection	  was	  
judged	  to	  be	  complete	  by	  TLC.	  
	  
Scheme	   100.	   Deprotection	   of	   amine	   59c	   using	   trifluoroacetic	   acid,	   and	   subsequent	   undesired	  
conjugate	  addition	  of	  trifluoroacetate	  yielding	  compound	  126.	  
	  
	  
With	  compound	  125	  in	  hand,	  the	  next	  step	  was	  to	  treat	  it	  with	  a	  base	  to	  neutralise	  the	  ammonium	  
salt	   and	   hopefully	   carry	   out	   the	   desired	   6-­‐endo-­‐trig	   cyclisation.	   This	   seemed	   to	   be	   a	   reasonable	  
prospect,	   given	   the	   work	   of	   Sutherland	   and	   co-­‐workers	   who	   cyclised	   substituted	   enones	  7	   using	  
Hünig’s	   base	   (Scheme	   101).12	   However,	   all	   attempts	   to	   carry	   out	   this	   cyclisation	   under	   similar	  
conditions,	   either	   under	   anhydrous	   conditions	   or	   in	   the	   presence	   of	   water,	   failed	   to	   yield	   any	  
identifiable	  products	   (Scheme	  102).	   In	  each	  case	  the	  reaction	  mixture	  was	  treated	  with	   (Boc)2O	  to	  
aid	  in	  the	  isolation	  of	  potentially	  water	  soluble	  products.	  
	  








































Scheme	  102.	  Attempted	  base	  mediated	  cyclisation	  and	  Boc	  protection	  of	  ammonium	  salt	  125.	  
	  
	  
It	   was	   decided	   to	   try	   and	   synthesise	   a	   phenyl-­‐substituted	   enone,	   as	   this	   would	   be	   more	   closely	  
related	  to	  the	  compounds	  that	  were	  cyclised	  by	  Sutherland	  and	  co-­‐workers.	  Accordingly,	  the	  cross	  
coupling	  reaction	  between	  the	  organozinc	  reagent	  57c	  derived	  from	  iodoalanine	  68	  and	  cinnamoyl	  
chloride	  was	  performed,	  yielding	  phenyl-­‐substituted	  enone	  128	   in	  a	  46%	  yield	   (Scheme	  103).	  This	  
compound	  was	   then	   deprotected	   using	   trifluoroacetic	   acid	   to	   give	   ammonium	   salt	  129,	   which	   is	  
almost	   identical	   to	  one	  of	   the	   intermediates	  127	   formed	  by	  Sutherland	   (R	  =	  Ph,	   see	  Scheme	  101,	  
p91).	  Finally,	  repetition	  of	  Sutherland’s	  cyclisation	  conditions	  gave	  the	  desired	  trans-­‐6-­‐phenyl-­‐4-­‐oxo-­‐
L-­‐pipecolate	  10a.	   The	   diastereomeric	   ratio	   of	   the	   two	   isomers	   of	   product	   was	   determined	   to	   be	  
70:30,	  which	  is	  similar	  to	  the	  reported	  ratio	  of	  75:25.	  However,	  the	  yield	  for	  the	  overall	  reaction	  was	  
much	   lower	   than	   the	   yield	   reported	   by	   Sutherland	   and	   co-­‐workers	   (8%	   cf.	   56%).	   Despite	   the	   low	  
(unoptimised)	   yield	   for	   this	   reaction,	   this	   result	   does	   suggest	   that	   the	   cyclisation	   of	   substituted	  
enones	   such	   as	   128	   using	   this	   methodology	   is	   easier	   than	   the	   cyclisation	   of	   the	   corresponding	  
















solvent  =  THF, CH2Cl2, CH2Cl2/MeOH, CH2Cl2/MeOH/H2O, MeOH/H2O
	  	  
	  93	  
Scheme	  103.	  Synthesis	  and	  subsequent	  cyclisation	  of	  phenyl-­‐substituted	  enone	  128.	  
	  
	  
2.4.3.2	  β-­‐Chloroketones	  as	  Starting	  Materials	  
	  
It	  was	  thought	  that	  the	  β-­‐chloroketone	  60c,	  the	  product	  of	  the	  HCl/Et2O	  mediated	  deprotection	  of	  
amino	   enone	  59c	   (see	   Scheme	   66,	   p65),	  might	   also	   be	   a	   suitable	   substrate	   for	   a	   base	  mediated	  
cyclisation.	  However,	  all	  attempts	  to	  cyclise	  this	  compound	  under	  basic	  conditions	  failed	  to	  yield	  any	  
identifiable	   products,	   after	   Boc	   protection	   (Scheme	   104,	   Table	   16).	   Variation	   of	   the	   base	   and	   the	  
solvent	   (entries	   1–4)	   had	   no	   effect	   on	   the	   outcome	   of	   the	   reaction.	   It	   was	   thought	   that	   the	  
cyclisation	  might	  be	  promoted	  under	  thermal	  conditions,	   if	  hydrogen	  chloride	  were	  extruded	  from	  
the	   starting	  material	   to	  give	   the	  more	  nucleophilic	   free	  amine.	   To	   this	  effect,	   compound	  60c	  was	  
heated	  in	  toluene	  at	  reflux	  with	  and	  without	  Et3N	  (entries	  5–6),	  but	  again	  no	  product	  was	  observed	  
after	  Boc	  protection.	  Finally,	  the	  starting	  material	  was	  placed	  under	  high	  vacuum	  using	  a	  Kügelrohr	  
distillation	  apparatus,	  and	  heated	  to	  try	  and	  force	  the	  extrusion	  of	  hydrogen	  chloride.	  Heating	  to	  240	  
°C	  (entry	  7)	  caused	  complete	  pyrolysis	  of	  compound	  60c,	  and	  although	  this	  could	  be	  minimised	  by	  




































Scheme	  104.	  Attempted	  base	  mediated	  cyclisation	  and	  Boc	  protection	  of	  ammonium	  salt	  60c.	  
	  
Table	  16.	  Various	  unsuccessful	  combinations	  of	  bases,	  solvents	  and	  temperatures	  in	  the	  attempted	  
cyclisation	  of	  ammonium	  salt	  60c.	  
Entry	   Base	   Solvent	   Temperature	  
1	   K2CO3	   MeOH	   r.t.	  
2	   iPr2NEt	   THF	   r.t.	  
3	   iPr2NEt	   MeOH/H2O	   r.t.	  
4	   Et3N	   MeOH-­‐d4	   r.t.	  
5	   Et3N	   toluene	   110	  °C	  
6	   –	   toluene	   110	  °C	  
a7a	   –	   –	   240	  °C	  
a8a	   –	   –	   150	  °C	  
a	  Reaction	  performed	  in	  a	  Kügelrohr	  distillation	  apparatus	  under	  high	  vacuum.	  
	  
2.4.3.3	  Attempted	  Base	  Mediated	  TFA	  Deprotection	  
	  
As	  well	  as	  removal	  of	   the	  Boc	  protecting	  group	  from	  amino	  enone	  59c,	   the	  deprotection	  of	  a	  TFA	  
protected	  amino	  enone	  was	  also	  briefly	  investigated,	  a	  process	  which	  highlighted	  potential	  problems	  
with	  this	  protecting	  group	  within	  the	  current	  synthetic	  strategy.	  TFA	  groups	  are	  removed	  under	  basic	  
conditions,	   and	   so	   compound	   84b	   was	   treated	   with	   Hünig’s	   base	   in	   a	   mixture	   of	   methanol	   and	  
water	   in	   order	   to	   try	   and	   remove	   the	   protecting	   group	   and	   encourage	   cyclisation	   (Scheme	   105).	  
However,	  after	  Boc	  protection,	  compound	  130	  was	  isolated	  instead	  of	  the	  desired	  4-­‐oxopiperidine.	  
Compound	  130	  arose	  from	  the	  addition	  of	  methanol	  to	  the	  enone,	  whilst	  the	  TFA	  protecting	  group	  
remained	  intact.	  The	  formation	  of	  this	  by-­‐product	  suggests	  that	  base	  promoted	  removal	  of	  the	  TFA	  
group	  in	  compounds	  such	  as	  84b	  may	  be	  very	  difficult,	  due	  to	  the	  competing	  reaction	  of	  any	  other	  
nucleophilic	  species	  with	  the	  highly	  electrophilic	  enone.	  As	  such,	  it	  was	  decided	  to	  focus	  on	  the	  Boc	  






















Scheme	   105.	   Attempted	   deprotection/cyclisation	   of	   TFA	   protected	   amine	  84b,	   leading	   instead	   to	  
methanol	  adduct	  130.	  
	  
	  
2.4.3.4	  Boron	  Trifluoride	  Mediated	  Boc	  Deprotection	  
	  
It	  was	  noted	  that	  boron	  trifluoride	  diethyl	  etherate	  had	  previously	  been	  employed	  as	  a	  Lewis	  acid	  to	  
encourage	   the	   cyclisation	   of	   amino	   enones,91-­‐92,95	   and	   is	   also	   a	   reagent	   used	   to	   deprotect	   Boc	  
protected	   amines.	   Compound	   59c	   was	   therefore	   treated	   with	   F3B·∙OEt2	   in	   an	   attempt	   to	  
simultaneously	  deprotect	  the	  amine	  and	  activate	  the	  electrophile	  towards	  cyclisation	  (Scheme	  106).	  
However,	  after	  re-­‐protection	  of	  the	  amine,	  none	  of	  the	  desired	  4-­‐oxopiperidine	  was	  observed.	  	  
	  




Analysis	   of	   the	   reaction	  mixture	   by	  mass	   spectrometry	   after	   the	   attempted	   cyclisation,	   and	   again	  
after	  re-­‐protection	  of	  the	  amine,	  showed	  mass	  ions	  with	  the	  exact	  masses	  214.1433	  and	  314.1962.	  
These	  are	  57	  mass	  units	  above	  the	  masses	  of	  the	  desired	  unprotected	  and	  protected	  products,	  and	  
match	   the	   molecular	   formulae	   of	   C11H20NO3+	   and	   C16H28NO3+.	   The	   observed	   mass	   ions	   may	  



































Although	  these	  compounds	  were	  not	  isolated	  from	  the	  reaction	  mixture,	  a	  plausible	  mechanism	  for	  
their	   formation	   involves	   an	   Alder-­‐ene	   reaction	   between	   the	   proposed	   intermediate	   131	   and	  
isobutene,	   liberated	   during	   the	   deprotection	   the	   starting	   material	   59c	   (Scheme	   107).	   This	  
mechanism	   seems	   reasonable,	   as	   coordination	   of	   the	   electron-­‐withdrawing	   BF3	   group	   to	   the	  
carbonyl	   in	   intermediate	  131	  will	   lower	   the	  LUMO	  energy	  of	   the	  alkene,	   facilitating	   the	  proposed	  
pericyclic	  reaction.	  It	  is	  possible	  that	  the	  free	  amine	  in	  compound	  131	  also	  coordinates	  to	  BF3,	  which	  
would	  make	  it	  less	  nucleophilic	  and	  so	  less	  able	  to	  undergo	  the	  desired	  6-­‐endo-­‐trig	  cyclisation.	  
	  
Scheme	  107.	  Proposed	  BF3	  mediated	  Alder-­‐ene	  reaction	  between	  isobutene	  and	  intermediate	  131.	  
	  







observed m/z = 214.1433
calculated m/z = 214.1443
133
observed m/z = 314.1962























2.4.3.5	  Formic	  Acid/Sodium	  Iodide	  Mediated	  Boc	  Deprotection	  
	  
Given	  the	  lack	  of	  success	  in	  cyclising	  Boc	  protected	  amino	  enone	  59c,	   inspiration	  was	  sought	  from	  
further	  afield	  in	  the	  literature.	  A	  study	  by	  Georg	  and	  co-­‐workers	  on	  the	  deprotection/cyclisation	  of	  
amino	  ynones	  13	  highlighted	  an	  interesting	  dependence	  on	  halide	  ions,	  based	  on	  their	  observation	  
that	  ynones	  13	  were	  converted	  to	  β-­‐haloenones	  before	  the	  cyclisation	  occurred	  (Scheme	  108,	  also	  
see	   Chapter	   1.2.2.2,	   p9).13	   These	   results	   are	   analogous	   to	   the	   formation	   of	   β-­‐chloroketones	   upon	  
treatment	  of	  amino	  enones	  59c	  and	  83a	  with	  HCl/Et2O	  (see	  Scheme	  66,	  p65).	  
	  
Scheme	  108.	  Formation	  of	  β-­‐haloenones	  during	  the	  cyclisation	  of	  amino	  ynones	  13.13	  
	  
	  
Georg	   and	   co-­‐workers	   reported	   three	   distinct	   deprotection	   methods:	   4	   M	   HCl	   in	   dioxane;	  
iodotrimethylsilane;	  and	  a	  combination	  of	  formic	  acid	  and	  sodium	  iodide.	  The	  latter	  of	  these	  proved	  
to	  be	  the	  best	  set	  of	  conditions	  for	  minimising	  stereochemical	  erosion	  of	  the	  starting	  materials	  when	  
terminal	   alkynes	   were	   employed.	   It	   was	   decided	   to	   apply	   these	   conditions	   to	   amino	   enone	  59c,	  
which	  was	  therefore	  treated	  with	  formic	  acid	  and	  sodium	  iodide,	  followed	  by	  potassium	  carbonate	  
in	   methanol	   and	   then	   Boc2O	   (Scheme	   109).	   Very	   pleasingly,	   this	   cyclisation	   was	   successful	   and	  
yielded	  the	  desired	  Boc	  protected	  4-­‐oxopiperidine	  91a,	  albeit	  in	  a	  modest	  yield	  of	  12%.	  
	  
Scheme	  109.	  Successful	  cyclisation	  of	  compound	  59c	  by	  applying	  Georg	  and	  co-­‐workers’	  conditions.	  
	  
	  The	  cyclic	  product	  91a	  was	  identified	  by	  comparison	  of	  its	  1H	  and	  13C	  NMR	  spectra	  with	  those	  of	  the	  
closely	   related	   ethyl	   N-­‐Boc-­‐4-­‐oxo-­‐L-­‐pipecolate	   91b,	   which	   has	   previously	   been	   synthesised	   by	  
















































signals	  highlighted	  in	  red	  and	  green),	  with	  the	  only	  slight	  variation	  being	  between	  the	  chemical	  shifts	  
of	  the	  carbamate	  carbonyls	  (highlighted	  in	  blue).	  However,	  the	  close	  correlation	  between	  the	  NMR	  
spectra,	   and	   the	   presence	   of	   the	   correct	   mass	   ion	   when	   the	   sample	   was	   analysed	   by	   mass	  
spectrometry	   (observed	   mass	   of	   Na	   adduct:	   280.1152,	   calculated	   mass	   of	   Na	   adduct:	   280.1161),	  
gave	  confidence	  that	  compound	  91a	  was	  indeed	  the	  desired	  4-­‐oxopiperidine.	  
	  
Table	  17.	  Comparison	  of	  the	  1H	  NMR	  data	  for	  compounds	  91a	  and	  91b.	  
Compound	  91a’s	  1H	  NMR	  Data	  (CDCl3)	   Compound	  91b’s	  1H	  NMR	  Data	  (CDCl3)90,105	  
	  








1.45	  (9H,	  br.	  s)	   1.48	  (9H,	  s)	   	  
2.41–2.60	  (2H,	  m)	   2.54	  (2H,	  m)	   	  
2.69–2.88	  (2H,	  m)	   2.80	  (2H,	  m)	   	  
3.54–3.70	  (1H,	  m)	   3.64	  (1H,	  m)	   	  
3.73	  (3H,	  s)	   –	   	  
4.00–4.10	  (1H,	  m)	   4.02	  (1H,	  dt,	  J	  =	  14.0,	  5.8)	   	  
–	   4.16	  (2H,	  q,	  J	  =	  7.4)	   	  
4.87	  and	  5.15	  (1H,	  2	  ×	  br.	  s)	   4.80	  and	  5.05	  (1H,	  m,	  two	  conformers)	   	  
	  
Table	  18.	  Comparison	  of	  the	  13C	  NMR	  data	  for	  compounds	  91a	  and	  91b.	  
Compound	  91a’s	  13C	  NMR	  Data	  (CDCl3)	   Compound	  91b’s	  13C	  NMR	  Data	  (CDCl3)90,105	  
	  
–	   14.1	  
	  
28.2	   28.2	  
39.3	  and	  40.5	   39.33	  and	  40.46	  
39.8	   39.7	  
41.0	  and	  41.2	   41.1	  
52.6	   –	  
53.9	  and	  54.7	   54.1	  and	  54.8	  
–	   61.7	  
81.2	   81.1	  
154.3	  and	  154.8	   146.7	  
171.5	  and	  171.7	   171.1	  



























The	  mechanism	  of	  this	  reaction	  is	  presumably	  related	  to	  the	  observations	  made	  previously	  as	  to	  the	  
highly	  electrophilic	  nature	  of	  terminal	  enones	  such	  as	  59c,	  and	  the	  findings	  of	  Georg	  and	  co-­‐workers	  
in	  the	  activation	  of	  amino	  ynones	  using	  halide	  sources.	  It	  is	  proposed	  that	  the	  formic	  acid	  removes	  
the	  Boc	  protecting	  group,	  whilst	  the	   iodide	  adds	  to	  the	  enone	  to	  form	  β-­‐iodoketone	  134	   (Scheme	  
110).	  This	  compound	  is	  then	  neutralised	  by	  the	  potassium	  carbonate	  before	  undergoing	  a	  6-­‐exo-­‐tet	  
cyclisation	  (or	  conceivably	  a	  6-­‐endo-­‐trig	  cyclisation,	  if	  HI	  is	  first	  eliminated	  from	  compound	  134)	  to	  
yield	  4-­‐oxopiperidine	  93b,	  which	  is	  finally	  Boc	  protected	  to	  give	  the	  observed	  product	  91a.	  
	  
Scheme	  110.	  Proposed	  mechanism	  for	  cyclisation	  of	  compound	  59c.	  
	  
Comparison	   of	   the	   1H	   NMR	   data	   for	   compound	   91a	  with	   some	   of	   the	   impure	   1H	   NMR	   spectra	  
recorded	   after	   the	   previously	   attempted	   base-­‐promoted	   cyclisations	   of	   compounds	  59c	   and	  60c	  
(see	   Scheme	   102,	   p92	   and	   Scheme	   104,	   p94)	   showed	   that	   the	   desired	   product	   had	   indeed	   been	  
present	   in	   these	   reaction	   mixtures,	   albeit	   in	   very	   small	   amounts.	   However,	   compound	   91a	   had	  
never	  been	  unambiguously	  identified	  as	  a	  product	  of	  these	  previous	  cyclisations.	  This	  may	  in	  part	  be	  
due	  to	  the	  fact	  that	  compound	  91a	  was	  not	  observable	  by	  mass	  spectrometry	  when	  it	  was	  passed	  
through	   a	   liquid	   chromatography	   column	   before	   entering	   the	   spectrometer;	   it	   was	   only	   detected	  
when	  it	  was	  directly	  infused	  into	  the	  spectrometer,	  after	  being	  stabilised	  with	  Na+	  ions.	  



























2.5	  Deprotection	  of	  Cyclised	  Product	  
	  
Unfortunately,	   the	   cyclisation	   of	   amino	   enone	  59c	  proved	   to	   be	   unreliable,	   either	   giving	   a	   lower	  
yield	  of	  product	  or	  no	  product	  at	  all	  upon	  repetition.	  Likewise,	  a	  single	  attempt	  to	  cyclise	  the	  related	  
L-­‐valine	  derived	  amino	  enone	  83a	  under	  the	  same	  conditions	  failed	  to	  yield	  the	  desired	  product.	  The	  
resulting	  lack	  of	  materials,	  coupled	  with	  time	  constraints,	  meant	  that	  the	  planned	  reduction	  of	  these	  
N-­‐Boc	  4-­‐oxopiperidines	  could	  not	  be	  attempted.	  However,	  compound	  91a	  was	  treated	  with	  1	  M	  HCl	  
in	   Et2O	   in	   order	   to	   access	   4-­‐oxopiperidine	   94b	   (Scheme	   111).	   The	   characterisation	   data	   for	   this	  
compound	   were	   compared	   with	   those	   of	   compound	   60c,	   to	   further	   test	   the	   proposal	   that	  
compound	  60c	  is	  an	  acyclic	  β-­‐chloroketone,	  and	  not	  a	  cyclic	  4-­‐oxopiperidine	  (see	  Chapter	  2.3,	  p60).	  
Scheme	  111.	  Deprotection	  of	  N-­‐Boc	  4-­‐oxopiperidine	  91a,	  and	  subsequent	  hemi-­‐acetal	  formation.	  
	  
The	  deprotection	  of	  4-­‐oxopiperidine	  91a	  took	  considerably	  longer	  than	  that	  of	  compound	  59c	  (11	  
days	  cf.	  3	  days),	  and	  the	  product	  appeared	  to	  be	  a	  hemi-­‐acetal	  when	  dissolved	  in	  MeOH-­‐d4.	  This	  is	  
not	   unexpected,	   as	   similar	   compounds	   in	   the	   literature	   have	   been	   reported	   to	   form	   hemi-­‐acetals	  
and	  hydrates.91-­‐93,106-­‐107	   The	   reaction	   yield	  based	  on	   the	  mass	  of	   the	  product	  was	   calculated	   to	  be	  
104%,	  which,	   given	   the	   previous	   discrepancies	   in	   the	   yields	   of	   similar	   reactions	   (see	   Chapter	   2.3,	  
p60)	   might	   raise	   questions	   about	   the	   structure	   of	   the	   product.	   However,	   this	   deprotection	   was	  
performed	  on	   a	   very	   small	   scale	   (0.15	  mmol),	  meaning	   that	   small	   changes	   in	  mass	   result	   in	   large	  
changes	  in	  the	  yield;	  the	  product	  weighed	  30.2	  mg,	  only	  1.2	  mg	  more	  than	  the	  theoretical	  maximum	  
mass.	  This	  additional	  mass	  may	  be	  due	  to	  a	  very	  small	  amount	  of	  an	  impurity	  visible	  in	  the	  1H	  NMR	  
spectrum,	  or	   it	  may	  be	  that	  this	  difference	  is	  within	  the	  error	  margin	  of	  the	  balance.	  As	  a	  result	  of	  
these	  factors,	  together	  with	  characterisation	  data	  that	  suggests	  that	  the	  structure	  of	  the	  product	  is	  
correct	  (see	  below),	  the	  yield	  of	  compound	  94b	  has	  been	  stated	  to	  be	  quantitative.	  
The	   fact	   that	   4-­‐oxopipecolate	   94b	   forms	   a	   hemi-­‐acetal	   in	   MeOH-­‐d4	   highlights	   the	   differences	  
between	  this	  compound	  and	  compound	  60c	  (Table	  19	  and	  Figure	  34).	  The	  clearest	  differences	  are	  
seen	  in	  the	  chemical	  shifts	  of	  the	  protons	  attached	  to	  carbons	  3	  and	  5	  (highlighted	  in	  red),	  although	  






















Table	  19.	  Comparison	  of	  the	  1H	  NMR	  data	  for	  compounds	  94b·∙CD3OD	  and	  60c	  in	  MeOH-­‐d4.	  
Compound	  94b’s	  1H	  NMR	  Data	  (CD3OD)	   Compound	  60c’s	  1H	  NMR	  Data	  (CD3OD)	  
	  
1.71–2.00	  (2H,	  m)	   3.06	  (2H,	  t,	  J	  =	  6.4)	  
	  
2.02–2.29	  (1H,	  m)	   3.21–3.30	  (2H,	  m)	  
2.37–2.61	  (1H,	  m)	   –	  
3.04–3.18	  (1H,	  m)	   3.80	  (2H,	  t,	  J	  =	  6.4)	  
3.39–3.53	  (1H,	  m)	   –	  
3.88	  (3H,	  s)	   3.84	  (3H,	  s)	  
4.16	  (1H,	  d,	  J	  =	  10.0)	   4.38	  (1H,	  dd,	  J	  =	  4.4,	  6.1)	  
	  




The	  differences	  between	  the	  two	  compounds	  can	  also	  be	  seen	  in	  the	  13C	  NMR	  data	  (Table	  20	  and	  	  
Figure	   35).	   The	   chemical	   shift	   of	   96.2	   ppm	   for	   carbon	   4	   (highlighted	   in	   red)	   in	   compound	  
94b·∙CD3OD	   is	   indicative	   of	   a	   hemi-­‐acetal,	   whereas	   the	   corresponding	   carbon	   in	   compound	   60c	  



















































Table	  20.	  Comparison	  of	  the	  13C	  NMR	  data	  for	  compounds	  94b·∙CD3OD	  and	  60c	  in	  MeOH-­‐d4.	  
Compound	  94b’s	  13C	  NMR	  Data	  (CD3OD)a,b	   Compound	  60c’s	  13C	  NMR	  Data	  (CD3OD)	  
	  
28.6	   37.3	  
	  
32.4	   41.4	  
40.8	   44.2	  
52.6	   48.1	  
54.5	   52.5	  
96.2	   –	  
168.3	   168.7	  
–	   204.1	  
a	  Only	  the	  data	  for	  the	  major	  product	  are	  shown	  (the	  extra	  signals	  in	  the	  13C	  NMR	  spectrum	  may	  be	  
due	  to	  the	  presence	  of	  the	  second	  possible	  diastereoisomer	  of	  the	  product).	  
b	  The	  septet	  expected	  for	  the	  CD3	  signal	  of	  the	  hemi-­‐acetal	  was	  not	  visible,	  presumably	  because	  it	  is	  
hidden	  by	  the	  large	  septet	  at	  47.7	  ppm	  arising	  from	  the	  use	  of	  CD3OD	  as	  the	  NMR	  solvent.	  
	  




























When	   compound	   94b·∙CD3OD	   was	   analysed	   by	   mass	   spectrometry	   the	   mass	   ion	   193.1265	   was	  
observed,	  which	  corresponds	  to	  the	  molecular	  formula	  C8H13D3NO4+	  and	  is	  consistent	  with	  structure	  
94b·∙CD3OH	  (Figure	  36).	  Although	  the	  sample	  submitted	  for	  mass	  spectrometry	  was	  fully	  deuterated	  
as	  it	  was	  dissolved	  in	  MeOH-­‐d4,	  the	  solvent	  system	  used	  during	  mass	  spectrometry	  was	  0.1%	  formic	  
acid	  dissolved	  in	  a	  gradient	  of	  acetonitrile/water.	  This	  means	  that	  any	  labile	  deuterium	  atoms	  would	  
exchange	   with	   hydrogen	   atoms	   in	   the	   mildly	   acidic	   medium,	   explaining	   the	   existence	   of	   the	  
observed	   product	  94b·∙CD3OH;	  whilst	   the	   deuterium	   atoms	   attached	   to	   the	   oxygen	   and	   nitrogen	  
atoms	  have	  been	  replaced	  by	  hydrogen	  atoms,	  the	  CD3	  group	  of	  the	  hemi-­‐acetal	  has	  remained	  in	  the	  
structure	  as	  these	  deuterium	  atoms	  were	  not	  labile	  in	  the	  solvent	  system.	  
	  
Figure	  36.	  Mass	  ion	  found	  upon	  accurate	  mass	  analysis	  of	  compound	  94b·∙CD3OD.	  
	  
	  
In	  order	  to	  try	  and	  simplify	  the	  1H	  and	  13C	  NMR	  spectra	  of	  compound	  94b,	  conversion	  of	  hemi-­‐acetal	  
94b·∙CD3OD	  into	  hydrate	  94b·∙D2O	  was	  attempted,	  as	  there	  is	  only	  one	  possible	  diastereoisomer	  for	  
this	   product.	   Repeated	   removal	   of	   the	   solvent	   from	   compound	  94b·∙CD3OD	   and	   re-­‐dissolution	   in	  
D2O	  resulted	  in	  the	  successful	  formation	  of	  the	  desired	  compound	  94b·∙D2O.	  When	  the	  sample	  was	  
submitted	  for	  NMR	  analysis,	   the	   labile	  protons	  attached	  to	  nitrogen	  and	  oxygen	  appeared	  to	  have	  
exchanged	  for	  deuterium	  atoms,	  as	  expected.	  Interestingly,	  it	  appeared	  that	  some	  of	  the	  protons	  α	  
to	  the	  ketone	  in	  94b·∙D2O	  had	  also	  exchanged	  with	  deuterium	  atoms,	  as	  judged	  by	  the	  reduction	  in	  
the	   integration	   of	   these	   signals	   in	   the	   1H	   NMR	   spectrum,	   and	   a	   reduction	   in	   intensity	   of	   the	  
corresponding	   carbon	   peaks	   in	   the	   13C	   NMR	   spectrum.	   A	   similar	   hydrogen-­‐deuterium	   exchange	  
process	  has	  previously	  been	  reported	  to	  occur	  in	  1,3-­‐disubstituted	  4-­‐oxopiperidines.106	  
	  
The	  α-­‐deuteration	  of	  compound	  94b	  can	  be	  explained	  by	  considering	  the	  intermediate	  ketone	  94b-­‐
d2,	  which	  would	  form	  during	  equilibration	  between	  the	  hemi-­‐acetal	  94b-­‐d2·∙CD3OD	  and	  the	  hydrate	  
94b-­‐d2·∙D2O	  (Scheme	  112).	  The	  α-­‐protons	  in	  compound	  94-­‐d2	  will	  be	  relatively	  acidic	  because	  they	  
are	  adjacent	  to	  a	  ketone.	  Furthermore,	  they	  will	  be	  particularly	  acidic	  in	  this	  compound	  because	  of	  
the	   inductive	   effect	   of	   protonated	   nitrogen.	   (This	   inductive	   effect	   is	   also	   responsible	   for	   the	  
CO2MeNH2
HO OCD3
94b·CD3OHobserved m/z = 193.1265
calculated m/z = 193.1268
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increased	  electrophilicity	  of	  the	  ketone,	  explaining	  the	  ease	  of	  hydrate/hemi-­‐acetal	  formation.)	  As	  a	  
result	  of	  the	  increased	  acidity	  of	  these	  α-­‐protons,	   it	   is	  not	  surprising	  that	  they	  are	  able	  to	  undergo	  
deuterium	  exchange	  under	  the	  equilibrating	  conditions.	  This	  can	  happen	  in	  theory	  up	  to	  four	  times	  
to	  produce	  compound	  94b-­‐d6·∙D2O.	  When	  a	  sample	  of	  compound	  94b-­‐dn·∙D2O	  dissolved	  in	  D2O	  was	  
submitted	  for	  analysis	  by	  mass	  spectrometry,	  mass	  ions	  for	  poly-­‐deuterated	  products	  with	  up	  to	  six	  
deuterium	  atoms	  were	  observed,	  as	  well	  as	  the	  non-­‐deuterated	  mass	  ion	  176.0916	  (Figure	  37).	  
	  
Scheme	  112.	  Proposed	  mechanism	  for	  the	  α-­‐deuteration	  of	  4-­‐oxopiperidine	  94b-­‐d2.	  
	  






































x = 1, 2 or 3
+ D2O
94b-d3+x·D2O























R = H or D
C7H14–nDnNO4+
n = 0, observed m/z = 176.0916.
n = 0, calculated m/z = 176.0923
n = 1, observed m/z = 177.0940
n = 2, observed m/z = 178.1016
n = 3, observed m/z = 179.1091
n = 4, observed m/z = 180.1158
n = 5, observed m/z = 181.1204
n = 6, observed m/z = 182.1281
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In	   order	   to	   be	   able	   to	   report	   complete	   NMR	   data	   for	   compound	   94b·∙D2O,	   and	   to	   be	   able	   to	  
compare	   its	  NMR	  data	  with	  those	  of	  compound	  60c,	  poly-­‐deuterated	  compound	  94b-­‐dn·∙D2O	  was	  
repeatedly	  dissolved	   in	  H2O	  and	  concentrated	  under	  vacuum	  to	  replace	  the	  deuterium	  atoms	  α	  to	  
the	   ketone	  with	   hydrogen	   atoms.	   After	   this,	   1H	   and	   13C	   NMR	   data	  were	   collected	   in	   D2O,	   and	   as	  
expected	  the	  α-­‐protons	  were	  once	  again	  visible,	  confirming	  the	  presence	  of	  the	  desired	  compound	  
94b·∙D2O.	   Accurate	  mass	   analysis	   of	   the	   product	   showed	   the	   desired	  mass	   ion	   176.0917,	   as	  well	  
mass	   ions	   showing	   the	   inclusion	   of	   up	   to	   three	   deuterium	   atoms,	   consistent	   with	   deuterium	  
exchange	  of	   some	  of	   the	   labile	  hydrogen	  atoms	  attached	   to	   the	  nitrogen	  or	  oxygen	  atoms	   (Figure	  
38).	  
	  
Figure	   38.	   Mass	   ions	   found	   upon	   accurate	   mass	   analysis	   of	   compound	   94b·∙D2O	   after	   repeated	  
equilibration	  in	  H2O.	  
	  
	  
Comparison	  of	  the	  1H	  and	  13C	  NMR	  data	  for	  compound	  94b·∙D2O	  and	  compound	  60c	  in	  D2O	  showed	  
differences	  consistent	  with	  those	  already	  described	  for	  compound	  94b·∙CD3OD	  (Table	  21,	  Figure	  39,	  
Table	  22,	  and	  Figure	  40,	  key	  signals	  highlighted	  in	  red,	  cf.	  Table	  19,	  p	  101	  and	  Table	  20,	  p102).	  
	  
Table	  21.	  Comparison	  of	  the	  1H	  NMR	  data	  for	  compounds	  94b·∙D2O	  and	  60c	  in	  D2O.	  
Compound	  94b’s	  1H	  NMR	  Data	  (D2O)	   Compound	  60c’s	  1H	  NMR	  Data	  (D2O)	  
	  
1.82–1.90	  (1H,	  m)	   3.00	  (2H,	  td,	  J	  =	  6.0,	  3.1)	  
	  
1.90–1.99	  (1H,	  m)	   –	  
2.02	  (1H,	  dd,	  J	  =	  11.0,	  14.3)	   3.27–3.32	  (2H,	  m)	  
2.31	  (1H,	  ddd,	  J	  =	  2.3,	  3.9,	  14.3)	   –	  
3.13–3.21	  (1H,	  m)	   3.68	  (2H,	  t,	  J	  =	  6.0)	  
3.43	  (1H,	  dt,	  J	  =	  13.1,	  4.6)	   –	  
3.75	  (3H,	  s)	   3.71	  (3H,	  s)	  







R = H or D
C7H14–nDnNO4+
n = 0, observed m/z = 176.0917.
n = 0, calculated m/z = 176.0923
n = 1, observed m/z = 177.0970
n = 2, observed m/z = 178.1043


















Table	  22.	  Comparison	  of	  the	  13C	  NMR	  data	  for	  compounds	  94b·∙D2O	  and	  60c	  in	  D2O.	  
Compound	  94b’s	  13C	  NMR	  Data	  (D2O)	   Compound	  60c’s	  13C	  NMR	  Data	  (D2O)	  
	  
33.5	   38.0	  
	  
36.8	   41.5	  
40.9	   44.0	  
53.7	   48.3	  
54.6	   53.8	  
90.4	   –	  
169.3	   169.8	  
























































The	   fact	   that	   a	   genuine	   sample	   of	   4-­‐oxopipecolate	   94b	   has	   different	   characterisation	   data	   to	  
compound	  60c	   (the	   product	   of	   the	   HCl/Et2O	  mediated	   deprotection	   of	   compound	  59c)	   provides	  
further	  evidence	  to	  support	  the	  earlier	  claim	  that	  treatment	  of	  N-­‐Boc	  amino	  enones	  100	  with	  HCl	  in	  
Et2O	  yields	  β-­‐chloroketones	  101,	  rather	  than	  the	  previously	  reported	  4-­‐oxopiperidines	  102	  (Scheme	  
113,	  also	  see	  Chapter	  2.3,	  p60).	  
	  
Scheme	  113.	  The	  products	  of	  the	  treatment	  of	  Boc	  protected	  amino	  enones	  100	  with	  HCl	  in	  Et2O	  are	  
β-­‐chloroketones	  101,	  rather	  than	  the	  previously	  claimed	  4-­‐oxopiperidines	  102.	  
	  
































Various	   α-­‐amino	   acid	   derived	   organozinc	   reagents	   50	   have	   been	   reacted	   with	   acryloyl	   chloride	  
under	   palladium	   catalysis	   to	   give	   the	   desired	   amino	   enones	   49,	   generally	   in	   moderate	   yields	  
(Scheme	   114).	   This	   reaction	   was	   exemplified	   with	   organozinc	   reagents	   containing	   three	   different	  
protecting	  groups,	  namely	  the	  tert-­‐butoxycarbonyl,	  trifluoroacetyl	  and	  benzyloxycarbonyl	  groups.	  Of	  
all	  the	  organozinc	  reagents	  studied,	  only	  the	  Boc	  protected	  L-­‐alanine	  derived	  reagent	  (i.e.	  PG	  =	  Boc,	  
R	  =	  Me)	  failed	  to	  undergo	  the	  Negishi	  cross	  coupling	  reaction	  efficiently,	  as	  a	  result	  of	  its	  particular	  
instability,	  presumably	  towards	  β-­‐elimination.	  
	  
Scheme	  114.	  Negishi	  cross	  coupling	  reaction	  between	  the	  α-­‐amino	  acid	  derived	  organozinc	  reagents	  
50	  and	  acryloyl	  chloride,	  leading	  to	  amino	  enones	  49.	  
	  	  
	  
L-­‐Serine	  derived	  organozinc	  reagent	  57c	  was	  also	  reacted	  with	  cinnamoyl	  chloride,	  showing	  that	  6-­‐
substituted	  amino	  enones	  can	  also	  be	  accessed	  using	  this	  methodology	  (Scheme	  115).	  
	  




Attempts	   to	  cyclise	   the	  Boc	  protected	  amino	  enones	  100,	  by	  applying	  conditions	   reported	   for	   the	  
synthesis	   of	   4-­‐oxopipecolates,52,56-­‐57	   led	   to	   the	   uncyclised	   β-­‐chloroketones	   101	   rather	   than	   the	  





















.50.R = Me, iPr, CO2Me, CO2tBu




















Scheme	  116.	  Treatment	  of	  amino	  enones	  100	  with	  hydrogen	  chloride	  in	  diethyl	  ether,	  leading	  to	  β-­‐
chloroketones	  101	  rather	  than	  4-­‐oxopiperidinium	  salts	  102.	  
	  
	  
The	  original	  hydrogen	  chloride	  mediated	  cyclisation	  reported	  in	  the	  literature	  was	  repeated	  (Scheme	  
117),56-­‐57	  and	  the	  product	  was	  shown	  to	  be	  β-­‐chloroketone	  60b	  rather	  than	  the	  previously	  claimed	  
4-­‐oxopipecolic	   acid	   hydrochloride,	   through	   extensive	   analysis	   of	   its	   characterisation	   data.	   It	   is	   of	  
interest	  to	  note	  that	  the	  original	  procedure	  was	  published	  in	  Organic	  Syntheses,57	  and	  therefore	  had	  
been	   independently	   checked	   in	   the	   laboratory	   of	   one	   of	   the	   members	   of	   the	   journal’s	   Board	   of	  
Editors	   before	   publication.	   While	   this	   aspect	   of	   Organic	   Syntheses’	   approach	   to	   publishing	  
undoubtedly	  gives	  the	  reader	  increased	  confidence	  in	  the	  reliability	  of	  the	  synthetic	  procedure,	  this	  
example	  highlights	   the	   fact	   that	  a	   reproducible	  procedure	   is	  not	   free	   from	  the	  possibility	  of	  error;	  
while	  Obrecht’s	  procedure	  consistently	  gives	  the	  same	  product	  (it	  has	  been	  successfully	  repeated	  by	  
the	  checkers	  at	  Organic	  Syntheses,	  and	  by	  the	  current	  author),	  the	  mistake	  made	  in	  identifying	  the	  
structure	  of	  the	  final	  product	  was	  not	  rectified	  through	  the	  checking	  procedure,	  and	  perhaps	  could	  
not	  have	  been.	  
	  
Scheme	  117.	  Repetition	  of	  Obrecht’s	  reported	  cyclisation	  reaction,	  which	  gave	  β-­‐chloroketone	  60b	  
rather	  than	  the	  previously	  reported	  4-­‐oxopipecolic	  acid	  hydrochloride.	  
	  
	  
Given	  the	  lack	  of	  success	  in	  cyclising	  the	  Boc	  protected	  amino	  enones	  100	  using	  hydrogen	  chloride	  
in	   diethyl	   ether,	   alternative	   cyclisation	   methods	   were	   sought.	   However,	   most	   of	   the	   reactions	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a	   range	   of	   identifiable	   by-­‐products	   135,	   136	   and	   137	   (Scheme	   118).	   Some	   of	   the	   difficulties	  
involved	  in	  carrying	  out	  this	  cyclisation	  included:	  the	  high	  reactivity	  of	  the	  terminal	  enone	  towards	  
nucleophiles;	  the	  low	  reactivity	  of	  the	  protected	  amine	  as	  a	  nucleophile;	  the	  acidity	  of	  the	  protons	  α	  
to	   the	   ketone,	   leading	   in	   some	   cases	   to	   oligomerisation;	   and	   the	   high	   water	   solubility	   of	   any	  
products	  containing	  a	  free	  amine	  as	  the	  result	  of	  a	  deprotection	  reaction.	  
	  
Scheme	  118.	  Various	  classes	  of	  by-­‐product	  formed	  from	  the	  unsuccessful	  attempts	  to	  cyclise	  amino	  
enones	  100.	  	  
	  
	  
In	  contrast	  to	  the	  terminal	  enones	  100,	  phenyl	  substituted	  amino	  enone	  128	  was	  cyclised	  relatively	  
easily	   (Scheme	   119).	   The	   Boc	   group	  was	   removed	   using	   trifluoroacetic	   acid,	  which	   generated	   the	  
trifluoroacetate	   salt	   129.	   This	   intermediate	   was	   cyclised	   by	   applying	   the	   conditions	   reported	   by	  
Sutherland	  and	  co-­‐workers	   for	  the	  cyclisation	  of	  essentially	   the	  same	   intermediate	  (generated	   in	  a	  
different	   manner),	   namely	   treatment	   with	   Hünig’s	   base	   in	   a	   mixture	   of	   methanol	   and	   water.12	  
Without	  reaction	  optimisation,	  the	  product	  10a	  was	  obtained	  in	  a	  much	  lower	  yield	  than	  Sutherland	  
and	  co-­‐workers	  reported	  (8%	  cf.	  56%),	  although	  the	  diastereomeric	  ratio	  of	  the	  products	  was	  similar	  
to	  the	  reported	  value.	  Surprisingly,	  this	  methodology	  proved	  to	  be	  unsuitable	  for	  the	  cyclisation	  of	  
the	  corresponding	  terminal	  enone	  59c,	  highlighting	  a	  difference	  in	  the	  ease	  of	  cyclising	  substituted	  






















E = electrophile, Nu = nucleophile
137
.3 examples.R = Me, iPr, CO2Me, CO2tBu




Scheme	  119.	  Cyclisation	  of	  phenyl	  substituted	  amino	  enone	  128	  by	  deprotection	  of	  the	  Boc	  group,	  
followed	  by	  application	  of	  the	  basic	  conditions	  reported	  by	  Sutherland	  and	  co-­‐workers.	  
	  
	  
Pleasingly,	   after	   extensive	   experimentation	   and	   careful	   searching	   of	   the	   literature,	   a	   successful	  
cyclisation	  methodology	  for	  the	  terminal	  enone	  59c	  was	  developed,	  inspired	  by	  the	  work	  of	  Georg	  
and	   co-­‐workers.13	   It	   is	   proposed	   that	   removal	   of	   the	   Boc	   group	   in	   the	   presence	   of	   sodium	   iodide	  
formed	   the	   intermediate	   β-­‐iodoketone	   134	   (Scheme	   120),	   which	   was	   cyclised	   using	   potassium	  
carbonate	  dissolved	  in	  methanol.	  Finally,	  the	  resulting	  amine	  was	  re-­‐protected	  in	  order	  to	  aid	  in	  its	  
isolation.	   This	   gave	   the	  desired	  Boc	  protected	  4-­‐oxopiperidine	  91a,	   albeit	   in	   a	   rather	   low	  yield	  of	  
12%.	  
	  




Unfortunately,	   this	   cyclisation	   reaction	   proved	   difficult	   to	   repeat,	   and	   one	   attempt	   to	   cyclise	   the	  
corresponding	  L-­‐valine	  derived	  amino	  enone	  83a	  using	  these	  conditions	  was	  also	  unsuccessful.	  As	  a	  
result,	   the	  planned	  reduction	  of	   the	  4-­‐oxopiperidines	  105	  to	   form	  the	  target	  4-­‐hydroxypiperidines	  
47	   could	  not	  be	  attempted	  due	   to	  a	   lack	  of	   the	   required	   compounds.	   Instead,	   the	  Boc	  protecting	  
group	  in	  compound	  91a	  was	  removed	  to	  give	  the	  free	  amine	  as	  its	  hydrochloride	  salt	  94b	  (Scheme	  
121).	   The	   1H	   and	   13C	   NMR	   characterisation	   data	   for	   compound	   94b	   were	   compared	   with	   the	  
corresponding	   data	   for	   compound	   60c,	   the	   product	   of	   the	   treatment	   of	   amino	   enone	  59c	   with	  





































provided	  further	  evidence	  that	  the	  product	  of	  the	  latter	  reaction	  was	  not	  the	  4-­‐oxopiperidine,	  as	  had	  
previously	  been	  reported	  for	  very	  similar	  compounds.52,56-­‐57	  
	  
Scheme	  121.	  Deprotection	  of	  compound	  91a,	  and	  comparison	  of	  the	  product	  94b	  with	  the	  product	  
of	  the	  treatment	  of	  amino	  enone	  59c	  with	  hydrogen	  chloride	  in	  diethyl	  ether.	  
	  
	  
In	  conclusion,	  while	  the	  palladium-­‐catalysed	  Negishi	  cross	  coupling	  reaction	  of	  a	  range	  of	  amino	  acid	  
derived	   organozinc	   reagents	  50	  with	   acryloyl	   chloride	   was	   successful	   in	   generating	   2-­‐substituted	  
amino	  enones	  49,	   the	  project’s	  ultimate	  aim	  of	  devising	  a	  general	   route	  to	  chiral,	  2-­‐substituted	  4-­‐
hydroxypiperidines	  47	  using	  this	  chemistry	  has	  proved	  largely	  unsuccessful.	  This	  is	  in	  part	  due	  to	  the	  
fact	   that	   the	   proposed	   synthetic	   route	   was	   based	   on	   a	   false	   premise,	   namely	   that	   treating	   Boc	  
protected	  amino	  enones	  100	  with	  hydrogen	  chloride	  in	  diethyl	  ether	  leads	  to	  the	  corresponding	  4-­‐
oxopiperidinium	  salts	  102,	  and	  also	  because	  this	  cyclisation	  proved	  particularly	  difficult	  to	  achieve,	  
despite	   its	  apparent	  simplicity.	  While	  these	  facts	  have	  resulted	   in	  a	  fair	  amount	  of	  disappointment	  
and	  frustration	  during	  the	  course	  of	  this	  PhD,	  there	  is	  some	  comfort	  for	  the	  author	  in	  the	  fact	  that	  
the	   real	   outcome	   of	   the	   hydrogen	   chloride	   mediated	   reactions	   has	   been	   determined,	   thus	  
contributing	  some	  new	  knowledge	  to	   the	  chemical	  community.	  The	  experience	  has	  also	  proved	  to	  
be	  a	  valuable	  exercise	  in	  scientific	  writing,	  as	  preparing	  this	  thesis	  required	  a	  clear,	  logical	  argument	  
to	  be	  written	  justifying	  the	  fact	  that	  it	  is	  claiming	  to	  correct	  the	  outcome	  of	  a	  reaction	  published	  in	  
Organic	   Syntheses.	   It	   is	   hoped	   that	   this	   result	  will	   be	   published	   in	   the	   near	   future,	   once	   the	   best	  
manner	  in	  which	  to	  do	  this	  has	  been	  established,	  given	  the	  potential	  sensitivity	  of	  the	  situation.	  
























4.	  Future	  Work	  
	  
The	   most	   obvious	   area	   for	   future	   work	   would	   be	   the	   development	   of	   a	   reliable	   method	   for	   the	  
cyclisation	  of	  amino	  enones	  49	  to	  give	  protected	  4-­‐oxopiperidines	  105	  (Scheme	  122).	  Although	  this	  
cyclisation	  has	  been	  performed	  for	  compound	  59c	  (R	  =	  CO2Me,	  PG	  =	  Boc),	  the	  reaction	  proved	  to	  be	  
difficult	  to	  repeat,	  and	  as	  such	  does	  not	  yet	  represent	  an	  efficient	  general	  methodology	  for	  carrying	  
out	  this	  transformation.	  
	  
Scheme	  122.	  Desired	  cyclisation	  of	  amino	  enones	  49	  to	  give	  4-­‐oxopiperidines	  105. 
	  
	  
One	   possible	   solution	   to	   this	   problem	   would	   be	   to	   adapt	   the	   synthetic	   strategy,	   and	   to	   react	  
organozinc	  reagents	  50	  with	  propiolyl	  chloride,	  which	  in	  principle	  would	  lead	  to	  amino	  ynones	  138	  
(Scheme	   123).	   These	   should	   prove	   to	   be	   suitable	   cyclisation	   precursors,	   as	   there	   have	   been	  
published	  examples	  of	   the	  cyclisation	  of	   this	   type	  of	  molecule,	  using	  either	  basic	   conditions13,16	  or	  
gold	  catalysis.14-­‐16	  The	  use	  of	  a	  Negishi	  cross	  coupling	  reaction	  to	  access	  amino	  ynones	  138	  would	  
provide	  a	  complementary	  method	  to	  the	  existing	  routes,	  which	  commonly	  involve	  the	  addition	  of	  an	  
alkynyl	  organometallic	   reagent	   to	  a	  Weinreb	  amide	   formed	   from	  the	   required	  β-­‐amino	  acid,	  often	  
itself	  produced	  by	  homologation	  of	  the	  corresponding	  α-­‐amino	  acid.13-­‐16	  
	  
Scheme	  123.	  Possible	  synthesis	  of	  2,3-­‐dihydro-­‐4-­‐pyridones	  139	  via	  amino	  ynones	  138.	  
	  
	  
The	  products	  of	  the	  above	  cyclisation	  reaction	  would	  be	  2,3-­‐dihydro-­‐4-­‐pyridones	  139,	  which	  contain	  


































conditions,	  as	  reported	  by	  Gouault14-­‐16	  and	  Comins,33-­‐35	  amongst	  others.	  Alternatively,	  a	  substituent	  
at	  the	  6-­‐position	  could	  be	   introduced	  through	  the	  conjugate	  addition	  of	  an	  organocopper	  reagent,	  
again	  as	  previously	  showcased	  by	  Gouault16	  and	  Comins.32,37	  
	  
Scheme	  124.	  Proposed	  synthesis	  of	  substituted	  4-­‐oxopiperidines	  105	  and	  140	  from	  2,3-­‐dihydro-­‐4-­‐
pyridones	  139.	  	  
	  
	  
Once	   a	   reliable	   method	   to	   produce	   the	   substituted	   4-­‐oxopiperidines	   105	   (or	   140)	   had	   been	  
developed,	   the	  next	   step	  would	  be	   to	   investigate	   the	   reduction	  of	   the	   ketone,	   enabling	   access	   to	  
both	  diastereoisomers	  of	  the	  target	  2-­‐substituted	  4-­‐hydroxypiperidines.	  There	  is	  a	  good	  precedent	  in	  
the	   literature	   for	   controlling	   the	   diastereoselectivity	   of	   the	   reduction	   of	   an	   N-­‐protected	   2-­‐
substituted	   4-­‐oxopiperidine,	   especially	   when	   the	   nitrogen	   is	   conjugated	   with	   the	   protecting	  
group.27,35,105,108-­‐113	   This	   relies	   on	   the	   fact	   that	   the	   substituent	   in	   the	   2-­‐position	  will	   adopt	   an	   axial	  
orientation	   so	   as	   to	   avoid	   pseudo	   1,3-­‐allylic	   strain	   with	   the	   protecting	   group,	   caused	   by	   the	  
delocalisation	  of	   the	  nitrogen	   lone	  pair	   (Figure	  41).10	  Once	   the	   chair	  has	   adopted	   this	  orientation,	  
reduction	  can	  occur	  from	  either	  face	  of	  the	  ketone,	  either	  along	  an	  axial	  or	  an	  equatorial	  trajectory.	  
A	  number	  of	  different	  theories	  have	  been	  put	  forward	  that	  attempt	  to	  explain	  the	  stereoselectivities	  
observed	  for	  the	  reduction	  of	  substituted	  cyclohexanones.114-­‐115	  This	  is	  a	  complicated	  matter,	  as	  the	  
outcome	   of	   these	   reductions	   is	   influenced	   by	   both	   the	   steric	   environment	   of	   the	   ketone	   and	   the	  
choice	   of	   reducing	   agent.114	   Future	   work	   for	   this	   project	   would	   involve	   investigating	   the	  
stereoselectivity	  of	  the	  reduction	  of	  a	  range	  of	  N-­‐Boc	  2-­‐substituted	  4-­‐oxopiperidines	  141,	  with	  the	  
aim	  of	   favouring	   the	  production	  of	   either	  diastereoisomer	  of	   the	  product	   by	   varying	   the	   reducing	  




























Figure	  41.	  Expected	  conformation	  of	  N-­‐Boc	  2-­‐substituted	  4-­‐oxopiperidines	  141,	  which	  should	  allow	  
for	  diastereocontrol	  during	  their	  reduction.	  
	  
	  
Other	   future	   work	   could	   involve	   investigating	   ways	   of	   synthesising	   more	   heavily	   substituted	   4-­‐
hydroxypiperidines	   using	   a	   Negishi	   cross	   coupling	   methodology,	   such	   as	   those	   including	   a	  
substituent	   in	   the	   5-­‐position.	   One	   possibility	   would	   be	   to	   react	   organozinc	   reagents	   50	   with	  
substituted	   α,β-­‐unsaturated	   acid	   chlorides	   142,	   which	   after	   cyclisation	   would	   produce	   2,5,6-­‐
trisubstituted	  4-­‐oxopiperidines	  143,	  with	  the	  introduction	  of	  two	  new	  stereocentres	  (Scheme	  125).	  	  
	  
Scheme	   125.	   Proposed	   synthesis	   of	   2,5,6-­‐trisubstituted	   4-­‐hydroxypiperidines	  144	   using	   a	   Negishi	  









































































Obviously,	  the	  success	  of	  this	  synthetic	  strategy	  relies	  on	  the	  development	  of	  a	  successful	  cyclisation	  
method	   for	   the	   substituted	   amino	   enones	   145.	   However,	   the	   cyclisation	   reaction	   conditions	  
reported	  by	  Sutherland	  and	  co-­‐workers12	  using	  Hünig’s	  base	  should	  be	  suitable,	  given	  the	  similarity	  
in	   structure	   between	   the	   compounds	   they	   were	   able	   to	   cyclise	   and	   compounds	   145.	   Finally,	  
reduction	   of	   the	   ketone	   in	   compounds	  143	  would	   lead	   to	   the	   desired	   4-­‐hydroxypiperidines	  144.	  
Again,	  a	  high	  level	  of	  diastereocontrol	  could	  be	  expected	  for	  the	  final	  reduction	  step,	  depending	  on	  
the	  exact	  stereochemical	  distribution	  of	  the	  substitutents	  in	  4-­‐oxopiperidines	  143.	  
	  
	  







All	  reactions	  were	  performed	  with	  stirring	  using	  a	  magnetic	  stirrer	  bar,	  and	  those	  that	  required	  dry	  
solvents	   were	   performed	   in	   flame	   dried	   glassware	   under	   an	   atmosphere	   of	   nitrogen,	   unless	  
otherwise	  stated.	  All	  solvents	  used	  were	  of	  HPLC	  quality	  and	  were	  purchased	  from	  Fisher	  Scientific,	  
VWR	  International	  or	  Sigma	  Aldrich.	  Dry	  DMA	  was	  distilled	  from	  calcium	  hydride	  and	  stored	  under	  
N2	   over	   4Å	  molecular	   sieves.	   All	   other	   dry	   solvents	  were	   obtained	   from	   the	   in-­‐house	   Grubbs	   dry	  
solvent	   system	   (model:	   SPS-­‐200-­‐6).	   Tosyl	   chloride	   was	   recrystallised	   from	   chloroform/petroleum	  
ether	   prior	   to	   use.69	   Acryloyl	   chloride	   and	   cinnamoyl	   chloride	   were	   freshly	   distilled	   before	   use.	  
Saturated	  hydrogen	  chloride	   in	  diethyl	   ether	  was	  prepared	  by	  bubbling	  dry	  hydrogen	  chloride	  gas	  
through	  dry	  diethyl	  ether.	  Dry	  hydrogen	  chloride	  gas	  was	  generated	  by	  slowly	  adding	  concentrated	  
sulfuric	  acid	   to	  sodium	  chloride,	  and	  was	  dried	  by	  bubbling	   through	  concentrated	  sulfuric	  acid.	  All	  
other	   reagents	   and	   solvents	   were	   used	   as	   received	   from	   suppliers	   without	   further	   purification,	  
unless	  otherwise	  stated.	  Petroleum	  ether	  refers	  to	  the	  fraction	  that	  boils	  between	  40	  and	  60	  °C.	  
	  
The	  volume	  of	  organic	  and	  aqueous	  solvents	  used	  during	  reaction	  work-­‐ups	  was	  proportional	  to	  the	  
scale	   of	   the	   reaction.	  Where	   the	   quantities	   are	   not	   given	   in	   the	   experimental	   then	   the	   following	  
general	   rules	  can	  be	  applied:	   for	   larger	  scale	   reactions	   (>10	  mmol)	   the	  portions	  of	   solvent	  used	   in	  
the	  workup	  are	  likely	  to	  be	  similar	  in	  volume	  to	  the	  total	  volume	  of	  the	  reaction	  mixture;	  for	  smaller	  
scale	  reactions	  (<10	  mmol)	  the	  portions	  of	  solvent	  used	  in	  the	  workup	  may	  well	  be	  larger	  in	  volume	  
than	  the	  total	  volume	  of	  the	  reaction	  mixture,	  but	  never	  by	  more	  than	  a	  factor	  of	  seven.	  
	  
Flash	   column	   chromatography	  was	   performed	   by	   hand	   under	   pressure	   on	   silica	   gel	   60	   purchased	  
from	   Davisil	   Fluorochem,	   or	   on	   a	   Teledyne	   Isco	   CombiFlash	   Companion	   or	   RF	   automated	  
chromatography	  machine	  (when	  heptane	  is	  reported	  as	  a	  solvent).	  All	  columns	  were	  monitored	  by	  
TLC	  using	  pre	  coated	  silica	  plates,	  which	  were	  visualised	  with	  UV	  irradiation	  at	  254	  nm,	  basic	  KMnO4	  
and/or	  methanolic	  ninhydrin.	  	  
	  
Melting	   points	  were	  measured	   on	   a	   Linkam	  HFS91	   heating	   stage,	  with	   a	   TC92	   controller,	   and	   are	  
uncorrected.	   Infrared	   spectra	   were	   measured	   on	   a	   Perkin	   Elmer	   Paragon	   1000,	   Spectrum	   RX	   I,	  
Spectrum	   Two,	   Spectrum	   65	   or	   Spectrum	   100	   FT-­‐IR	   spectrometer.	   Only	   selected	   peaks	   were	  
reported,	  and	  the	  absorption	  maxima	  are	  given	  to	  the	  nearest	  cm−1.	   1H	  and	  13C	  NMR	  spectra	  were	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recorded	  on	  a	  Bruker	  Avance	  III	  HD	  500,	  Avance	  DRX	  500,	  Avance	  III	  HD	  400,	  Avance	  I	  400,	  Avance	  
DPX	  400	  or	  Avance	  I	  250	  spectrometer	  at	  room	  temperature.	  Chemical	  shifts	  are	  assigned	  relative	  to	  
the	  residual	  solvent	  peaks	  and	  are	  quoted	  in	  parts	  per	  million	  to	  the	  nearest	  0.01	  ppm	  for	  1H	  spectra	  
and	  the	  nearest	  0.1	  ppm	  for	  13C	  spectra.	  The	  multiplicities	  are	  defined	  as	  s	  =	  singlet,	  d	  =	  doublet,	  t	  =	  
triplet,	  q	  =	  quartet,	  m	  =	  multiplet,	  br.	  =	  broad,	  app.	  =	  apparent.	  Coupling	  constants	  are	  quoted	   in	  
Hertz	  to	  the	  nearest	  0.1	  Hz,	  and	  have	  been	  rationalised.	  High	  resolution	  mass	  spectra	  were	  recorded	  
on	   a	   MicroMass	   LCT	   Premier	   XE	   or	   a	   Thermo	   Scientific	   LTQ-­‐FT	   spectrometer	   operating	   in	  
electrospray	   mode.	   Optical	   rotations	   were	   measured	   on	   an	   Optical	   Activity	   Ltd.	   AA-­‐10	   Series	  
Automatic	  polarimeter	  at	  589	  nm.	  Specific	   rotations	  are	  given	  to	   the	  nearest	  0.1	  degrees,	  and	  the	  
concentrations	  are	  given	  to	  the	  nearest	  0.1	  units	  of	  10	  mg/mL.	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5.2	  Synthesis	  of	  Amino	  Acid	  Derived	  Iodides	  
	  
Methyl	  (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐hydroxypropanoate	  (73)	  
	  
	  
Acetyl	  chloride	  (46	  mL,	  647	  mmol,	  2.8	  eq.)	  was	  added	  dropwise	  to	  MeOH	  (300	  mL)	  at	  0	  °C	  over	  15	  
min	  under	  N2	  in	  a	  flame-­‐dried	  flask.	  To	  this	  was	  added	  L-­‐serine	  (24.004	  g,	  228	  mmol,	  1.0	  eq.),	  and	  the	  
solution	  was	  heated	  to	  reflux	  for	  2	  h.	  The	  solution	  was	  then	  cooled	  to	  room	  temperature,	  and	  the	  
solvent	  was	  removed	  under	  reduced	  pressure	  to	  yield	  L-­‐serine	  methyl	  ester	  hydrochloride	  72	  as	  a	  
white	  solid	  (47.453	  g),	  which	  was	  used	  without	  further	  purification:	  m.p.	  150–165	  °C	  (decomp.)	  (lit.	  
~165	  °C)116;	  δH	  (250	  MHz,	  D2O)	  3.73	  (3H,	  s,	  CH3),	  3.86	  (1H,	  dd,	  J	  =	  3.5,	  12.6,	  CHHOH),	  3.98	  (1H,	  dd,	  J	  =	  
4.1,	  12.6,	  CHHOH),	  4.15	  (1H,	  t,	  J	  =	  3.8,	  CH);	  δC	  (101	  MHz,	  D2O)	  53.9	  (CH	  or	  CH3),	  54.8	  (CH	  or	  CH3),	  59.4	  
(CH2),	  169.0	  (CO);	  [α]D23	  +5.0,	  c	  2.0,	  MeOH	  (lit.	  +5.0	  ±	  0.5,	  c	  2.0,	  MeOH).116	  
	  
The	  crude	  L-­‐serine	  methyl	  ester	  hydrochloride	  72	   (47.449	  g)	  was	  dissolved	   in	  H2O	  (115	  mL).	  K2CO3	  
(31.573	  g,	  228	  mmol,	  1.0	  eq.)	  was	  added	  to	  the	  solution	  and	  allowed	  to	  dissolve	  over	  a	  few	  minutes.	  
(Boc)2O	   (49.769	   g,	   228	  mmol,	   1.0	   eq.)	  was	   added	   to	   the	   solution,	   and	   the	   reaction	  was	   stirred	   at	  
room	   temperature	   overnight.	   The	   reaction	   mixture	   was	   extracted	   with	   Et2O	   (3	   ×	   115	   mL).	   the	  
combined	   organic	   extracts	   were	   dried	   over	   MgSO4,	   filtered	   and	   the	   solvent	   was	   removed	   under	  
reduced	   pressure	   (rotary	   evaporator,	   then	   high	   vacuum	   for	   2	   d)	   to	   yield	   methyl	   (2S)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐3-­‐hydroxypropanoate	  73	  as	  a	  colourless	  oil	  (47.885	  g,	  96%	  crude	  yield	  from	  
L-­‐serine),	  which	  was	   used	  without	   further	   purification:	   	   δH	   (400	  MHz,	   CDCl3)	   1.47	   (9H,	   s,	   C(CH3)3),	  
2.51	  (1H,	  t,	  J	  =	  6.1,	  OH),	  3.80	  (3H,	  s,	  CO2CH3),	  3.88–4.02	  (2H,	  m,	  CH2),	  4.19–4.49	  (1H,	  m,	  CHNH),	  5.50	  
(1H,	  br.	  d,	   J	  =	  5.3,	  NH);	  δC	   (101	  MHz,	  CDCl3)	  28.2	   (C(CH3)3),	  52.5	   (NHCH	  or	  CO2CH3),	  55.7	   (NHCH	  or	  
CO2CH3),	  63.0	  (CH2),	  80.1	  (C(CH3)3),	  155.8	  (CO	  carbamate),	  171.5	  (CO	  ester);	  [α]D20	  −16.3,	  c	  4.1,	  MeOH	  
(lit.	  −19.1,	  c	  4.07,	  MeOH).70	  
	  
This	  product	  contained	  2%	  (Boc)2O	  and	  11%	  tBuOH	  by	  1H	  NMR	  analysis.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.70	  















Methyl	  (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐[(4-­‐methylbenzenesulfonyl)oxy]propanoate	  (74)	  
	  
	  
Crude	  methyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐hydroxypropanoate	  73	   (26.236	  g,	  120	  mmol,	  
1.0	  eq.)	  was	  dissolved	   in	  dry	  CH2Cl2	   (200	  mL).	   4-­‐DMAP	   (0.703	  g,	   5.75	  mmol,	  4.8	  mol%),	  Me3N·∙HCl	  
(1.113	  g,	  11.6	  mmol,	  9.7	  mol%)	  and	  TsCl	  (22.664	  g,	  119	  mmol,	  1.0	  eq.)	  were	  added	  to	  the	  solution	  at	  
0	  °C.	  Et3N	  (17	  mL,	  122	  mmol,	  1.0	  eq.)	  dissolved	  in	  dry	  CH2Cl2	  (50	  mL)	  was	  added	  to	  the	  suspension	  
dropwise	  at	  0	  °C	  over	  45	  min.	  The	  resulting	  white	  suspension	  was	  stirred	  for	  a	  further	  2	  h	  at	  0	  °C,	  
before	   it	   was	   poured	   onto	   a	  mixture	   of	   ice	   (100	  mL),	   water	   (100	  mL)	   and	   2	  M	   HCl	   (50	  mL).	   The	  
aqueous	  layer	  was	  extracted	  with	  CH2Cl2	  (2	  ×	  100	  mL).	  The	  combined	  organic	  extracts	  were	  washed	  
with	   brine	   (2	   ×	   120	  mL),	   dried	   over	  MgSO4,	   filtered	   and	   the	   solvent	  was	   removed	   under	   reduced	  
pressure	  to	  yield	  the	  crude	  product	  as	  a	  mixture	  of	  a	  white	  solid	  and	  a	  colourless	  oil	  (42.335	  g).	  The	  
mixture	  was	  dissolved	  in	  hot	  Et2O	  (140	  mL)	  and	  filtered	  to	  remove	  the	  insoluble	  white/cream	  solid.	  
The	  filtrate	  was	  allowed	  to	  cool	  to	  room	  temperature	  before	  being	  further	  cooled	  to	  0	  °C.	  Petroleum	  
ether	  (250	  mL)	  was	  added	  in	  5	  portions	  over	  2	  h	  until	  crystallisation	  began,	  and	  the	  crude	  product	  
was	  left	  at	  −20	  °C	  over	  the	  weekend.	  Filtration	  of	  the	  crystals	  formed	  yielded	  methyl	  (2S)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐3-­‐[(4-­‐methylbenzenesulfonyl)oxy]propanoate	   74	   as	   a	   white	   powder	  
(28.090	  g,	  63%):	  m.p.	  72–76	  °C	  (lit.	  74–76	  °C)69;	  δH	  (400	  MHz,	  CDCl3)	  1.44	  (9H,	  s,	  C(CH3)3),	  2.48	  (3H,	  s,	  
C6H4CH3),	   3.72	   (3H,	   s,	   CO2CH3),	   4.31	   (1H,	   dd,	   J	   =	   2.9,	   10.1,	   CHHOSO2),	   4.42	   (1H,	   dd,	   J	   =	   3.0.	   10.1,	  
CHHOSO2),	  4.50–4.56	  (1H,	  m,	  CHNH),	  5.32	  (1H,	  d,	  J	  =	  7.6,	  NH),	  7.38	  (2H,	  app.	  d,	  J	  =	  8.2,	  Ar	  H),	  7.79	  
(2H,	  app.	  d,	  J	  =	  8.2,	  Ar	  H);	  δC	  (101	  MHz,	  CDCl3)	  21.7	  (C6H4CH3),	  28.2	  (C(CH3)3),	  52.9	  (CH	  or	  CO2CH3),	  
53.0	  (CH	  or	  CO2CH3),	  69.5	  (CH2),	  80.5	  (C(CH3)3),	  128.0	  (Ar	  CH),	  129.9	  (Ar	  CH),	  132.4	  (Ar	  quat.	  C),	  145.2	  
(Ar	   quat.	   C),	   154.9	   (CO	   carbamate),	   169.0	   (CO	   ester);	   [α]D23	   +3.5,	   c	   2.0,	   MeOH	   (lit.	   +3.0,	   c	   2.0,	  
MeOH).69	  
	  
















Methyl	  (2R)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐iodopropanoate	  (68)	  
	  
	  
Methyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐[(4-­‐methylbenzenesulfonyl)oxy]propanoate	   74	  
(28.090	  g,	  75.2	  mmol,	  1.0	  eq.)	  was	  dissolved	  in	  acetone	  (160	  mL).	  NaI	  (13.530	  g,	  90.3	  mmol,	  1.2	  eq.)	  
was	  added	  in	  one	  portion,	  and	  the	  flask	  was	  covered	  in	  aluminium	  foil.	  After	  stirring	  for	  3	  d,	  further	  
NaI	  (3.383	  g,	  22.6	  mmol,	  0.3	  eq.)	  was	  added	  in	  one	  portion	  and	  the	  reaction	  was	  stirred	  for	  1	  d.	  The	  
brown	  slurry	  was	  filtered,	  and	  the	  brown	  solid	  isolated	  was	  washed	  with	  acetone	  until	  the	  solid	  was	  
colourless.	  The	  flask	  containing	  the	  filtrate	  was	  covered	  with	  aluminium	  foil	  to	  exclude	  light	  and	  the	  
solvent	  was	  removed	  under	  reduced	  pressure	  to	  yield	  a	  brown	  oil.	  This	  oil	  was	  partitioned	  between	  
Et2O	  (150	  mL)	  and	  1	  M	  Na2S2O3	  (60	  mL).	  The	  organic	  layer	  was	  washed	  with	  1	  M	  Na2S2O3	  (40	  mL)	  and	  
brine	  (50	  mL),	  dried	  over	  MgSO4,	  filtered	  and	  the	  solvent	  removed	  under	  reduced	  pressure	  to	  yield	  
the	  crude	  product	  as	  a	  white	  solid	  (21.225	  g).	  The	  solid	  was	  dissolved	  in	  hot	  petroleum	  ether	  (30	  mL)	  
before	  being	  cooled	  to	  0	  °C.	  This	  began	  the	  crystallisation,	  which	  was	  allowed	  to	  complete	  at	  −20	  °C	  
overnight.	   After	   filtration,	   a	   pale	   yellow	   solid	   was	   isolated.	   This	   solid	   was	   washed	   with	   cold	  
petroleum	  ether	  and	  air	  dried	  to	  give,	  after	  grinding,	  methyl	  (2R)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐
iodopropanoate	  68	  as	  a	  pale	  yellow	  powder	  (19.101	  g,	  77%):	  m.p.	  42–49	  °C	  (lit.	  45–47	  °C)69;	  δH	  (400	  
MHz,	  CDCl3)	  1.48	   (9H,	   s,	  C(CH3)3),	  3.54–3.65	   (2H,	  m,	  CH2I),	  3.83	   (3H,	   s,	  CO2CH3),	  4.50–4.58	   (1H,	  m,	  
CHNH),	  5.37	  (1H,	  d,	  J	  =	  6.8,	  NH);	  δC	  (101	  MHz,	  CDCl3)	  7.8	  (CH2),	  28.3	  (C(CH3)3),	  53.0	  (CH	  or	  CH3),	  53.7	  
(CH	   or	   CH3),	   80.5	   (C(CH3)3),	   154.8	   (CO	   carbamate),	   170.0	   (CO	   ester);	   [α]D20	   −3.7,	   c	   3.0,	  MeOH	   (lit.	  
−3.7,	  c	  3.0,	  MeOH).69	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.69	  
	  
	  













NaBH4	  (6.969	  g,	  184.2	  mmol,	  2.9	  eq.)	  and	  L-­‐valine	  (7.540	  g,	  64.4	  mmol,	  1.0	  eq.)	  were	  added	  to	  dry	  
THF	   (200	  mL),	  and	  the	  resulting	  white	  suspension	  was	  cooled	  to	  0	   °C.	   I2	   (19.299	  g,	  76.0	  mmol,	  1.2	  
eq.)	   dissolved	   in	   dry	   THF	   (50	   mL)	   was	   added	   dropwise	   to	   the	   suspension	   over	   1.25	   h,	   and	   gas	  
evolution	  was	   observed.	   A	   stopper	  was	   removed	   during	   the	   addition	   to	   allow	   release	   of	   this	   gas.	  
Once	  all	  the	  I2	  had	  been	  added,	  the	  solution	  was	  heated	  at	  reflux	  overnight.	  After	  cooling	  to	  room	  
temperature,	  MeOH	   (60	  mL)	  was	  added	  slowly	  until	   all	  of	   the	  white	   solid	  had	  dissolved,	   leaving	  a	  
colourless	   solution.	   Gas	   evolution	   was	   observed	   while	   the	   MeOH	   was	   added.	   The	   solvent	   was	  
removed	  under	  reduced	  pressure	  to	  yield	  a	  white	  slurry,	  which	  was	  dissolved	  in	  20%	  aq.	  KOH	  (150	  
mL).	  This	  solution	  was	  stirred	  at	  room	  temperature	  for	  4.25	  h,	  before	  being	  extracted	  with	  CH2Cl2	  (3	  
×	  150	  mL).	  Extra	  water	  and	  brine	  were	  added	  to	  aid	  this	  difficult	  separation.	  The	  combined	  organic	  
extracts	  were	  dried	  over	  Na2SO4,	   filtered	  and	  the	  solvent	  was	  removed	  under	  reduced	  pressure	  to	  
yield	   the	   crude	   (2S)-­‐2-­‐amino-­‐3-­‐methylbutan-­‐1-­‐ol	  75	   as	   a	   colourless	   oil	   (~6.3	   g,	   95%	   crude	   yield),	  
which	  was	  used	  without	  further	  purification:	  δH	  (400	  MHz,	  CDCl3)	  0.86	  (3H,	  d,	  J	  =	  6.8,	  CH3),	  0.87	  (3H,	  
d,	  J	  =	  6.8,	  CH3),	  1.46–1.64	  (1H,	  m,	  CH(CH3)2),	  2.54	  (1H,	  ddd,	  J	  =	  3.7,	  6.4,	  8.5,	  NHCH),	  3.07	  (app.	  3.5H,	  
br.	  s,	  NH2	  and	  OH),	  3.28	  (1H,	  dd,	  J	  =	  8.5,	  10.7,	  CHH),	  3.59	  (1H,	  dd,	  J	  =	  3.7,	  10.7,	  CHH).	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.117	  
	  
	  
	   	  
H2N








tert-­‐Butyl	  N-­‐[(2S)-­‐1-­‐hydroxy-­‐3-­‐methylbutan-­‐2-­‐yl]carbamate	  (76a)	  
	  
	  
Crude	   (2S)-­‐2-­‐amino-­‐3-­‐methylbutan-­‐1-­‐ol	  75	   (~6.1	  g)	  was	  dissolved	   in	  THF	   (140	  mL).	   1	  M	  NaOH	   (65	  
mL,	   65.0	  mmol,	   1.1	   eq.)	  was	   added,	   followed	   by	   (Boc)2O	   (12.919	   g,	   59.1	  mmol,	   1.0	   eq.	   assuming	  
100%	  conversion	  of	   L-­‐valine	   to	   (2S)-­‐2-­‐amino-­‐3-­‐methylbutan-­‐1-­‐ol).	  The	   reaction	  mixture	  was	  stirred	  
at	   room	   temperature	   overnight	   before	   the	   THF	   was	   removed	   under	   reduced	   pressure.	   The	  
remaining	  aqueous	  solution	  was	  acidified	  to	  pH	  5	  with	  2	  M	  HCl	  and	  extracted	  with	  EtOAc	  (3	  ×	  100	  
mL).	  The	  combined	  organic	  extracts	  were	  dried	  over	  MgSO4,	   filtered	  and	  the	  solvent	  was	  removed	  
under	   reduced	   pressure	   to	   yield	   crude	   tert-­‐butyl	  N-­‐[(2S)-­‐1-­‐hydroxy-­‐3-­‐methylbutan-­‐2-­‐yl]carbamate	  
76a	  as	  a	  colourless	  oil	  (10.785	  g,	  82%	  crude	  yield	  over	  two	  steps),	  which	  was	  used	  without	  further	  
purification:	   δH	   (400	   MHz,	   CDCl3)	   0.95	   (3H,	   d,	   J	   =	   6.9,	   CH(CH3)(CH3)),	   0.97	   (3H,	   d,	   J	   =	   6.9,	  
CH(CH3)(CH3)),	  1.46	  (9H,	  s,	  C(CH3)3),	  1.75–1.93	  (1H,	  m,	  CH(CH3)2),	  2.52	  (1H,	  br.	  s,	  OH),	  3.30–3.54	  (1H,	  
m,	  NHCH),	  3.62	  (1H,	  dd,	  J	  =	  6.6,	  10.8,	  CHH),	  3.67–3.76	  (1H,	  m,	  CHH),	  4.70	  (1H,	  d,	  J	  =	  6.7,	  NH);	  δC	  (101	  
MHz,	   CDCl3)	   18.4	   (CH3),	   19.4	   (CH3),	   28.3	   (C(CH3)3	   or	   CH(CH3)2),	   29.1	   (C(CH3)3	   or	   CH(CH3)2),	   57.8	  
(NHCH),	  63.2	  (CH2),	  79.1	  (C(CH3)3),	  156.7	  (CO);	  [α]D23	  −14.2,	  c	  1.1,	  MeOH	  (lit.	  −16.7,	  c	  1.0,	  MeOH).79	  
	  
This	  sample	  was	  found	  to	  contain	  13%	  of	  (Boc)2O	  by	  1H	  NMR	  analysis.	  
	  







	   	  
H2N








	  2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐1-­‐hydroxy-­‐3-­‐methylbutan-­‐2-­‐yl]acetamide	  (76b)	  
	  
	  
Commercially	   available	   L-­‐valinol	  75	   (4.645	   g,	   45.0	  mmol,	   1.0	   eq.)	   dissolved	   in	   CH2Cl2	   (20	  mL)	   and	  
Et3N	   (22	  mL,	   158	  mmol,	   3.5	   eq.)	  were	   added	   to	   CH2Cl2	   (300	  mL),	   and	   the	   colourless	   solution	  was	  
cooled	  to	  0	  °C.	  TFAA	  (7.5	  mL,	  53.7	  mmol,	  1.2	  eq.)	  was	  added	  over	  40	  min,	  producing	  a	  white	  gas.	  The	  
reaction	   mixture	   was	   warmed	   at	   room	   temperature	   overnight	   before	   being	   concentrated	   under	  
reduced	  pressure.	  EtOAc	   (100	  mL)	  was	  added,	  and	   the	  solution	  was	  washed	  sequentially	  with	  sat.	  
aq.	  NaHCO3	  (120	  mL),	  1	  M	  HCl	  (120	  mL)	  and	  brine	  (120	  mL).	  The	  organic	  layer	  was	  dried	  over	  MgSO4,	  
filtered	   and	   the	   solvent	   was	   removed	   under	   reduced	   pressure	   to	   yield	   2,2,2-­‐trifluoro-­‐N-­‐[(2S)-­‐1-­‐
hydroxy-­‐3-­‐methylbutan-­‐2-­‐yl]acetamide	  76b	   as	   an	   off-­‐white	   solid	   (7.166	   g,	   80%),	   which	   was	   used	  
without	  further	  purification:	  m.p.	  91–97	  °C	  (lit.	  85–86	  °C)119;	  δH	  (400	  MHz,	  CDCl3)	  0.99	  (3H,	  d,	  J	  =	  6.8,	  
CH(CH3)(CH3)),	   1.03	   (3H,	   d,	   J	   =	   6.8,	   CH(CH3)(CH3)),	   1.87	   (app.	   1.8H,	   br.	   s,	   OH),	   1.93–2.05	   (1H,	   m,	  
CH(CH3)2),	  3.74–3.87	  (3H,	  m,	  CH2	  and	  NHCH),	  6.57	  (1H,	  s,	  NH);	  δC	  (101	  MHz,	  CDCl3)	  18.7	  (CH3),	  19.3	  
(CH3),	  28.9	  (CH(CH3)2),	  57.5	  (NHCH),	  62.1	  (CH2),	  116.0	  (q,	  J	  =	  287.7,	  CF3),	  157.8	  (q,	  J	  =	  36.8,	  CO);	  [α]D23	  
−9.5,	  c	  13.5,	  MeOH	  (lit.	  +7.01,	  c	  13.5,	  MeOH,	  opposite	  enantiomer).119	  
	  
Repeating	   this	   procedure	   using	   crude	   (2S)-­‐2-­‐amino-­‐3-­‐methylbutan-­‐1-­‐ol	   75	   produced	   from	   the	  
reduction	  of	  L-­‐valine	  gave	  the	  product	  76b	  in	  a	  59%	  yield	  over	  two	  steps.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.119-­‐120	  
	  
	  










tert-­‐Butyl	  N-­‐[(2S)-­‐1-­‐iodo-­‐3-­‐methylbutan-­‐2-­‐yl]carbamate	  (61a)	  
	  
	  
PPh3	  (6.585	  g,	  25.1	  mmol,	  1.6	  eq.)	  and	  imidazole	  (1.699	  g,	  25.0	  mmol,	  1.5	  eq.)	  were	  dissolved	  in	  dry	  
CH2Cl2	  (325	  mL)	  to	  give	  a	  colourless	  solution.	  I2	  (7.072	  g,	  27.9	  mmol,	  1.7	  eq.)	  was	  added	  portionwise,	  
producing	  a	  brown	  solution.	  After	  ~30	  min,	  commercially	  available	  N-­‐Boc-­‐L-­‐valinol	  76a	  (3.292	  g,	  16.2	  
mmol,	  1.0	  eq.)	   in	  dry	  CH2Cl2	   (75	  mL)	  was	  added	   to	   the	   reaction	  mixture.	  The	   flask	  was	  covered	   in	  
aluminium	   foil	   and	   stirred	  at	   room	   temperature	   for	  5	  h.	   The	   solvent	  was	   removed	  under	   reduced	  
pressure	  to	  yield	  a	  brown	  slurry,	  which	  was	  dissolved	  in	  the	  minimum	  volume	  of	  CH2Cl2	  and	  filtered	  
through	  a	  silica	  plug,	  eluting	  with	  Et2O.	  The	  solvent	  was	  removed	  under	   reduced	  pressure	   to	  yield	  
the	  crude	  product	  as	  a	  brown	  oil.	  This	  oil	  was	  purified	  by	  column	  chromatography,	  using	  a	  gradient	  
of	  0:100	  EtOAc/heptane	  to	  10:90	  EtOAc/heptane	  as	  the	  solvent	  system.	  tert-­‐Butyl	  N-­‐[(2S)-­‐1-­‐iodo-­‐3-­‐
methylbutan-­‐2-­‐yl]carbamate	   61a	   was	   isolated	   as	   a	   pale	   yellow	   solid	   (2.848	   g,	   56%),	   which	   was	  
stored	  under	  N2	  in	  the	  dark	  at	  −20	  °C:	  m.p.	  73–74	  °C	  (lit.	  49–51	  °C)58;	  Rf	  0.6	  (20:80	  EtOAc/petroleum	  
ether);	  δH	   (400	  MHz,	  CDCl3)	  0.94	   (3H,	  d,	   J	  =	  6.7,	  CH(CH3)(CH3)),	  0.99	   (3H,	  d,	   J	  =	  6.7,	  CH(CH3)(CH3)),	  
1.47	   (9H,	   s,	  C(CH3)3),	   1.72–1.86	   (1H,	  m,	  CH(CH3)2),	   3.09–3.17	   (1H,	  m,	  NHCH),	   3.35	   (1H,	  dd,	   J	  =	  4.5,	  
10.3,	  CHH),	  3.44	  (1H,	  dd,	  J	  =	  4.2,	  10.3,	  CHH),	  4.59	  (1H,	  d,	  J	  =	  8.6,	  NH);	  δC	  (101	  MHz,	  CDCl3)	  13.3	  (CH2),	  
18.2	  (CH(CH3)(CH3)),	  19.3	  (CH(CH3)(CH3)),	  28.4	  (C(CH3)3),	  32.3	  (CH(CH3)2),	  55.5	  (NHCH),	  79.5	  (C(CH3)3),	  
155.4	  (CO);	  [α]D23	  −15.5,	  c	  1.8,	  CHCl3	  (lit.	  −18.1,	  c	  1.75,	  CHCl3).58	  
	  
Repeating	   this	   procedure	   using	   tert-­‐butyl	   N-­‐[(2S)-­‐1-­‐hydroxy-­‐3-­‐methylbutan-­‐2-­‐yl]carbamate	   76a	  
produced	  from	  the	  reduction	  and	  subsequent	  Boc	  protection	  of	  L-­‐valine	  gave	  the	  product	  61a	  as	  a	  
yellow	  solid	  in	  a	  39%	  yield.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.58	  	  
	  
	  















PPh3	   (8.975	  g,	  34.2	  mmol,	  1.05	  eq.),	   imidazole	   (2.333	  g,	  34.3	  mmol,	  1.05	  eq.)	  and	   I2	   (8.726	  g,	  34.4	  
mmol,	   1.05	   eq.)	   were	   dissolved	   in	   dry	   CH2Cl2	   (110	  mL)	   at	   0	   °C,	   producing	   an	   orange	   suspension.	  
2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐1-­‐hydroxy-­‐3-­‐methylbutan-­‐2-­‐yl]acetamide	  76b	   (6.504	   g,	   32.7	  mmol,	   1.0	   eq.)	  
was	   added	   portionwise	   to	   the	   reaction	   mixture	   over	   30	   min	   at	   0	   °C.	   The	   flask	   was	   covered	   in	  
aluminium	   foil	   and	   stirred	  at	   room	   temperature	  overnight.	   The	   reaction	  mixture	  was	   filtered,	   and	  
solvent	  was	  removed	  under	  reduced	  pressure	  to	  yield	  a	  light	  brown	  slurry.	  This	  slurry	  was	  dissolved	  
in	  EtOAc	  (290	  mL),	  filtered	  again,	  and	  the	  white	  solid	  was	  washed	  with	  a	  small	  portion	  of	  EtOAc.	  The	  
solution	  was	  washed	  with	  sat.	  aq.	  Na2S2O3	  (330	  mL)	  and	  brine	  (330	  mL),	  and	  was	  dried	  over	  MgSO4,	  
filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  yield	  the	  crude	  product	  as	  a	  yellow	  oil.	  This	  oil	  
was	   purified	   by	   column	   chromatography,	   using	   a	   gradient	   of	   0:100	   EtOAc/heptane	   to	   20:80	  
EtOAc/heptane	   as	   the	   solvent	   system.	   2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐1-­‐iodo-­‐3-­‐methylbutan-­‐2-­‐yl]acetamide	  
61b	  was	  isolated	  as	  a	  white	  solid	  (6.908	  g,	  68%),	  which	  was	  stored	  under	  N2	  in	  the	  dark	  at	  −20	  °C:	  
m.p.	  101–109	  °C	  (lit.	  114–116	  °C)60;	  Rf	  0.3	  (10:90	  EtOAc/petroleum	  ether);	  δH	  (250	  MHz,	  CDCl3)	  0.99	  
(3H,	  d,	  J	  =	  6.6,	  CH(CH3)(CH3)),	  1.01	  (3H,	  d,	  J	  =	  6.6,	  CH(CH3)(CH3)),	  1.79–1.98	  (1H,	  m,	  CH(CH3)2),	  3.22–
3.56	   (3H,	  m,	  NHCH	   and	  CH2),	   6.24	   (1H,	   br.	   s,	  NH);	   δC	   (101	  MHz,	   CDCl3)	   9.9	   (CH2),	   18.3	   (CH3),	   19.0	  
(CH3),	  32.3	  (CH(CH3)2),	  55.1	  (NHCH),	  115.8	  (q,	  J	  =	  288.1,	  CF3),	  156.9	  (q,	  J	  =	  37.2,	  CO);	  [α]D23	  −43.0,	  c	  
1.0,	  CHCl3	  (lit.	  −42.0,	  c	  1.0,	  CHCl3).60	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.60	  	  
	  
	  












Methyl	  (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}propanoate	  (77)	  
	  
	  
Acetyl	  chloride	  (23	  mL,	  323	  mmol,	  2.8	  eq.)	  was	  added	  dropwise	  to	  MeOH	  (150	  mL)	  at	  0	  °C	  over	  10	  
min.	  After	  5	  min,	  L-­‐alanine	  (10.155	  g,	  114	  mmol,	  1.0	  eq.)	  was	  added,	  and	  the	  solution	  was	  heated	  at	  
reflux	  overnight.	  The	  solution	  was	  cooled	  to	  room	  temperature,	  and	  the	  solvent	  was	  removed	  under	  
reduced	   pressure	   to	   yield	   the	   crude	   (2S)-­‐1-­‐methoxy-­‐1-­‐oxopropan-­‐2-­‐aminium	   chloride	   (17.483	   g),	  
which	  was	  used	  without	  further	  purification:	  δH	  (400	  MHz,	  D2O)	  1.43	  (3H,	  d,	  J	  =	  7.3,	  CHCH3),	  3.71	  (3H,	  
s,	  CO2CH3),	  4.08	  (1H,	  q,	  J	  =	  7.3,	  CH).	  
	  
The	  crude	  (2S)-­‐1-­‐methoxy-­‐1-­‐oxopropan-­‐2-­‐aminium	  chloride	  (17.483	  g)	  was	  dissolved	  in	  H2O	  (57	  mL).	  
K2CO3	  (15.756	  g,	  114	  mmol,	  1.0	  eq.)	  was	  added	  to	  the	  solution	  which	  was	  stirred	  for	  5	  min.	  (Boc)2O	  
(24.870	   g,	   114	   mmol,	   1.0	   eq.)	   was	   added	   to	   the	   solution,	   and	   the	   reaction	   was	   stirred	   at	   room	  
temperature	   for	  3	  d.	  The	  reaction	  mixture	  was	  extracted	  with	  Et2O	   (3	  ×	  60	  mL)	  and	  the	  combined	  
organic	  extracts	  were	  dried	  over	  MgSO4,	  filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  yield	  a	  
mixture	   of	  methyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}propanoate	   and	   (Boc)2O.	   Petroleum	   ether	  
(30	  mL)	  was	  added,	  and	  the	  solvent	  removed	  under	  reduced	  pressure	  to	  yield	  methyl	  (2S)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}propanoate	  77	  as	  a	  white	  solid	   (19.902	  g,	  86%	  crude	  yield	   from	  L-­‐alanine),	  
which	  was	  used	  without	   further	  purification:	  m.p.	   28–33	   °C	   (lit.	   31–33	   °C)121;	   δH	   (400	  MHz,	  CDCl3)	  
1.39	  (3H,	  d,	  J	  =	  7.2,	  CHCH3),	  1.45	  (9H,	  s,	  C(CH3)3),	  3.76	  (3H,	  s,	  CO2CH3),	  4.08–4.41	  (1H,	  m,	  CH),	  5.07	  
(1H,	  br.	   s,	  NH);	  δC	   (101	  MHz,	  CDCl3)	  18.6	   (CHCH3),	  28.3	   (C(CH3)3),	  49.1	   (CH	  or	  CO2CH3),	  52.3	   (CH	  or	  
CO2CH3),	  79.8	  (C(CH3)3),	  155.1	  (CO	  carbamate),	  173.8	  (CO	  ester);	  [α]D20	  −2.0,	  c	  1.0,	  CHCl3	  (lit.	  −3.4,	  c	  
1.0,	  CHCl3).122	  
	  
This	  product	  was	  found	  to	  contain	  14%	  (Boc)2O	  and	  4%	  tBuOH	  by	  1H	  NMR	  analysis.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.121-­‐122	  
	  















tert-­‐Butyl	  N-­‐[(2S)-­‐1-­‐hydroxypropan-­‐2-­‐yl]carbamate	  (78a)	  
	  
	  
Crude	   methyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}propanoate	   77	   (19.795	   g,	   97.4	   mmol,	   1.0	   eq.)	  
was	  dissolved	  in	  THF	  (140	  mL).	  To	  the	  reaction	  mixture	  was	  added	  LiCl	  (8.260	  g,	  195	  mmol,	  2.0	  eq.),	  
which	  had	  previously	  been	  dried	  by	  heating	  with	  a	  blow	  torch	  under	  high	  vacuum.	  NaBH4	  (7.369g,	  
195	  mmol,	  2.0	  eq.)	  was	  added	  portionwise	  before	  EtOH	   (280	  mL)	  was	  added.	  After	   stirring	   for	  15	  
min	  an	  exotherm	  was	  noted,	  so	  an	  ice	  bath	  was	  used	  to	  cool	  the	  reaction	  for	  10	  min	  before	  being	  
stirred	  at	  room	  temperature	  overnight.	  A	  white	  foamy	  mixture	  was	  produced,	  to	  which	  was	  slowly	  
added	  10%	  citric	  acid	  (100	  mL)	  with	  cooling	  from	  an	  ice	  bath.	  After	  stirring	  at	  0	  °C	  for	  ~2	  h,	  most	  of	  
the	  solid	  had	  dissolved,	  leaving	  a	  white	  gum.	  The	  liquid	  was	  decanted	  from	  this	  white	  gum,	  and	  the	  
solvent	  was	  removed	  under	  reduced	  pressure	  yielding	  a	  white	  solid.	  H2O	  (280	  mL)	  was	  added,	  and	  
the	  solution	  was	  extracted	  with	  CH2Cl2	  (3	  ×	  240	  mL).	  The	  combined	  organic	  extracts	  were	  dried	  over	  
Na2SO4,	  filtered	  and	  the	  solvent	  was	  removed	  under	  reduced	  pressure	  to	  yield	  tert-­‐butyl	  N-­‐[(2S)-­‐1-­‐
hydroxypropan-­‐2-­‐yl]carbamate	  78a	   as	  a	  white	   solid	   (13.924	  g).	  The	  white	  gum	  previously	   isolated	  
was	  re-­‐dissolved	  in	  10%	  citric	  acid	  (100	  mL),	  and	  the	  solvent	  was	  removed	  under	  reduced	  pressure	  
to	  yield	  a	  white	  solid.	  This	  solid	  was	  dissolved	  in	  H2O	  (100	  mL),	  and	  extracted	  with	  CH2Cl2	  (3	  ×	  100	  
mL).	  The	  combined	  organic	  extracts	  were	  dried	  over	  Na2SO4,	  filtered	  and	  the	  solvent	  was	  removed	  
under	   reduced	   pressure	   to	   yield	  more	   product	   as	   a	  mixture	   of	   a	   white	   solid	   and	   a	   colourless	   oil	  
(0.081	   g).	   The	   two	   crops	   of	   product	   were	   combined	   and	   the	   solvent	   removed	   under	   reduced	  
pressure	   again	   to	   yield	   tert-­‐butyl	   N-­‐[(2S)-­‐1-­‐hydroxypropan-­‐2-­‐yl]carbamate	   78a	   as	   a	   white	   solid	  
(13.828	  g,	  81%),	  which	  was	  used	  without	  purification:	  m.p.	  57–61	  °C	  (lit.	  59–61	  °C)122;	  δH	  (400	  MHz,	  
CDCl3)	  1.14	  (3H,	  d,	  J	  =	  6.8,	  CHCH3),	  1.44	  (9H,	  s,	  C(CH3)3),	  3.19	  (1H,	  br.	  s,	  OH),	  3.44–3.54	  (1H,	  m,	  CHH),	  
3.56–3.65	  (1H,	  m,	  CHH),	  3.67–3.85	  (1H,	  m,	  CH),	  4.84	  (1H,	  d,	  J	  =	  5.8,	  NH);	  δC	   (101	  MHz,	  CDCl3)	  17.3	  
(CHCH3),	  28.4	  (C(CH3)3),	  48.4	  (NHCH),	  66.8	  (CH2),	  79.5	  (C(CH3)3),	  156.3	  (CO);	  [α]D23	  −14.9,	  c	  1.0,	  CHCl3	  
(lit.	  −9.3,	  c	  1.0,	  CHCl3).122	  
	  
This	  product	  was	   found	   to	   contain	  5%	  methyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}propanoate	  77	  
by	  1H	  NMR	  analysis.	  
	  














Commercially	  available	  L-­‐alaninol	  (3.5	  mL,	  45.0	  mmol,	  1.0	  eq.)	  and	  Et3N	  (22	  mL,	  158	  mmol,	  3.5	  eq.)	  
were	  dissolved	  in	  CH2Cl2	  (300	  mL),	  and	  the	  solution	  was	  cooled	  to	  0	  °C.	  TFAA	  (7.5	  mL,	  53.7	  mmol,	  1.2	  
eq.)	  was	  added	  portionwise	  over	  45	  min.	  The	   reaction	  mixture	  was	  warmed	  to	   room	  temperature	  
and	  stirred	  overnight,	  before	  the	  solution	  was	  concentrated	  under	  reduced	  pressure	  to	  give	  a	  yellow	  
liquid.	  EtOAc	  (100	  mL)	  was	  added,	  and	  the	  solution	  was	  washed	  with	  sat.	  aq.	  NaHCO3	  (120	  mL).	  The	  
aqueous	   layer	   was	   re-­‐extracted	   with	   EtOAc	   (100	   mL),	   and	   the	   combined	   organic	   extracts	   were	  
washed	   with	   0.1	   M	   HCl	   (240	   mL)	   and	   brine	   (240	   mL).	   The	   organic	   layer	   was	   dried	   over	   MgSO4,	  
filtered	   and	   the	   solvent	   was	   removed	   under	   reduced	   pressure	   to	   yield	   2,2,2-­‐trifluoro-­‐N-­‐[(2S)-­‐1-­‐
hydroxypropan-­‐2-­‐yl]acetamide	  78b	  as	  a	  white	  solid	  (5.239	  g,	  68%),	  which	  was	  used	  without	  further	  
purification:	  m.p.	  68–72	  °C	  (lit.	  80	  °C)119;	  δH	  (400	  MHz,	  CDCl3)	  1.29	  (3H,	  d,	  J	  =	  6.8,	  CH3),	  2.10	  (app.	  2H,	  
br.	  s,	  OH),	  3.65	  (1H,	  dd,	  J	  =	  4.8,	  11.1,	  CHH),	  3.78	  (1H,	  dd,	  J	  =	  3.7,	  11.1,	  CHH),	  4.10–4.21	  (1H,	  m,	  CH),	  
6.72	  (1H,	  br.	  s,	  NH);	  δC	  (101	  MHz,	  CDCl3)	  16.5	  (CH3),	  47.8	  (CH),	  65.1	  (CH2),	  115.8	  (q,	  J	  =	  287.8,	  CF3),	  
156.9	  (q,	  J	  =	  37.1,	  CO);	  [α]D23	  −12.9,	  c	  1.0,	  CHCl3	  (lit.	  −16.3,	  c	  1.0,	  CHCl3).68	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.68,119	  
	  










tert-­‐Butyl	  N-­‐[(2S)-­‐1-­‐iodopropan-­‐2-­‐yl]carbamate	  (64a)	  
	  
	  
PPh3	  (11.76	  g,	  44.8	  mmol,	  1.0	  eq.)	  and	  imidazole	  (3.06	  g,	  45.0	  mmol,	  1.0	  eq.)	  were	  dissolved	  in	  dry	  
CH2Cl2	   (200	  mL).	   I2	   (12.60	   g,	   49.6	  mmol,	   1.1	   eq.)	  was	   added	  portionwise,	   producing	   a	   dark	  brown	  
solution.	  After	  5	  min,	  commercially	  available	  N-­‐Boc-­‐L-­‐alaninol	  78a	  (7.91	  g,	  45.1	  mmol,	  1.0	  eq.)	  in	  dry	  
CH2Cl2	   (40	   mL)	   was	   added	   to	   the	   reaction	   mixture.	   The	   flask	   was	   covered	   in	   aluminium	   foil	   and	  
stirred	  at	   room	   temperature	   for	  5	  h.	   The	   solvent	  was	   removed	  under	   reduced	  pressure	   to	   yield	  a	  
brown	   slurry,	  which	  was	   dissolved	   in	   the	  minimum	   volume	   of	   CH2Cl2	   and	   filtered	   through	   a	   silica	  
plug,	  eluting	  with	  Et2O.	  The	  resulting	  brown	  solution	  was	  concentrated	  under	  reduced	  pressure	  to	  
give	  the	  crude	  product	  as	  a	  brown	  oil.	  The	  crude	  product	  was	  purified	  by	  column	  chromatography,	  
using	  a	  gradient	  of	  0:100	  EtOAc/heptane	  to	  20:80	  EtOAc/heptane	  as	  the	  solvent	  system.	  tert-­‐Butyl	  
N-­‐[(2S)-­‐1-­‐iodopropan-­‐2-­‐yl]carbamate	  64a	  was	   isolated	  as	  a	  yellow	  solid	   (7.087	  g,	  55%),	  which	  was	  
stored	  under	  N2	  in	  the	  dark	  at	  −20	  °C:	  m.p.	  60–62	  °C	  (lit.	  60–62	  °C)67;	  Rf	  0.3	  (10:90	  EtOAc/petroleum	  
ether);	  δH	  (400	  MHz,	  CDCl3)	  1.22	  (3H,	  d,	  J	  =	  6.5,	  CHCH3),	  1.47	  (9H,	  s,	  C(CH3)3),	  3.31	  (1H,	  dd,	  J	  =	  3.5,	  
9.8,	  CHH),	  3.36–3.48	  (1H,	  m,	  CHH	  or	  CH),	  3.48–3.61	  (1H,	  m,	  CHH	  or	  CH),	  4.62	  (1H,	  br.	  s,	  NH);	  δC	  (101	  
MHz,	   CDCl3)	   15.9	   (CH2),	   21.2	   (CHCH3),	   28.4	   (C(CH3)3),	   	   45.9	   (CH),	   79.7	   (C(CH3)3),	   154.8	   (CO	  
carbamate);	  [α]D23	  −21.0,	  c	  1.0,	  CHCl3	  (lit.	  −15.3,	  c	  1.0,	  CHCl3).67	  
	  
Repeating	   this	   procedure	   using	   tert-­‐butyl	   N-­‐[(2S)-­‐1-­‐hydroxypropan-­‐2-­‐yl]carbamate	   78a	   produced	  
from	  the	  reduction	  of	  methyl	  (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}propanoate	  77	  gave	  the	  product	  
64a	  as	  a	  yellow	  solid	  in	  an	  unoptimised	  28%	  yield.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.67	  
	  















PPh3	   (6.890	  g,	  26.3	  mmol,	  1.05	  eq.),	   imidazole	   (1.779	  g,	  26.1	  mmol,	  1.05	  eq.)	  and	   I2	   (6.667	  g,	  26.3	  
mmol,	   1.05	   eq.)	   were	   dissolved	   in	   dry	   CH2Cl2	   (75	   mL)	   at	   0	   °C.	   2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐1-­‐
hydroxypropan-­‐2-­‐yl]acetamide	  78b	   (4.273	   g,	   25.0	  mmol,	   1.0	   eq.)	   was	   added	   portionwise	   at	   0	   °C	  
over	   30	  min.	   The	   flask	   was	   covered	   in	   aluminium	   foil,	   warmed	   to	   room	   temperature	   and	   stirred	  
overnight.	  The	  reaction	  mixture	  was	   filtered,	  and	  solvent	  was	  removed	  under	  reduced	  pressure	  to	  
yield	  a	  brown	  oil.	  This	  oil	  was	  dissolved	   in	  EtOAc	   (250	  mL)	  and	   filtered	  again.	  The	   resulting	  brown	  
solution	  was	  washed	  with	  sat.	  aq.	  Na2S2O3	  (250	  mL)	  and	  brine	  (250	  mL).	  The	  organic	  layer	  was	  dried	  
over	   MgSO4,	   filtered	   and	   the	   solvent	   was	   removed	   under	   reduced	   pressure	   to	   yield	   the	   crude	  
product	  as	  a	  yellow	  oil,	  which	  solidified	  upon	  standing.	  The	  crude	  product	  was	  purified	  by	  column	  
chromatography,	  using	  a	  gradient	  of	  0:100	  EtOAc/heptane	   to	  20:80	  EtOAc/heptane	  as	   the	   solvent	  
system.	   2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐1-­‐iodopropan-­‐2-­‐yl]acetamide	   64b	   was	   isolated	   as	   a	   white	   solid	  
(4.757	  g,	  68%),	  which	  was	  stored	  under	  N2	  in	  the	  dark	  at	  −20	  °C:	  m.p.	  88–90	  °C	  (sublimation	  begins	  
at	  lower	  temperatures);	  Rf	  0.6	  (30:70	  EtOAc/petroleum	  ether);	  δH	  (400	  MHz,	  CDCl3)	  1.35	  (3H,	  d,	  J	  =	  
6.6,	  CH3),	  3.33	  (1H,	  dd,	  J	  =	  4.0,	  10.5,	  CHH),	  3.50	  (1H,	  dd,	  J	  =	  4.6,	  10.5,	  CHH),	  3.86–3.97	  (1H,	  m,	  CH),	  
6.31	  (1H,	  br.	  s,	  NH);	  δC	  (101	  MHz,	  CDCl3)	  12.4	  (CH2),	  20.7	  (CH3),	  45.6	  (CH),	  115.6	  (q,	  J	  =	  287.8,	  CF3),	  
156.5	  (q,	  J	  =	  37.4,	  CO);	  [α]D23	  −46.2,	  c	  1.0,	  CHCl3	  (lit.	  −47.2,	  c	  1.0,	  CHCl3).68	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.68	  	  












Methyl	  (2R)-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐3-­‐iodopropanoate	  (113)	  
	  
	  
PPh3	  (5.243	  g,	  20.0	  mmol,	  1.0	  eq.),	   imidazole	  (1.364	  g,	  20.0	  mmol,	  1.0	  eq.)	  and	  ground	  I2	   (5.591	  g,	  
22.0	  mmol,	  1.1	  eq.)	  were	  dissolved	  in	  dry	  CH2Cl2	  (100	  mL).	  After	  5	  min,	  N-­‐Cbz-­‐L-­‐serine	  methyl	  ester	  
(5.068	  g,	  20.0	  mmol,	  1.0	  eq.)	  was	  added	  to	  the	  reaction	  mixture.	  The	  flask	  was	  covered	  in	  aluminium	  
foil	  and	  stirred	  at	   room	  temperature	   for	  4.5	  h.	  The	  solvent	  was	   removed	  under	   reduced	  pressure,	  
the	   resulting	   residue	  was	  dissolved	   in	   the	  minimum	  volume	  of	  CH2Cl2	   and	   filtered	   through	  a	   silica	  
plug,	   eluting	  with	   Et2O.	   The	   solution	  was	   concentrated	   under	   reduced	   pressure	   to	   give	   the	   crude	  
product	   as	   a	   brown	  oil.	   	   The	   crude	   product	  was	   purified	   by	   column	   chromatography,	   using	   10:90	  
EtOAc/petroleum	   ether	   as	   the	   solvent	   system.	   The	   pinky	   orange	   solid	   isolated	   was	   dissolved	   in	  
CH2Cl2	   and	   washed	   sequentially	   with	   sat.	   aq.	   Na2S2O3	   and	   H2O.	   The	   organic	   layer	   was	   dried	   over	  
Na2SO4,	   filtered	   and	   the	   solvent	   removed	   under	   reduced	   pressure	   to	   yield	   methyl	   (2R)-­‐2-­‐
{[(benzyloxy)carbonyl]amino}-­‐3-­‐iodopropanoate	   113	   as	   a	   white	   solid	   (5.784	   g,	   80%),	   which	   was	  
stored	  under	  N2	  in	  the	  dark	  at	  −20	  °C:	  m.p.	  69–70	  °C	  (lit.	  69–71	  °C)123;	  Rf	  0.2	  (10:90	  EtOAc/petroleum	  
ether);	  δH	  (400	  MHz,	  CDCl3)	  3.60	  (1H,	  dd,	  J	  =	  4.0,	  10.4,	  ICHH),	  3.64	  (1H,	  dd,	  J	  =	  3.7,	  10.4,	  ICHH),	  3.83	  
(3H,	  s,	  CH3),	  4.58–4.65	  (1H,	  m,	  CH),	  5.14	  (1H,	  d,	  J	  =	  12.2,	  PhCHH),	  5.18	  (1H,	  d,	  J	  =	  12.2,	  PhCHH),	  5.66	  
(1H,	  d,	  J	  =	  7.2,	  NH),	  7.33–7.43	  (5H,	  m,	  Ar	  H);	  δC	  (101	  MHz,	  CDCl3)	  7.4	  (CH2I),	  53.2	  (CH	  or	  CH3),	  54.4	  
(CH	  or	  CH3),	  67.3	  (PhCH2),	  128.1	  (Ar	  CH),	  128.3	  (Ar	  CH),	  128.6	  (Ar	  CH),	  136.0	  (Ar	  quat.	  C),	  155.5	  (CO	  
carbamate),	  169.7	  (CO	  ester);	  [α]D23	  +40.0,	  c	  1.0,	  CHCl3	  (lit.	  −6.1,	  c	  1.0,	  CHCl3).123	  
	  
With	  the	  exception	  of	  the	  specific	  rotation,	  these	  characterisation	  data	  are	   in	  accordance	  with	  the	  
literature	  values.123	  












tert-­‐Butyl	  (2R)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐3-­‐iodopropanoate	  (96)	  
	  
	  
PPh3	  (0.792	  g,	  3.0	  mmol,	  1.0	  eq.),	   imidazole	  (0.203	  g,	  3.0	  mmol,	  1.0	  eq.)	  and	  I2	  (0.790	  g,	  3.1	  mmol,	  
1.0	  eq.)	  were	  dissolved	   in	  dry	  CH2Cl2	   (50	  mL),	  producing	  an	  orange	   solution.	  After	  5	  min,	  N-­‐Boc-­‐L-­‐
serine	  tert-­‐butyl	  ester	  (0.784	  g,	  3.0	  mmol,	  1.0	  eq.)	  was	  added	  to	  the	  reaction	  mixture.	  The	  flask	  was	  
covered	  in	  aluminium	  foil	  and	  stirred	  at	  room	  temperature	  for	  1	  h.	  The	  solvent	  was	  removed	  under	  
reduced	  pressure,	  and	  the	  resulting	  oil	  was	  dissolved	  in	  the	  minimum	  volume	  of	  CH2Cl2	  and	  filtered	  
through	  a	   silica	  plug,	  eluting	  with	  Et2O.	  The	   solution	  was	  concentrated	  under	   reduced	  pressure	   to	  
give	  the	  crude	  product	  as	  a	  brown	  oil.	  The	  crude	  product	  was	  purified	  by	  column	  chromatography,	  
using	   3:97	   EtOAc/petroleum	   ether	   as	   the	   solvent	   system.	   tert-­‐Butyl	   (2R)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐3-­‐iodopropanoate	  96	  was	   isolated	  as	   a	   cream	  solid	   (0.982	  g,	   88%),	  which	  
was	   stored	   under	   N2	   in	   the	   dark	   at	   −20	   °C:	   m.p.	   77–78	   °C	   (lit.	   67–71	   °C)124;	   Rf	   0.7	   (30:70	  
EtOAc/petroleum	  ether);	  δH	   (250	  MHz,	  CDCl3)	  1.47	   (9H,	  s,	  C(CH3)3),	  1.52	   (9H,	  s,	  C(CH3)3),	  3.52–3.62	  
(2H,	  m,	  CH2),	  4.33–4.40	   (1H,	  m,	  CH),	  5.37	   (1H,	  d,	   J	  =	  6.8,	  NH);	  δC	   (101	  MHz,	  CDCl3)	  8.9	   (CH2),	  28.0	  
(C(CH3)3),	  28.3	   (C(CH3)3),	  53.7	   (CH),	  80.2	   (C(CH3)3),	  83.3	   (C(CH3)3),	  154.9	   (CO	  carbamate),	  168.5	   (CO	  
ester);	  [α]D23	  +20.2,	  c	  1.0,	  CH2Cl2	  (lit.	  +19.7,	  c	  1.0,	  CH2Cl2).124	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.124	  
	  












5.3	  Formation	  of	  Organozinc	  Reagents	  and	  Cross	  Coupling	  Reactions	  
	  




A	  flame-­‐dried	  round-­‐bottomed	  side	  arm	  flask	  was	  charged	  with	  zinc	  (3.0	  eq.)	  and	  briefly	  flame-­‐dried	  
again	  under	  vacuum,	  before	  dry	  DMA	  (0.4	  mL/mmol	  iodide,	  4.3	  eq.)	  was	  added	  under	  nitrogen	  with	  
stirring.	  Iodine	  (8	  mol%)	  was	  added,	  and	  the	  solution	  became	  brown	  before	  returning	  to	  colourless	  
again.	  The	  amino	  acid	  derived	   iodide	   (1.0	  eq.)	  was	  added	   to	   the	   flask,	   followed	  by	  more	   iodine	   (8	  
mol%),	   resulting	   in	   the	   same	   colour	   changes.	   The	   zinc	   insertion	  was	  monitored	  by	   TLC,	   and	  when	  
complete	  (≥10min)	  the	  reaction	  was	  placed	  into	  a	  water	  bath,	  and	  dry	  toluene	  (2	  mL/mmol	  iodide)	  
was	  added	   to	   the	   reaction	  mixture,	   followed	  by	   (Ph3P)2PdCl2	   (5	  mol%).	  Finally,	   the	   freshly	  distilled	  
acid	  chloride	  (1.3	  eq.)	  was	  added	  via	  syringe	  over	  5	  min.	  The	  reaction	  was	  left	  stirring	  overnight	   in	  
the	  water	  bath.	  The	  reaction	  mixture	  was	  either	  purified	  directly	  using	  column	  chromatography,	  or	  
worked	  up	  before	  column	  chromatography,	  as	  described	  in	  the	  individual	  experiments.	  
	  















Methyl	  (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  (59c)	  
	  
	  
The	   general	   procedure	   was	   followed,	   using	   3.0	   mmol	   (0.987	   g)	   of	   methyl	   (2R)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐3-­‐iodopropanoate	  68.	   The	   crude	  product	  was	  placed	  directly	  onto	  a	   silica	  
gel	  column	  and	  purified	  using	  a	  gradient	  of	  10:90	  EtOAc/petroleum	  ether	  to	  20:80	  EtOAc/petroleum	  
ether	   as	   the	   solvent	   system.	  Methyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  59c	  
was	   isolated	  as	  a	  white	  solid	  when	  very	  pure,	  or	  more	  commonly	  as	  a	  brown	  solid	  (0.395–0.510	  g,	  
51–66%):	  m.p.	   49–53	   °C;	   Rf	   0.5	   (50:50	   EtOAc/petroleum	   ether);	   νmax(ATR)/cm−1	   3386,	   2966,	   1747,	  
1737,	  1692,	  1678,	  1617,	  1502;	  δH	   (400	  MHz,	  CDCl3)	  1.43	   (9H,	   s,	  C(CH3)3),	  3.16	   (1H,	  dd,	   J	   =	  4.1	  and	  
18.0,	  COCHH),	  3.34	  (1H,	  dd,	  J	  =	  4.2	  and	  18.0,	  COCHH),	  3.73	  (3H,	  s,	  CH3),	  4.44–4.65	  (1H,	  m,	  CHNH),	  
5.53	  (1H,	  d,	  J	  =	  8.3,	  NH),	  5.92	  (1H,	  dd,	  J	  =	  1.2	  and	  10.0,	  Hb),	  6.25	  (1H,	  dd,	  J	  =	  1.2	  and	  17.7,	  Hc),	  	  6.33	  
(1H,	  dd,	  J	  =	  10.0	  and	  17.7,	  Ha);	  δC	  (101	  MHz,	  CDCl3)	  28.3	  (C(CH3)3),	  41.4	  (CH2),	  49.4	  (CO2CH3	  or	  CHNH),	  
52.6	  (CO2CH3	  or	  CHNH),	  80.0	  (C(CH3)3),	  129.7	  (CH=CH2),	  136.0	  (CH=CH2),	  155.5	  (CO	  ester),	  171.9	  (CO	  
carbamate),	   198.3	   (CO	   enone);	   [α]D22	   +32.0,	   c	   1.0,	   CHCl3;	  m/z	   (ES+)	   found:	   258.1341,	   C12H19NO5	  
requires	  MH+	  258.1341.	  
	  











tert-­‐Butyl	  N-­‐[(3R)-­‐2-­‐methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐yl]carbamate	  (83a)	  
	  
	  
The	   general	   procedure	   was	   followed,	   using	   2.9	   mmol	   (0.895	   g)	   of	   tert-­‐butyl	   N-­‐[(2S)-­‐1-­‐iodo-­‐3-­‐
methylbutan-­‐2-­‐yl]carbamate	  61a.	   The	   crude	   product	  was	   placed	   directly	   onto	   a	   silica	   gel	   column	  
and	  purified	  using	  10:90	  EtOAc/petroleum	  ether	  as	  the	  solvent	  system,	  yielding	  a	  white	  solid	  (0.340	  
g).	  1H	  NMR	  analysis	  showed	  that	  93%	  of	  this	  solid	  was	  tert-­‐butyl	  N-­‐[(3R)-­‐2-­‐methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐
yl]carbamate	   83a	   (0.318g,	   46%):	   m.p.	   52–55	   °C;	   Rf	   0.4	   (30:70	   EtOAc/petroleum	   ether);	  
νmax(ATR)/cm−1	   3370,	   2962,	   2930,	   2877,	   1682,	   1616,	   1516,	   1443,	   1404,	   1391,	   1365,	   1333,	   1308,	  
1246,	   1168;	   δH	   (400	   MHz,	   CDCl3)	   0.91	   (3H,	   d,	   J	   =	   6.9,	   CH(CH3)(CH3)),	   0.93	   (3H,	   d,	   J	   =	   6.9,	  
CH(CH3)(CH3)),	   1.43	   (9H,	   br.	   s,	   C(CH3)3),	   1.84–1.97	   (1H,	   m,	   CH(CH3)2),	   2.77	   (1H,	   dd,	   J	   =	   5.2,	   15.9,	  
COCHH),	  2.84	  (1H,	  dd,	  J	  =	  6.4,	  15.9,	  COCHH),	  3.73–3.87	  (1H,	  m,	  NHCH),	  4.91	  (1H,	  br.	  d,	  J	  =	  8.7,	  NH),	  
5.87	  (1H,	  app.	  d,	  J	  =	  10.4,	  Hb),	  6.25	  (1H,	  app.	  d,	  J	  =	  17.6,	  Hc),	  6.38	  (1H,	  dd,	  J	  =	  10.4,	  17.6,	  Ha);	  δC	  (101	  
MHz,	  CDCl3)	  18.5	  (C(CH3)(CH3)),	  19.5	  (C(CH3)(CH3)),	  28.4	  (C(CH3)3),	  31.5	  (CH(CH3)2),	  41.8	  (COCH2),	  53.1	  
(NHCH),	  79.1	   (C(CH3)3),	   128.6	   (CH=CH2),	   136.5	   (CH=CH2),	   155.6	   (CO	  carbamate),	   199.7	   (CO	  enone);	  
[α]D25	  −25.0,	  c	  1.0,	  CHCl3;	  m/z	  (ES+)	  found:	  242.1768,	  C13H23NO3	  requires	  MH+	  242.1756.	  
	  
The	  remaining	  7%	  of	  the	  white	  solid	  isolated	  was	  found	  to	  be	  tert-­‐butyl	  N-­‐(prop-­‐2-­‐enoyl)carbamate	  



























The	   general	   procedure	  was	   followed,	   using	   3.0	  mmol	   (0.925	   g)	   of	   2,2,2-­‐trifluoro-­‐N-­‐[(2S)-­‐1-­‐iodo-­‐3-­‐
methylbutan-­‐2-­‐yl]acetamide	  61b.	  The	  reaction	  mixture	  was	  diluted	  with	  EtOAc	  (50	  mL),	  and	  washed	  
sequentially	  with	  1	  M	  HCl	  (50	  mL)	  and	  brine	  (3	  ×	  30	  mL).	  The	  aqueous	   layer	  was	  re-­‐extracted	  with	  
EtOAc	   (3	   ×	   50	   mL),	   and	   the	   combined	   organic	   extracts	   were	   dried	   over	   Na2SO4,	   filtered	   and	  
concentrated	  under	  reduced	  pressure	  to	  yield	  the	  crude	  product	  as	  a	  brown	  oil.	  The	  crude	  product	  
was	  purified	  by	  column	  chromatography	  using	  a	  gradient	  of	  10:90	  EtOAc/petroleum	  ether	  to	  20:80	  
EtOAc/petroleum	   ether	   as	   the	   solvent	   system.	   2,2,2-­‐Trifluoro-­‐N-­‐[(3R)-­‐2-­‐methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐
yl]acetamide	   83b	   (0.290	   g,	   41%)	   was	   isolated	   as	   a	   white	   solid:	   m.p.	   83–84	   °C;	   Rf	   0.5	   (40:60	  
EtOAc/petroleum	   ether);	   νmax(ATR)/cm−1	   3287,	   2976,	   2914,	   1702,	   1613,	   1562,	   1474,	   1402,	   1373,	  
1306,	  1257,	  1153;	  δH	  (400	  MHz,	  CDCl3)	  	  0.94	  (3H,	  d,	  J	  =	  6.8,	  CH3),	  0.97	  (3H,	  d,	  J	  =	  6.8,	  CH3),	  1.97–2.11	  
(1H,	  m,	  CH(CH3)2),	  2.79	  (1H,	  dd,	  J	  =	  4.7,	  17.7,	  COCHH),	  3.12	  (1H,	  dd,	  J	  =	  4.9,	  17.7,	  COCHH),	  3.99–4.08	  
(1H,	  m,	  NHCH),	  5.96	  (1H,	  dd,	  J	  =	  1.2,	  10.1,	  Hb),	  6.29	  (1H,	  dd,	  J	  =	  1.2,	  17.6,	  Hc),	  6.38	  (1H,	  dd,	  J	  =	  10.1,	  
17.7,	  Ha),	  7.26	  (1H,	  br.	  s,	  NH,	  coincides	  with	  CHCl3	  residual	  solvent	  peak);	  δC	  (101	  MHz,	  CDCl3)	  19.0	  
(CH3),	  19.5	  (CH3),	  30.8	  (CH(CH3)2),	  39.6	  (CH2),	  52.7	  (NHCH),	  115.9	  (q,	  J	  =	  288.0,	  CF3),	  129.7	  (CH=CH2),	  
136.3	  (CH=CH2),	  156.8	  (q,	  J	  =	  36.7,	  CO	  amide),	  199.4	  (CO	  enone);	  [α]D23	  −57.0,	  c	  1.0,	  CHCl3;	  m/z	  (ES+)	  
found:	  238.1047,	  C10H14NO2F3	  requires	  MH+	  238.1055.	  
	  













tert-­‐Butyl	  N-­‐[(2S)-­‐4-­‐oxohex-­‐5-­‐en-­‐2-­‐yl]carbamate	  (84a)	  
	  
	  
The	  general	  procedure	  was	  followed,	  using	  3.0	  mmol	  (0.775	  g)	  of	  tert-­‐butyl	  N-­‐[(2S)-­‐1-­‐iodopropan-­‐2-­‐
yl]carbamate	  64a,	  except	  that	  an	  ice	  bath	  was	  used	  in	  place	  of	  a	  water	  bath.	  The	  reaction	  was	  put	  in	  
the	   ice	  bath	  before	   the	   iodide	  was	  added,	  and	  once	  all	   the	  reagents	  had	  been	  added	  the	  reaction	  
was	  left	  to	  warm	  up	  to	  room	  temperature	  in	  the	  ice	  bath	  overnight.	  The	  reaction	  mixture	  was	  then	  
diluted	  with	  EtOAc	  (50	  mL),	  and	  washed	  sequentially	  with	  1	  M	  HCl	  (50	  mL)	  and	  brine	  (3	  ×	  30	  mL).	  The	  
aqueous	   layer	  was	   re-­‐extracted	  with	   EtOAc	   (4	   ×	   50	  mL),	   and	   the	   combined	   organic	   extracts	  were	  
dried	  over	  Na2SO4,	  filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  yield	  the	  crude	  product	  as	  a	  
mixture	   of	   a	   brown	   oil	   and	   a	   brown	   solid.	   The	   crude	   product	   was	   purified	   by	   column	  
chromatography	  using	  a	  gradient	  of	  10:90	  EtOAc/petroleum	  ether	  to	  20:80	  EtOAc/petroleum	  ether	  
as	   the	   solvent	   system.	   tert-­‐Butyl	   N-­‐[(2S)-­‐4-­‐oxohex-­‐5-­‐en-­‐2-­‐yl]carbamate	   84a	   (<0.041	   g,	   <6%)	   was	  
observed	   by	   1H	   NMR,	   13C	   NMR	   and	   MS	   analysis	   of	   the	   fractions	   collected:	   Rf	   0.2	   (20:80	  
EtOAc/petroleum	  ether);	  δH	  (400	  MHz,	  CDCl3)	  1.21	  (3H,	  d,	  J	  =	  6.8,	  CHCH3),	  1.43	  (9H,	  br.	  s,	  C(CH3)3),	  
2.69	   (1H,	  dd,	   J	  =	  6.6	  and	  16.0,	  COCHH),	  2.93	   (1H,	  dd,	   J	  =	  4.5	  and	  16.0,	  COCHH),	  3.97–4.13	   (1H,	  m,	  
CHH),	  4.94	  (1H,	  br.	  s,	  NH),	  5.88	  (1H,	  dd,	  J	  =	  1.4	  and	  10.1,	  Hb),	  6.26	  (1H,	  dd,	  J	  =	  1.4	  and	  17.7,	  Hc),	  	  6.35	  
(1H,	  dd,	  J	  =	  10.1	  and	  17.7,	  Ha);	  δC	  (101	  MHz,	  CDCl3)	  20.5	  (CHCH3),	  28.4	  (C(CH3)3),	  33.8	  (CH2),	  43.6	  (CH),	  
79.3	  (C(CH3)3),	  128.8	  (CH=CH2),	  136.8	  (CH=CH2),	  155.1	  (CO	  carbamate),	  199.4	  (CO	  enone);	  m/z	  (ES+)	  
found:	  214.1438,	  C11H19NO3	  requires	  MH+	  214.1443.	  
	  
	  

















The	   general	   procedure	  was	   followed,	   using	   1.0	  mmol	   (0.282	   g)	   of	   2,2,2-­‐trifluoro-­‐N-­‐[(2S)-­‐1-­‐iodo-­‐3-­‐
methylbutan-­‐2-­‐yl]acetamide	  64b.	  The	  reaction	  mixture	  was	  diluted	  with	  EtOAc	  (50	  mL),	  and	  washed	  
sequentially	  with	  1	  M	  HCl	  (50	  mL)	  and	  brine	  (3	  ×	  30	  mL).	  The	  aqueous	   layer	  was	  re-­‐extracted	  with	  
EtOAc	   (3	   ×	   50	   mL),	   and	   the	   combined	   organic	   extracts	   were	   dried	   over	   Na2SO4,	   filtered	   and	  
concentrated	  under	  reduced	  pressure	  to	  yield	  the	  crude	  product	  as	  a	  brown	  oil.	  The	  crude	  product	  
was	  purified	  by	  column	  chromatography	  using	  25:75	  EtOAc/petroleum	  ether	  as	  the	  solvent	  system.	  
2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐4-­‐oxohex-­‐5-­‐en-­‐2-­‐yl]acetamide	  84b	   (0.100	   g,	   49%)	   was	   isolated	   as	   a	   brown	  
solid:	  Rf	  0.2	  (20:80	  EtOAc/petroleum	  ether);	  δH	  (250	  MHz,	  CDCl3)	  1.33	  (3H,	  d,	  J	  =	  6.8,	  CH3),	  2.83	  (1H,	  
dd,	  J	  =	  5.7,	  17.4,	  CHH),	  3.03	  (1H,	  dd,	  J	  =	  4.3,	  17.4,	  CHH),	  4.36–4.47	  (1H,	  m,	  CH),	  5.96	  (1H,	  dd,	  J	  =	  1.3,	  
10.0,	  Hb),	  6.28	  (1H,	  dd,	  J	  =	  1.3,	  17.7,	  Hc),	  6.37	  (1H,	  dd,	  J	  =	  10.0,	  17.7,	  Ha),	  7.36	  (1H,	  br.	  s,	  NH);	  δC	  (101	  
MHz,	  CDCl3)	  19.4	   (CH3),	  42.8	   (CH2),	  43.0	   (CH),	  115.8	   (app.	  d,	   J	  =	  287.9,	  CF3),	  129.9	   (CH=CH2),	  136.5	  
(CH=CH2),	   156.5	   (app.	   d,	   J	   =	   36.7,	   CO	   amide),	   199.3	   (CO	   enone);	   m/z	   (ES+)	   found:	   210.0733,	  
C8H10NO2F3	   requires	  MH+	   210.0742.	  Unfortunately	   the	   product	   could	   not	   be	   further	   characterised	  
due	   to	   extensive	   decomposition	   after	   long-­‐term	   storage,	   along	   with	   difficulties	   encountered	   in	  
obtaining	  a	  clean	  sample	  when	  re-­‐synthesising	  or	  re-­‐purifying	  the	  compound.	  














Methyl	  (2S)-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  (59d)	  
	  
	  
The	   general	   procedure	   was	   followed,	   using	   3.0	   mmol	   (1.092	   g)	   of	   methyl	   (2R)-­‐2-­‐{[(benzyloxy)	  
carbonyl]amino}-­‐3-­‐iodopropanoate	  113.	  The	  reaction	  mixture	  was	  diluted	  with	  EtOAc	  (50	  mL),	  and	  
washed	  with	  brine	  (3	  ×	  30	  mL).	  The	  aqueous	  layer	  was	  re-­‐extracted	  with	  EtOAc	  (3	  ×	  50	  mL),	  and	  the	  
combined	   organic	   extracts	   were	   dried	   over	   Na2SO4,	   filtered	   and	   concentrated	   under	   reduced	  
pressure	   to	   yield	   the	   crude	   product	   as	   a	   brown	   oil.	   The	   crude	   product	   was	   purified	   by	   column	  
chromatography	   using	   10:90	   EtOAc/petroleum	   ether	   as	   the	   solvent	   system.	   Methyl	   (2S)-­‐2-­‐
{[(benzyloxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  59d	  (0.472	  g,	  54%)	  was	  isolated	  as	  a	  brown	  oil:	  Rf	  
0.5	  (50:50	  EtOAc/petroleum	  ether);	  νmax(ATR)/cm−1	  3365,	  3034,	  2953,	  1706,	  1616,	  1508,	  1454,	  1437,	  
1400,	  1337,	  1211;	  δH	  (400	  MHz,	  CDCl3)	  3.19	  (1H,	  dd,	  J	  =	  4.2,	  18.2,	  COCHH),	  3.41	  (1H,	  dd,	  J	  =	  4.2,	  18.2,	  
COCHH),	  3.76	  (3H,	  s,	  CH3),	  4.63–4.71	  (1H,	  m,	  CH),	  5.13	  (2H,	  s,	  PhCH2),	  5.82	  (1H,	  d,	  J	  =	  8.6,	  NH),	  5.95	  
(1H,	  dd,	  J	  =	  1.2,	  10.0,	  Hb),	  6.27	  (1H,	  dd,	  J	  =	  1.2,	  17.6,	  Hc),	  6.35	  (1H,	  dd,	  J	  =	  10.0,	  17.6,	  Ha),	  7.31–7.43	  
(5H,	  m,	  Ar	  H);	  δC	  (62.8	  MHz,	  CDCl3)	  41.3	  (COCH2),	  49.9	  (CH	  or	  CH3),	  52.7	  (CH	  or	  CH3),	  67.1	  (PhCH2),	  
128.0	  (Ar	  CH),	  128.2	  (Ar	  CH),	  128.5	  (Ar	  CH),	  129.6	  (CH=CH2),	  136.0	  (CH=CH2),	  136.2	  (Ar	  quat.	  C),	  156.0	  
(CO	   carbamate),	   171.4	   (CO	   ester),	   198.0	   (CO	   enone);	   [α]D24	   −9.2,	   c	   0.4,	   DMSO;	  m/z	   (ES+)	   found:	  
292.1194,	  C15H17NO5	  requires	  MH+	  292.1185.	  












tert-­‐Butyl	  (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  (59b)	  
	  
	  
The	   general	   procedure	   was	   followed,	   using	   2.7	   mmol	   (1.007	   g)	   of	   tert-­‐butyl	   (2R)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐3-­‐iodopropanoate	   96.	   The	   reaction	   mixture	   was	   diluted	   with	   EtOAc	   (50	  
mL),	  and	  washed	  with	  brine	  (3	  ×	  30	  mL).	  The	  aqueous	  layer	  was	  re-­‐extracted	  with	  EtOAc	  (3	  ×	  50	  mL),	  
and	  the	  combined	  organic	  extracts	  were	  dried	  over	  Na2SO4,	  filtered	  and	  concentrated	  under	  reduced	  
pressure	   to	   yield	   the	   crude	   product	   as	   a	   brown	   oil.	   The	   crude	   product	   was	   purified	   by	   column	  
chromatography	   using	   5:95	   EtOAc/toluene	   as	   the	   solvent	   system.	   tert-­‐Butyl	   (2S)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  59b	   (0.346	  g,	  43%)	  was	   isolated	  as	  a	  white	   solid:	  m.p.	  
69–74	  °C;	  Rf	  0.3	  (20:80	  EtOAc/petroleum	  ether);	  νmax(ATR)/cm−1	  3450,	  2979,	  2931,	  1720,	  1692,	  1676,	  
1616,	  1491,	  1454,	  1399,	  1366,	  1334,	  1286,	  1248,	  1221,	  1152;	  δH	  (400	  MHz,	  CDCl3)	  1.45	  (18H,	  s,	  2	  ×	  
C(CH3)3),	  3.10	  (1H,	  dd,	  J	  =	  4.3,	  17.8,	  COCHH),	  3.31	  (1H,	  dd,	  J	  =	  4.3,	  17.8,	  COCHH),	  4.33–4.55	  (1H,	  m,	  
NHCH),	  5.51	  (1H,	  d,	  J	  =	  8.3,	  NH),	  5.94	  (1H,	  dd,	  J	  =	  1.3,	  10.1,	  Hb),	  6.27	  (1H,	  dd,	  J	  =	  1.3,	  17.7,	  Hc),	  6.36	  
(1H,	   dd,	   J	   =	   10.1,	   17.7,	   Ha);	   δC	   (101	   MHz,	   CDCl3)	   27.9	   (C(CH3)3),	   28.3	   (C(CH3)3),	   41.5	   (CH2),	   50.1	  
(NHCH),	  79.7	  (C(CH3)3),	  82.1	  (C(CH3)3),	  129.3	  (CH=CH2),	  136.3	  (CH=CH2),	  155.6	  (CO	  carbamate),	  170.3	  
(CO	   ester),	   198.4	   (CO	   enone);	   [α]D23	   +21.0,	   c	   1.0,	   CHCl3;	   m/z	   (ES+)	   found:	   300.1804,	   C15H25NO5	  
requires	  MH+	  300.1811.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values	  for	  the	  racemic	  compound	  
(±)-­‐59b.56-­‐57	  	  
	  













Methyl	  (2S,5E)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐4-­‐oxo-­‐6-­‐phenylhex-­‐5-­‐enoate	  (128)	  
	  
	  
The	   general	   procedure	   was	   followed,	   using	   3.0	   mmol	   (0.989	   g)	   of	   methyl	   (2R)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐3-­‐iodopropanoate	   68.	   The	   reaction	   mixture	   was	   diluted	   with	   EtOAc	   (50	  
mL),	  and	  washed	  with	  brine	  (3	  ×	  30	  mL).	  The	  aqueous	  layer	  was	  re-­‐extracted	  with	  EtOAc	  (3	  ×	  50	  mL),	  
and	  the	  combined	  organic	  extracts	  were	  dried	  over	  Na2SO4,	  filtered	  and	  concentrated	  under	  reduced	  
pressure	  to	  yield	  the	  crude	  product	  as	  a	  brown	  oily	  solid.	  The	  crude	  product	  was	  purified	  by	  column	  
chromatography	  using	  20:80	  EtOAc/petroleum	  ether	  as	  the	  solvent	  system.	  Methyl	  (2S,5E)-­‐2-­‐{[(tert-­‐
butoxy)carbonyl]amino}-­‐4-­‐oxo-­‐6-­‐phenylhex-­‐5-­‐enoate	  128	   (0.461	   g,	   46%)	   was	   isolated	   as	   a	   brown	  
oily	  solid:	  Rf	  0.5	  (30:70	  EtOAc/petroleum	  ether);	  νmax(ATR)/cm−1	  3437,	  2978,	  1744,	  1706,	  1662,	  1609,	  
1577,	  1495,	  1450,	  1437,	  1392,	  1366,	  1339,	  1288,	  1248,	  1207,	  1162;	  δH	  (400	  MHz,	  CDCl3)	  1.44	  (9H,	  s,	  
C(CH3)3),	  3.24	  (1H,	  dd,	  J	  =	  4.2,	  17.9,	  CHH),	  3.45	  (1H,	  dd,	  J	  =	  4.4,	  17.9,	  CHH),	  3.74	  (3H,	  s,	  CH3),	  4.58–
4.67	  (1H,	  m,	  NHCH),	  5.63	  (1H,	  d,	  J	  =	  8.7,	  NH),	  6.71	  (1H,	  d,	  J	  =	  16.3,	  COCH=CH),	  7.32–7.42	  (3H,	  m,	  Ar	  
H),	  7.50–7.60	  (3H,	  m,	  COCH=CH	  and	  Ar	  H);	  δC	  (101	  MHz,	  CDCl3)	  28.3	  (C(CH3)3),	  42.4	  (CH2),	  49.6	  (CH	  or	  
CO2CH3),	  52.6	  (CH	  or	  CO2CH3),	  80.0	  (C(CH3)3),	  125.6	  (COCH=CH	  or	  Ar	  CH),	  128.4	  (COCH=CH	  or	  Ar	  CH),	  
129.0	  (COCH=CH	  or	  Ar	  CH),	  130.8	  (COCH=CH	  or	  Ar	  CH),	  134.1	  (Ar	  quat.	  C),	  143.9	  (COCH=CH),	  155.6	  
(CO	   carbamate),	   172.0	   (CO	   ester),	   197.6	   (CO	   enone);	   [α]D23	   +38.8,	   c	   1.0,	   CHCl3	   (lit.	   +56.9,	   c	   1.0,	  
CHCl3)125;	  m/z	  (ES+)	  found:	  334.1639,	  C18H23NO5	  requires	  MH+	  334.1654.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.125	  
	  









5.4	  Attempted	  Hydrogen	  Chloride	  Mediated	  Cyclisations	  
	  
(2S)-­‐6-­‐Chloro-­‐1-­‐methoxy-­‐1,4-­‐dioxohexan-­‐2-­‐aminium	  chloride	  (60c)	  
	  
	  
Methyl	   (2S)-­‐2-­‐(tert-­‐butoxycarbonylamino)-­‐4-­‐oxohex-­‐5-­‐enoate	  59c	   (0.320	  g,	  1.2	  mmol,	  1.0	  eq.)	  was	  
dissolved	  in	  1	  M	  hydrogen	  chloride	  in	  diethyl	  ether	  (12.5	  mL,	  12.5	  mmol,	  10	  eq.)	  and	  stirred	  at	  room	  
temperature	   for	   3	   d.	   Removal	   of	   the	   solvent	   under	   reduced	   pressure	   yielded	   (2S)-­‐6-­‐chloro-­‐1-­‐
methoxy-­‐1,4-­‐dioxohexan-­‐2-­‐aminium	  chloride	  60c	  as	  a	  pale	  orange	  solid	  (0.270	  g,	  94%):	  m.p.	  138	  °C	  
(decomp.);	  Rf	  0.5	   (10:90	  MeOH/CH2Cl2);	  νmax(ATR)/cm−1	  2920,	  2849,	  2636,	  1745,	  1711,	  1596,	  1570,	  
1495,	  1442,	  1428,	  1402,	  1380,	  1321,	  1296,	  1252,	  1234,	  1194,	  1162;	  δH	  (400	  MHz,	  D2O)	  3.00	  (2H,	  td,	  J	  
=	  6.0,	  3.1,	  CH2),	  3.27–3.32	  (2H,	  m,	  CH2),	  3.68	  (2H,	  t,	  J	  =	  6.0,	  CH2),	  3.71	  (3H,	  s,	  CH3),	  4.35	  (1H,	  t,	  J	  =	  5.1,	  
CH);	  δH	  (400	  MHz,	  CD3OD)	  3.06	  (2H,	  t,	  J	  =	  6.4,	  CH2),	  3.21–3.30	  (2H,	  m,	  CH2),	  3.80	  (2H,	  t,	  J	  =	  6.4,	  CH2),	  
3.84	  (3H,	  s,	  CH3),	  4.38	  (1H,	  dd,	  J	  =	  4.4,	  6.1,	  CH);	  δC	  (101	  MHz,	  D2O)	  38.0	  (CH2),	  41.5	  (CH2),	  44.0	  (CH2),	  
48.3	  (CH	  or	  CH3),	  53.8	  (CH	  or	  CH3),	  169.8	  (CO	  ester),	  207.7	  (CO	  ketone);	  δC	  (101	  MHz,	  CD3OD)	  37.3	  
(CH2),	  41.4	  (CH2),	  44.2	  (CH2),	  48.1	  (CH3),	  52.5	  (CH),	  168.7	  (CO	  ester),	  204.1	  (CO	  ketone);	  [α]D23	  +20.0,	  





















(3R)-­‐7-­‐Chloro-­‐2-­‐methyl-­‐5-­‐oxoheptan-­‐3-­‐aminium	  chloride	  (90)	  
	  
	  
tert-­‐Butyl	   N-­‐[(3R)-­‐2-­‐methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐yl]carbamate	   83a	   (0.097	   g,	   0.4	   mmol,	   1.0	   eq.)	   was	  
dissolved	  in	  1	  M	  hydrogen	  chloride	  in	  diethyl	  ether	  (4.0	  mL,	  4.0	  mmol,	  10	  eq.)	  and	  stirred	  at	  room	  
temperature	  for	  3	  d.	  Removal	  of	  the	  solvent	  under	  reduced	  pressure	  yielded	  (3R)-­‐7-­‐chloro-­‐2-­‐methyl-­‐
5-­‐oxoheptan-­‐3-­‐aminium	  chloride	  90	  as	  a	  brown	  oil	  (0.082	  g,	  96%),	  after	  drying	  under	  high	  vacuum:	  
Rf	   0.0	   (EtOAc);	   νmax(ATR)/cm−1	   2962,	   2902,	   1711,	   1610,	   1510,	   1471,	   1395;	   δH	   (400	  MHz,	  D2O)	   0.86	  
(3H,	  d,	  J	  =	  6.8,	  CH3),	  0.87	  (3H,	  d,	  J	  =	  6.8,	  CH3),	  1.81–1.95	  (1H,	  m,	  CH(CH3)2),	  2.78	  (1H,	  dd,	  J	  =	  9.3,	  19.3,	  
H3NCHCHH),	   2.95–3.04	   (app.	   2.6H,	  m,	   H3NCHCHH	   and	   ClCH2CH2),	   3.39–3.52	   (1H,	  m,	   H3NCH),	   3.69	  
(app.	  1.7H,	  t,	  J	  =	  6.1,	  ClCH2);	  δC	  (101	  MHz,	  CDCl3)	  16.7	  (CH3),	  17.3	  (CH3),	  29.8	  (CH),	  38.1	  (CH2),	  41.1	  
(CH2),	   44.5	   (CH2),	   52.3	   (CH),	   209.5	   (CO);	   [α]D20	   +38.5,	   c	   3.6,	   MeOH;	  m/z	   (ES+)	   found:	   178.0997,	  
C8H17NO35Cl2	  requires	  (M−Cl)+	  178.0999.	  












(1S)-­‐1-­‐Carboxy-­‐5-­‐chloro-­‐3-­‐oxopentan-­‐1-­‐aminium	   chloride	   (60b)	   and	   (2S)-­‐2-­‐carboxy-­‐4,4-­‐
dihydroxypiperidin-­‐1-­‐ium	  chloride	  (94a·∙H2O)	  
	  
	  
(2S)-­‐6-­‐Chloro-­‐1-­‐methoxy-­‐1,4-­‐dioxohexan-­‐2-­‐aminium	  chloride	  60c	  (0.097	  g,	  0.42	  mmol,	  1.0	  eq.)	  was	  
dissolved	  in	  6	  M	  hydrochloric	  acid	  (2.5	  mL,	  15.0	  mmol,	  35.5	  eq.)	  and	  heated	  at	  reflux	  for	  3	  h.	  After	  
cooling	   to	   room	  temperature,	   the	   reaction	  was	  diluted	  with	  MeOH,	  and	   the	   solvent	  was	   removed	  
under	  reduced	  pressure	  to	  yield	  the	  mixture	  of	  products	  as	  a	  brown	  gum	  (0.075	  g).	  1H	  NMR	  analysis	  
showed	   that	   the	   product	   consisted	   of	   an	   approximate	   80:20	   mix	   of	   (1S)-­‐1-­‐carboxy-­‐5-­‐chloro-­‐3-­‐
oxopentan-­‐1-­‐aminium	   chloride	   60b	   and	   (2S)-­‐2-­‐carboxy-­‐4,4-­‐dihydroxypiperidin-­‐1-­‐ium	   chloride	  
94a·∙H2O.	  
	  
(1S)-­‐1-­‐Carboxy-­‐5-­‐chloro-­‐3-­‐oxopentan-­‐1-­‐aminium	   chloride	  60b:	   δH	   (400	  MHz,	   D2O)	   2.99	   (2H,	   t,	   J	   =	  
6.1,	  ClCH2CH2),	  3.21–3.25	  (2H,	  m,	  H3NCHCH2),	  3.67	  (2H,	  t,	  J	  =	  6.1,	  ClCH2),	  4.23	  (1H,	  t,	  J	  =	  5.3,	  CH);	  δC	  
(101	  MHz,	  D2O)	  38.0	  (CH2),	  41.6	  (CH2),	  44.1	  (CH2),	  48.4	  (CH),	  171.1	  (CO	  acid),	  207.8	  (CO	  ketone).	  
	  
(2S)-­‐2-­‐Carboxy-­‐4,4-­‐dihydroxypiperidin-­‐1-­‐ium	   chloride	  94a·∙H2O:	   δH	   (400	  MHz,	   D2O)	   1.79–1.97	   (3H,	  
m,	  H3a,	  H5a,	  H5e),	  2.30	  (1H,	  ddd,	  J	  =	  2.5,	  3.8,	  14.3,	  H3e),	  3.11	  (1H,	  td,	  J	  =	  12.5,	  3.9,	  H6a),	  3.36–3.42	  (1H,	  
m,	  H6e),	  4.03	  (1H,	  dd,	  J	  =	  3.8,	  11.7,	  H2a);	  δC	   (101	  MHz,	  D2O)	  33.5	  (C5),	  37.0	  (C3),	  40.9	  (C6),	  54.8	  (C2),	  
90.7	  (C4),	  171.1	  (CO);	  m/z	  (ES+)	  found:	  162.0764,	  C6H12NO4Cl	  requires	  (M−Cl)+	  162.0766.	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.91-­‐93	  
	  
	  























(1S)-­‐1-­‐Carboxy-­‐5-­‐chloro-­‐3-­‐oxopentan-­‐1-­‐aminium	  chloride	  (60b)	  
	  
	  
tert-­‐Butyl	   (2S)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	   59b	   (0.059	   g,	   0.20	   mmol,	   1.0	  
eq.)	  was	  dissolved	  in	  saturated	  hydrogen	  chloride	  in	  Et2O	  (1.8	  mL)	  and	  the	  reaction	  was	  left	  without	  
stirring	  at	  room	  temperature	  overnight.	  The	  solvent	  was	  removed	  with	  a	  pipette	  and	  the	  yellow	  solid	  
was	   sequentially	   washed	   with	   dry	   Et2O	   (4	   ×	   5	   mL),	   which	   was	   removed	   by	   pipette	   after	   each	  
successive	   washing.	   The	   resulting	   solid	   was	   dried	   under	   high	   vacuum,	   yielding	   (1S)-­‐1-­‐carboxy-­‐5-­‐
chloro-­‐3-­‐oxopentan-­‐1-­‐aminium	   chloride	   60b	   as	   a	   pale	   cream	   solid	   (0.037	   g,	   87%):	   m.p.	   >135	   °C	  
(decomp.);	  Rf	   0.0	   (10:90	  MeOH/EtOAc);	   νmax(ATR)/cm−1	  2871,	  2635,	  2560,	  2159,	  2024,	  1977,	  1743,	  
1709,	  1586,	  1501,	  1482,	  1423,	  1390,	  1349,	  1242,	  1220,	  1205,	  1152,	  1141;	  δH	  (400	  MHz,	  CD3OD)	  3.06	  
(2H,	   td,	   J	  =	  6.4,	  1.9,	  ClCH2CH2),	  3.19	   (1H,	  dd,	   J	  =	  7.1,	  19.0,	  H3NCHCHH),	  3.29	   (1H,	  dd,	   J	  =	  3.8,	  19.0,	  
H3NCHCHH,	  inferred	  due	  to	  partial	  overlap	  with	  CD3OH	  signal),	  3.81	  (2H,	  t,	  J	  =	  6.4,	  ClCH2),	  4.31	  (1H,	  
dd,	   J	   =	   3.8,	   7.1,	   H3NCH);	   δH	   (400	   MHz,	   D2O)	   2.97	   (2H,	   t,	   J	   =	   6.1,	   ClCH2CH2),	   3.18–3.25	   (2H,	   m,	  
H3NCHCH2),	  3.65	  (2H,	  t,	  J	  =	  6.1,	  ClCH2),	  4.22	  (1H,	  t,	  J	  =	  5.2,	  CH);	  δC	  (101	  MHz,	  CD3OD)	  37.3	  (CH2),	  41.5	  
(CH2),	  44.3	  (CH2),	  48.1	  (CH),	  169.5	  (CO	  acid),	  204.2	  (CO	  ketone);	  δC	  (101	  MHz,	  D2O)	  38.0	  (CH2),	  41.6	  
(CH2),	  44.1	  (CH2),	  48.6	  and	  48.9	  (CH),	  171.2	  (CO	  acid),	  207.8	  (CO	  ketone);	  [α]D25	  +20.2,	  c	  1.0,	  MeOH;	  
m/z	   (ES+)	   found:	   180.0429,	   C6H1135Cl2NO3	   requires	   (M−Cl)+	   180.0427;	   found	  C	   33.80%,	  H	   4.59%,	  N	  
6.14%,	  Cl	  31.67%,	  C6H11Cl2NO3	  requires	  C	  33.35%,	  H	  5.13%,	  N	  6.48%,	  Cl	  32.82%.	  
	  
These	  characterisation	  data	  are	   in	  accordance	  with	  the	   literature	  values.56-­‐57	   (See	  Chapter	  2.3,	  p60	  
for	   the	   reason	   why	   there	   are	   structural	   differences	   between	   this	   compound	   and	   the	   compound	  
reported	  in	  the	  literature.)	  
	  
	  














5.5	  Alternative	  Cyclisation	  Strategies	  
	  
2,2,2-­‐Trifluoro-­‐N-­‐[(2R)-­‐1-­‐{2-­‐[2-­‐(2-­‐hydroxyethoxy)ethyl]-­‐1,3-­‐dioxolan-­‐2-­‐yl}-­‐3-­‐methylbutan-­‐2-­‐




A	   non-­‐flame-­‐dried	   round	   bottomed	   flask	   under	   N2	   was	   charged	   with	   2,2,2-­‐trifluoro-­‐N-­‐[(3R)-­‐2-­‐
methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐yl]acetamide	  83b	   (0.089	   g,	   0.38	  mmol,	   1.0	   eq.)	   and	   TsOH·∙H2O	   (0.005	   g,	  
0.02	  mmol,	   6	  mol%)	  before	  being	   evacuated	   and	  purged	  with	  nitrogen	   five	   times.	   Ethylene	   glycol	  
(0.11	  mL,	   1.97	  mmol,	   5.3	   eq.)	   and	   CH(OMe)3	   (0.21	  mL,	   1.92	  mmol,	   5.1	   eq.)	  were	   added,	   and	   the	  
reaction	  was	  stirred	  at	  room	  temperature	  overnight.	  The	  reaction	  mixture	  was	  diluted	  with	  CH2Cl2	  (5	  
mL),	   and	  washed	  with	   sat.	   aq.	  NaHCO3	   (5	  mL)	   and	  brine	   (5	  mL).	   The	  organic	   layer	  was	  dried	  over	  
MgSO4,	  filtered	  and	  concentrated	  to	  give	  the	  crude	  product	  as	  a	  pale	  brown	  oil.	  The	  crude	  product	  
was	  purified	   chromatographically	  on	   three	   successive	   columns,	  using	  a	   gradient	  of	   0:100	   to	  100:0	  
EtOAc/heptane	  as	  the	  first	  solvent	  system,	  followed	  by	  a	  gradient	  of	  0:100	  to	  50:50	  EtOAc/heptane	  




yl]acetamide	  109	  was	  isolated	  as	  a	  brown	  oil	  (0.042	  g,	  32%):	  Rf	  0.5	  (50:50	  EtOAc/petroleum	  ether);	  
νmax(thin	  film)/cm−1	  3306,	  2964,	  2930,	  2881,	  1703,	  1206,	  1188,	  1156;	  δH	  (400	  MHz,	  CDCl3)	  0.91	  (6H,	  t,	  
J	  =	  7.1,	  2	  ×	  CH3),	  1.81–2.23	   (app.	  7H,	  m,	  CH(CH3)2,	  CH2CCH2	  and	  OH),	  3.51–3.64	   (4H,	  m,	  CH2OCH2),	  
3.72–3.78	  (2H,	  m,	  HOCH2),	  3.89–4.00	  (4H,	  m,	  OCH2CH2O),	  4.03–4.13	  (1H,	  m,	  NHCH),	  6.97	  (1H,	  d,	  J	  =	  
7.1,	  NH);	  δC	   (101	  MHz,	  CDCl3)	   17.8	   (CH3),	   18.0	   (CH3),	   31.9	   (CH(CH3)2),	   36.8	   (2	  ×	  CH2),	   51.5	   (NHCH),	  
61.7	   (CH2),	   64.5	   (CH2),	   64.9	   (CH2),	   66.9	   (CH2),	   72.0	   (CH2),	   109.9	   (quat.	  C),	   116.0	   (q,	   J	  =	  288.2,	  CF3),	  
156.8	   (q,	   J	   =	   36.4,	   CO	   amide);	   [α]D23	   0.0,	   c	   1.2,	   CHCl3;	  m/z	   (ES+)	   found:	   366.15042,	   C14H24NO5F3	  

















2,2,2-­‐Trifluoro-­‐N-­‐[(2R)-­‐1-­‐[2-­‐(2-­‐methoxyethyl)-­‐1,3-­‐dioxolan-­‐2-­‐yl]-­‐3-­‐methylbutan-­‐2-­‐yl]acetamide	   110	  
was	   isolated	   as	   a	   pale	   brown	   oil	   (0.027	   g,	   23%):	   Rf	   0.1	   (50:50	   EtOAc/petroleum	   ether);	   νmax(thin	  
film)/cm−1	  3308,	  2965,	  2928,	  2897,	  2879,	  1704,	  1557,	  1466,	  1391,	  1373,	  1205,	  1184,	  1159,	  1118;	  δH	  
(400	  MHz,	  CDCl3)	  0.88	   (3H,	  d,	   J	  =	  6.9,	  CH(CH3)(CH3)),	  0.92	   (3H,	  d,	   J	  =	  6.9,	  CH(CH3)(CH3)),	  1.79–1.96	  
(4H,	   m,	   CH2CCH2),	   1.98–2.10	   (1H,	   m,	   CH(CH3)2),	   3.35	   (3H,	   s,	   OCH3),	   3.45–3.55	   (2H,	   m,	   CH3OCH2),	  
3.89–3.99	   (4H,	  m,	   OCH2CH2O),	   4.00–4.08	   (1H,	  m,	   NHCH),	   7.17	   (1H,	   d,	   J	   =	   5.4,	   NH);	   δC	   (101	  MHz,	  
CDCl3)	   17.4	   (CH(CH3)(CH3)),	   18.1	   (CH(CH3)(CH3)),	   31.6	   (CH(CH3)2),	   36.1	   (CH2CCH2),	   36.9	   (CH2CCH2),	  
51.6	  (NHCH),	  58.6	  (OCH3),	  64.4	  (OCH2CH2O),	  64.8	  (OCH2CH2O),	  68.6	  (CH3OCH2),	  109.9	  (quat.	  C),	  116.1	  
(q,	   J	   =	   288.4,	   CF3),	   156.8	   (q,	   J	   =	   36.3,	   CO	   amide);	   [α]D23	   −11.4,	   c	   1.1,	   CHCl3;	   m/z	   (ES+)	   found:	  
314.15781,	  C13H22NO4F3	  requires	  MH+	  314.15837.	  
	  







2,2,2-­‐Trifluoro-­‐N-­‐[(3R)-­‐2-­‐methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐yl]acetamide	  83b	   (0.095	   g,	   0.40	  mmol,	   1.0	   eq.)	  
was	  dissolved	  in	  dry	  CH2Cl2	  (0.8	  mL)	  under	  N2	  in	  a	  non-­‐flame-­‐dried	  flask,	  and	  TsOH·∙H2O	  (0.008	  g,	  0.04	  
mmol,	  10	  mol%)	  was	  added.	  The	  resulting	  solution	  was	  stirred	  at	  room	  temperature	  for	  3	  d,	  before	  
being	   diluted	  with	   CH2Cl2	   (5	  mL)	   and	  washed	  with	   sat.	   aq.	   NaHCO3	   (5	  mL)	   and	   brine	   (5	  mL).	   The	  
organic	  layer	  was	  dried	  over	  MgSO4,	  filtered	  and	  concentrated	  to	  give	  the	  crude	  product	  as	  a	  brown	  
solid.	  The	  crude	  product	  was	  purified	  by	  column	  chromatography	  using	  a	  gradient	  of	  0:100	  to	  100:0	  
EtOAc/heptane	   as	   the	   solvent	   system.	   2,2,2-­‐Trifluoro-­‐N-­‐[(3R)-­‐2-­‐methyl-­‐7-­‐{[(5R)-­‐6-­‐methyl-­‐3-­‐oxo-­‐5-­‐
(trifluoroacetamido)heptyl]oxy}-­‐5-­‐oxoheptan-­‐3-­‐yl]acetamide	   111	   was	   isolated	   as	   a	   white	   solid	  
(0.060	   g,	   61%):	  m.p.	   145–150	   °C;	   Rf	   0.3	   (50:50	   EtOAc/petroleum	  ether);	   νmax(thin	   film)/cm−1	   3292,	  
2968,	  1703,	  1558,	  1383,	  1208,	  1183,	  1167;	  δH	  (400	  MHz,	  CDCl3)	  0.94	  (6H,	  d,	  J	  =	  6.7,	  CH3),	  0.95	  (6H,	  d,	  
J	  =	  6.7,	  CH3),	  1.92–2.06	  (2H,	  m,	  CH(CH3)2),	  2.64	  (4H,	  t,	  J	  =	  5.9,	  OCH2CH2),	  2.69	  (2H,	  dd,	  J	  =	  4.6,	  17.7,	  
NHCHCHH),	   2.88	   (2H,	   dd,	   J	  =	   5.9,	   17.7,	   NHCHCHH),	   3.67	   (4H,	   t,	   J	  =	   5.9,	   OCH2),	   3.96–4.06	   (2H,	  m,	  
NHCH),	   7.14	   (2H,	  d,	   J	  =	  8.6,	  NH);	  δC	   (101	  MHz,	  CDCl3)	   18.9	   (CH3),	   19.4	   (CH3),	   30.9	   (CH(CH3)2),	   43.1	  
(COCH2),	   43.6	   (COCH2),	   52.4	   (NHCH),	   65.9	   (OCH2),	   115.9	   (q,	   J	  =	   288.1,	   CF3),	   156.8	   (q,	   J	  =	   36.7,	   CO	  
amide),	   208.3	   (CO	   ketone);	   [α]D23	   −54.2,	   c	   1.0,	   CHCl3;	  m/z	   (ES+)	   found:	   493.21286,	   C20H30N2O5F6	  
requires	  MH+	  493.21317.	  

















2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐4-­‐oxohex-­‐5-­‐en-­‐2-­‐yl]acetamide	   84b	   (0.070	   g,	   0.34	   mmol,	   1.0	   eq.)	   was	  
dissolved	   in	   2:1	   MeOH/H2O	   (15	   mL).	   iPr2NEt	   (3.5	   mL,	   20.2	   mmol,	   60.2	   eq.)	   was	   added,	   and	   the	  
solution	   was	   stirred	   at	   room	   temperature	   overnight.	   The	   MeOH	   was	   removed	   under	   reduced	  
pressure,	  before	  a	  solution	  of	  (Boc)2O	  (0.096	  g,	  0.44	  mmol,	  1.3	  eq.)	  in	  THF	  (10	  mL)	  was	  added,	  and	  
the	   reaction	   was	   stirred	   at	   room	   temperature	   for	   a	   further	   24	   h.	   The	   THF	   was	   removed	   under	  
reduced	  pressure,	  and	  the	  aqueous	  solution	  was	  diluted	  with	  H2O	  (5	  mL)	  and	  extracted	  with	  EtOAc	  
(3	  ×	  10	  mL).	  The	  combined	  organic	  extracts	  were	  dried	  over	  MgSO4,	  filtered	  and	  concentrated	  under	  
reduced	   pressure	   to	   give	   the	   crude	   product	   as	   a	   yellow	   oil.	   The	   crude	   product	   was	   purified	   by	  
column	  chromatography	  using	  a	  gradient	  of	  0:100	   to	  40:60	  EtOAc/heptane	  as	   the	   solvent	   system.	  
2,2,2-­‐Trifluoro-­‐N-­‐[(2S)-­‐6-­‐methoxy-­‐4-­‐oxohexan-­‐2-­‐yl]acetamide	  130	  was	  isolated	  as	  a	  white	  oily	  solid	  
(0.033	  g,	  41%),	  which	   fully	  solidified	  upon	  standing:	  m.p.	  57–58	  °C;	  Rf	  0.3	   (50:50	  EtOAc/petroleum	  
ether);	  νmax(thin	  film)/cm−1	  3424,	  2985,	  2935,	  1704,	  1650,	  1644,	  1639,	  1561,	  1459,	  1376,	  1208,	  1188,	  
1158;	  δH	  (400	  MHz,	  CDCl3)	  1.31	  (3H,	  d,	  J	  =	  6.8,	  CHCH3),	  2.67	  (2H,	  app.	  t,	  J	  =	  6.0,	  OCH2CH2),	  2.73	  (1H,	  
dd,	   J	  =	  5.4,	  17.6,	  NHCHCHH),	  2.85	   (1H,	  dd,	   J	  =	  4.5,	  17.6,	  NHCHCHH),	  3.34	   (3H,	   s,	  OCH3),	  3.60–3.71	  
(2H,	  m,	  OCH2),	  4.29–4.42	  (1H,	  m,	  NHCH),	  7.31	  (1H,	  br.	  s,	  NH);	  δC	  (101	  MHz,	  CDCl3)	  19.4	  (CHCH3),	  42.9	  
(CH),	   43.6	   (COCH2),	   46.8	   (COCH2),	   58.9	   (OCH3),	   67.5	   (OCH2),	   115.8	   (q,	   J	  =	  287.8,	  CF3),	   156.4	   (q,	   J	  =	  
36.8,	   CO	   amide),	   208.6	   (CO	   ketone);	   [α]D23	   −48.0,	   c	   1.3,	   CHCl3;	   m/z	   (ES+)	   found:	   242.09987,	  

















2,2,2-­‐Trifluoro-­‐N-­‐[(3R)-­‐2-­‐methyl-­‐5-­‐oxohept-­‐6-­‐en-­‐3-­‐yl]acetamide	  83b	   (0.095	   g,	   0.40	  mmol,	   1.0	   eq.)	  
and	  DABCO	  (0.047	  g,	  0.42	  mmol,	  1.0	  eq.)	  were	  dissolved	   in	  DME	  (5	  mL)	   in	  a	  flame-­‐dried	  flask,	  and	  
the	   reaction	  was	   stirred	   at	   room	   temperature	   for	   3	   d.	   The	   reaction	  mixture	  was	   poured	   onto	   5%	  
AcOH	  (5	  mL)	  at	  0	  °C,	  before	  being	  extracted	  with	  EtOAc	  (10	  mL)	  and	  washed	  with	  H2O	  (10	  mL).	  The	  
organic	   layer	  was	  dried	  over	  Na2SO4,	   filtered	  and	   the	   solvent	   removed	  under	   reduced	  pressure	   to	  
yield	   the	   crude	   product	   as	   a	   light	   brown	   oil.	   The	   crude	   product	   was	   purified	   by	   column	  
chromatography	  using	  a	  gradient	  of	  10:90	  to	  50:50	  EtOAc/petroleum	  ether	  as	  the	  solvent	  system.	  N-­‐
[(3R,11R)-­‐2,12-­‐Dimethyl-­‐6-­‐methylidene-­‐5,9-­‐dioxo-­‐11-­‐(trifluoroacetamido)tridecan-­‐3-­‐yl]-­‐2,2,2-­‐
trifluoroacetamide	  122	  was	  isolated	  as	  a	  white	  solid	  (0.026	  g,	  27%):	  m.p.	  135–137	  °C;	  Rf	  0.5	  (50:50	  
EtOAc/petroleum	  ether);	  νmax(thin	  film)/cm−1	  3297,	  3105,	  2965,	  2924,	  2877,	  2854,	  1701,	  1677,	  1638,	  
1559,	  1474,	  1427,	  1416,	  1390,	  1372,	  1327,	  1303,	  1279,	  1261,	  1204,	  1180;	  δH	  (400	  MHz,	  CDCl3)	  0.90–
1.00	   (12H,	   m,	   4	   ×	   CH3),	   1.91–2.03	   (2H,	   m,	   2	   ×	   CH(CH3)2),	   2.47–2.68	   (5H,	   m,	   CH2=CCH2CH2	   and	  
NHCHCHH),	  2.83	  (1H,	  dd,	  J	  =	  5.8,	  17.5,	  NHCHCHH),	  2.90	  (1H,	  dd,	  J	  =	  4.4,	  16.9,	  NHCHCHH),	  3.12	  (1H,	  
dd,	  J	  =	  6.3,	  16.9,	  NHCHCHH),	  3.92–4.10	  (2H,	  m,	  2	  ×	  NHCH),	  5.92	  (1H,	  s,	  C=CHH),	  6.07	  (1H,	  s,	  C=CHH),	  
7.10	  (2H,	  app.	  t,	  J	  =	  8.9,	  2	  ×	  NH);	  δC	  (101	  MHz,	  CDCl3)	  18.9	  (CH3),	  18.9	  (CH3),	  19.5	  (CH3),	  19.5	  (CH3),	  
25.1	   (CH2=CCH2),	   30.9	   (CH(CH3)2),	   31.0	   (CH(CH3)2),	   38.0	   (COCH2),	   41.8	   (COCH2),	   42.8	   (COCH2),	   52.6	  
(NHCH),	  53.1	  (NHCH),	  115.9	  (app.	  d,	  J	  =	  288.5,	  2	  ×	  CF3),	  126.9	  (CH2=C),	  147.0	  (CH2=C),	  156.8	  (app.	  d,	  J	  
=	  37.0,	  CO	  amide),	  156.9	  (app.	  d,	  J	  =	  36.8,	  CO	  amide),	  200.1	  (CO	  enone),	  208.7	  (CO	  ketone);	   [α]D23	  
−54.0,	  c	  0.5,	  CHCl3;	  m/z	  (ES+)	  found:	  475.2033,	  C20H28N2O4F6	  requires	  MH+	  475.2032.	  
	  



















Methyl	   (2S)-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐4-­‐oxohex-­‐5-­‐enoate	  59d	   (0.232	   g,	   0.79	   mmol,	   1.0	   eq.)	  
and	  TsOH·∙H2O	  (0.010	  g,	  0.05	  mmol,	  7	  mol%)	  were	  dissolved	  in	  ethylene	  glycol	  (0.22	  mL,	  3.94	  mmol,	  
5.0	  eq.)	  and	  CH(OMe)3	  (0.43	  mL,	  3.93	  mmol,	  4.9	  eq.).	  The	  reaction	  was	  stirred	  at	  room	  temperature	  
for	   5	   h,	   before	   being	   diluted	  with	   CH2Cl2	   (5	  mL)	   and	   stirred	   at	   room	   temperature	   overnight.	   The	  
solution	   was	   further	   diluted	   with	   CH2Cl2	   (5	   mL)	   and	   washed	   with	   sat.	   aq.	   NaHCO3	   (10	   mL).	   The	  
aqueous	  layer	  was	  re-­‐extracted	  with	  CH2Cl2	  (10	  mL)	  and	  EtOAc	  (10	  mL)	  due	  to	  formation	  of	  a	  gel.	  The	  
combined	   organic	   extracts	   were	   dried	   over	   Na2SO4,	   filtered	   and	   the	   solvent	   was	   removed	   under	  
reduced	  pressure	   to	  give	   the	   crude	  product,	  which	  was	  purified	  by	   column	  chromatography	  using	  
50:50	  EtOAc/petroleum	  ether	  as	  the	  solvent	  system.	  Methyl	  (2S)-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐3-­‐
[2-­‐(2-­‐methoxyethyl)-­‐1,3-­‐dioxolan-­‐2-­‐yl]propanoate	   114	   was	   isolated	   as	   a	   colourless	   oil	   (0.051	   g,	  
18%):	   Rf	   0.3	   (50:50	   EtOAc/petroleum	   ether);	   νmax(ATR)/cm−1	   3422,	   2952,	   2893,	   1718,	   1501,	   1454,	  
1437,	  1347,	  1205,	  1175,	  1111,	  1047;	  δH	  (400	  MHz,	  CDCl3)	  1.89	  (2H,	  t,	  J	  =	  6.5,	  CH3OCH2CH2),	  2.24	  (1H,	  
dd,	  J	  =	  6.8,	  15.1,	  NHCHCHH),	  2.30	  (1H,	  dd,	  J	  =	  4.6,	  15.1	  NHCHCHH),	  3.33	  (3H,	  s,	  CH2OCH3),	  3.45	  (2H,	  t,	  
J	  =	  6.5,	  CH3OCH2),	  3.74	  (3H,	  s,	  CO2CH3),	  3.86–4.05	  (4H,	  m,	  OCH2CH2O),	  4.40–4.50	  (1H,	  m,	  NHCH),	  5.10	  
(1H,	  d,	  J	  =	  12.3,	  PhCHH),	  5.16	  (1H,	  d,	  J	  =	  12.3,	  PhCHH),	  6.05	  (1H,	  d,	  J	  =	  7.4,	  NH),	  7.29–7.45	  (5H,	  m,	  Ar	  
H);	  δC	   (101	  MHz,	  CDCl3)	  37.2	  (CH2CCH2),	  37.8	  (CH2CCH2),	  50.7	  (CO2CH3	  or	  CH),	  52.2	  (CO2CH3	  or	  CH),	  
58.7	   (CH2OCH3),	  64.4	   (OCH2CH2O),	  64.8	   (OCH2CH2O),	  66.8	   (CH2Ph),	  68.2	   (CH3OCH2),	  109.9	   (quat.	  C),	  
128.1	   (Ar	   CH),	   128.1	   (Ar	   CH),	   128.5	   (Ar	   CH),	   136.5	   (Ar	   quat.	   C),	   156.0	   (CO	   carbamate),	   172.7	   (CO	  
ester);	  [α]D23	  +5.1,	  c	  1.6,	  CHCl3;	  m/z	  (ES+)	  found:	  368.1708,	  C18H25NO7	  requires	  MH+	  368.1709.	  














Methyl	  (2S,6R)-­‐4-­‐oxo-­‐6-­‐phenylpiperidine-­‐2-­‐carboxylate	  (10a)	  
	  
	  
Methyl	   (2S,5E)-­‐2-­‐{[(tert-­‐butoxy)carbonyl]amino}-­‐4-­‐oxo-­‐6-­‐phenylhex-­‐5-­‐enoate	   128	   (0.190	   g,	   0.57	  
mmol,	  1.0	  eq.)	  was	  dissolved	  in	  CH2Cl2	  (6	  mL)	  and	  CF3CO2H	  (0.42	  mL,	  5.5	  mmol,	  9.6	  eq.)	  was	  added.	  
The	   reaction	  was	   stirred	  at	   room	   temperature	   for	   1.5	  h	  before	  being	   concentrated	  by	  blowing	  N2	  
over	  the	  reaction	  for	  ~1	  h.	  The	  residue	  was	  placed	  under	  vacuum	  for	  15	  min,	  before	  being	  dissolved	  
in	   2:1	  MeOH/H2O	   (30	  mL).	   iPr2NEt	   (0.5	  mL,	   2.87	  mmol,	   5.0	   eq.)	  was	   added	   and	   the	   reaction	  was	  
stirred	   at	   room	   temperature	  overnight.	   The	   reaction	  was	  partitioned	  between	  EtOAc	   (40	  mL)	   and	  
brine	   (40	   mL),	   and	   the	   aqueous	   layer	   was	   extracted	   with	   EtOAc	   (40	   mL).	   The	   combined	   organic	  
extracts	  were	  dried	  over	  MgSO4,	  filtered	  and	  concentrated	  under	  reduced	  pressure	  to	  give	  the	  crude	  
product	   as	   a	   mixture	   of	   a	   white	   solid	   and	   a	   light	   brown	   oil.	   The	   crude	   product	   was	   purified	   by	  
column	  chromatography	  using	  a	  gradient	  of	  1:10:90	  to	  1:30:70	  Et3N/EtOAc/petroleum	  ether	  as	  the	  
solvent	   system.	  Methyl	   (2S,6R)-­‐4-­‐oxo-­‐6-­‐phenylpiperidine-­‐2-­‐carboxylate	  10a	  was	   isolated	   as	   a	   pale	  
yellow	  solid	  (0.011	  g,	  8%):	  m.p.	  112–116	  °C;	  Rf	  0.2	  (10	  mL	  of	  30:70	  EtOAc/petroleum	  ether	  +	  3	  drops	  
Et3N);	  δH	  (400	  MHz,	  CDCl3)	  2.51–2.68	  (4H,	  m,	  H3a,	  H3e,	  H5a	  and	  NH),	  2.78–2.86	  (1H,	  m,	  H5e),	  3.76–3.84	  
(4H,	  m,	  CH3	  and	  H6),	  3.94–4.00	  (1H,	  m,	  H2),	  7.32–7.46	  (5H,	  m,	  Ar	  H);	  δC	  (101	  MHz,	  CDCl3)	  43.9	  (CH2),	  
50.1	   (CH2),	   52.5	   (CH3),	   57.9	   (CH),	  60.2	   (CH),	  126.6	   (Ar	  CH),	  128.2	   (Ar	  CH),	  128.9	   (Ar	  CH),	  141.7	   (Ar	  
quat.	  C),	  171.4	  (CO	  ester),	  206.5	  (CO	  ketone);	  [α]D23	  +53.5,	  c	  0.4,	  CHCl3	  (lit.	  +43.9,	  c	  0.9,	  CHCl3).12	  
	  
These	  characterisation	  data	  are	  in	  accordance	  with	  the	  literature	  values.12	  
	  
	  



















1-­‐tert-­‐Butyl	  2-­‐methyl	  (2S)-­‐4-­‐oxopiperidine-­‐1,2-­‐dicarboxylate	  (91a)	  
	  
	  
Methyl	  (2S)-­‐2-­‐(tert-­‐butoxycarbonylamino)-­‐4-­‐oxohex-­‐5-­‐enoate	  59c	  (0.129	  g,	  0.50	  mmol,	  1.0	  eq.)	  was	  
dissolved	   in	   formic	   acid	   (5	   mL,	   132.5	   mmol,	   264.5	   eq.)	   under	   argon	   in	   a	   flame-­‐dried	   flask.	   The	  
reaction	  was	  stirred	  for	  6.25	  h	  at	  room	  temperature,	  before	  the	  solvent	  was	  removed	  by	  blowing	  air	  
over	  the	  reaction	  overnight.	  The	  resulting	  material	  was	  dissolved	  in	  methanol	  (50	  mL)	  and	  potassium	  
carbonate	  (0.358	  g,	  2.59	  mmol,	  5.2	  equiv.)	  was	  added.	  The	  reaction	  was	  stirred	  at	  room	  temperature	  
for	   6	   h,	   before	   the	   solvent	   was	   removed	   and	   the	   remaining	   material	   was	   re-­‐dissolved	   in	   4:1	  
CH2Cl2/MeOH	  (25	  mL).	   (Boc)2O	   (0.171	  g,	  0.79	  mmol,	  1.6	  eq.)	  and	   iPr2NEt	   (0.17	  mL,	  0.98	  mmol,	  2.0	  
eq.)	   were	   added,	   and	   the	   reaction	   was	   stirred	   at	   room	   temperature	   for	   5	   d.	   The	   solvent	   was	  
removed	  the	  crude	  reaction	  mixture	  was	  dissolved	  in	  2:1	  Et2O/CH2Cl2	  (30	  mL)	  and	  was	  washed	  with	  1	  
M	  HCl	  (30	  mL).	  Brine	  was	  added	  to	  aid	  the	  difficult	  separation.	  The	  aqueous	  layer	  was	  re-­‐extracted	  
with	  2:1	   Et2O/CH2Cl2	   (30	  mL),	   and	   the	   combined	  organic	   extracts	  were	  dried	  over	  Na2SO4,	   filtered	  
and	  concentrated	  under	  reduced	  pressure	  to	  yield	  the	  crude	  product	  as	  a	  brown	   liquid.	  The	  crude	  
product	   was	   purified	   by	   column	   chromatography	   using	   a	   gradient	   of	   0:100	   to	   30:70	  
EtOAc/petroleum	   ether	   as	   the	   solvent	   system.	   1-­‐tert-­‐Butyl	   2-­‐methyl	   (2S)-­‐4-­‐oxopiperidine-­‐1,2-­‐
dicarboxylate	   91a	   was	   isolated	   as	   a	   white	   solid	   (0.016	   g,	   12%):	   Rf	   0.2	   (30:70	   EtOAc/petroleum	  
ether);	  νmax(ATR)/cm−1	  2976,	  1734,	  1695,	  1393,	  1366,	  1318,	  1249,	  1202,	  1159;	  δH	  (500	  MHz,	  CDCl3)	  
1.45	   (9H,	  br.	   s,	  C(CH3)3),	  2.41–2.60	   (2H,	  m,	  H5a	  and	  H5e),	  2.69–2.88	   (2H,	  m,	  H3a	  and	  H3e),	  3.54–3.70	  
(1H,	  m,	  H6a),	  3.73	  (3H,	  s,	  CO2CH3),	  4.00–4.10	  (1H,	  m,	  H6e),	  4.87	  and	  5.15	  (1H,	  2	  ×	  br.	  s,	  H2);	  δC	   (126	  
MHz,	  CDCl3)	  28.2	  (C(CH3)3),	  39.3	  and	  40.5	  (C3,	  C5	  or	  C6),	  39.7	  (C3,	  C5	  or	  C6),	  41.0	  and	  41.2	  (C3,	  C5	  or	  C6),	  
52.6	  (CO2CH3	  or	  C2),	  53.9	  and	  54.7	  (CO2CH3	  or	  C2),	  81.2	  (C(CH3)3),	  154.3	  and	  154.8	  (CO	  carbamate),	  
171.5	  and	  171.7	  (CO	  ester),	  205.8	  (CO	  ketone);	  [α]D24	  −16.0,	  c	  1.5,	  CHCl3;	  m/z	  (ES+)	  found:	  280.1152,	  
C12H19NO5	  requires	  MNa+	  280.1161.	  
	  




















5.6	  Deprotection	  of	  Cyclised	  Product	  
	  
(2S)-­‐2-­‐(Methoxycarbonyl)-­‐4-­‐oxopiperidin-­‐1-­‐ium	  chloride	  (94b)	  
	  
	  
1-­‐tert-­‐Butyl	  2-­‐methyl	   (2S)-­‐4-­‐oxopiperidine-­‐1,2-­‐dicarboxylate	  91a	   (0.039	  g,	  0.15	  mmol,	  1.0	  eq.)	  was	  
dissolved	  in	  1	  M	  hydrogen	  chloride	  in	  diethyl	  ether	  (1.5	  mL,	  1.5	  mmol,	  10.0	  eq.)	  and	  stirred	  at	  room	  
temperature	   for	   17	   d.	   The	   solvent	   was	   removed	   under	   reduced	   pressure	   to	   yield	   (2S)-­‐2-­‐
(methoxycarbonyl)-­‐4-­‐oxopiperidin-­‐1-­‐ium	   chloride	  94b	   as	   a	   colourless	   solid	   (0.031	   g,	   quantitative).	  
Upon	   dissolution	   in	  MeOH-­‐d4	   the	   product	  was	   converted	   into	   its	   hemi-­‐acetal	  94b·∙CD3OD,	   which	  
was	  isolated	  as	  a	  colourless	  oil	  after	  removal	  of	  the	  solvent.	  After	  repeated	  removal	  of	  the	  solvent	  
and	  re-­‐dissolution	  of	   the	  compound	   in	  D2O	   it	  was	  converted	   into	   its	  hydrate	  94b·∙D2O,	  which	  was	  
isolated	  as	  a	  brown	  oil	  after	  removal	  of	  the	  solvent.	  
	  
(2S)-­‐4-­‐(2H3)Methoxy-­‐2-­‐(methoxycarbonyl)-­‐4-­‐[(2H)oxy]piperidin-­‐1-­‐ium	   chloride	   94b·∙CD3OD:	   δH	   (400	  
MHz,	  CD3OD)	  1.71–2.00	  (2H,	  m,	  H5a	  and	  H5e),	  2.02–2.29	  (1H,	  m,	  H3a),	  2.37–2.61	  (1H,	  m,	  H3e),	  3.04–
3.18	  (1H,	  m,	  H6a),	  3.39–3.53	  (1H,	  m,	  H6e),	  3.88	  (3H,	  s,	  CH3),	  4.16	  (1H,	  d,	   J	  =	  10.0,	  H2);	  δC	   (101	  MHz,	  
CD3OD)	  28.6	  (C5),	  32.4	  (C3),	  40.8	  (C6),	  52.6	  (C2	  or	  CH3),	  54.5	  (C2	  or	  CH3),	  96.2	  (C4),	  168.3	  (CO	  ester);	  
m/z	  (ES+)	  found:	  193.1265,	  C8H13D3NO4Cl	  (94b·∙CD3OH)	  requires	  (M−Cl)+	  193.1268.	  
	  
(2S)-­‐2-­‐(Methoxycarbonyl)-­‐4,4-­‐bis[(2H)oxy]piperidin-­‐1-­‐ium	   chloride	   94b·∙D2O:	   νmax(ATR)/cm−1	   3320,	  
2958,	   2737,	   2484,	   1737,	   1627,	   1437,	   1360,	   1275,	   1219,	   1155,	   1097;	  δH	   (500	  MHz,	  D2O)	  1.82–1.90	  
(1H,	  m,	  H5a),	  1.90–1.99	  (1H,	  m,	  H5e),	  2.02	  (1H,	  dd,	  J	  =	  11.0,	  14.3,	  H3a),	  2.31	  (1H,	  ddd,	  J	  =	  2.3,	  3.9,	  14.3,	  
H3e),	  3.13–3.21	  (1H,	  m,	  H6a),	  3.43	  (1H,	  dt,	  J	  =	  13.1,	  4.6,	  H6e),	  3.75	  (3H,	  s,	  CH3),	  4.20	  (1H,	  dd,	  J	  =	  3.9,	  
11.0,	  H2);	  δC	  (101	  MHz,	  D2O)	  33.5	  (C5),	  36.8	  (C3),	  40.9	  (C6),	  53.7	  (C2	  or	  CH3),	  54.6	  (C2	  or	  CH3),	  90.4	  (C4),	  
169.3	  (CO	  ester);	  [α]D24	  +5.9,	  c	  0.5,	  H2O;	  m/z	  (ES+)	  found:	  176.0917,	  C7H14NO4Cl	  (94b·∙H2O)	  requires	  
(M−Cl)+	  176.0923.	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